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Preface 
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spend 9 months in Dr. Sue Ozannes lab at Institute of Metabolic Science, University of Cambridge, 
UK.  The research was funded by Centre for Fetal programming, Centre for Biological Sequence 
Analysis DTU, Master of Engineering Frants Allings foundation, Otto Mønsted foundation, Aase 
and Ejnar Danielsen’s foundation and Reinholdt W. Jorck and wife’s foundation. 
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Abstract 
The number of obese women in the childbearing age is drastically increasing globally. As a 
consequence, more children are born by obese mothers. Unfortunately, maternal obesity and/ or 
high fat intake during pregnancy increase the risk of developing obesity, type-2 diabetes, cardio-
vascular disease and non-alcoholic fatty liver disease in the children, which passes obesity and 
metabolic dysfunction on from generation to generation. Several studies try to elucidate causative 
effects of maternal metabolic markers on the metabolic imprinting in the children; however diet-
induced obesity is also associated with chronic low grade inflammation. Nobody have yet 
investigated the role of this inflammatory phenotype, but here we demonstrate that obesity 
induced inflammation is reversed during pregnancy in mice, and is therefore less likely to affect 
the fetal programming of metabolic dysfunction. Instead, we suggest that an early elevated lipid 
exposure caused by a maternal high fat feeding might be more important for long term metabolic 
imprinting in the offspring. Therefore, we study the effect of maternal high fat/high sucrose diet 
during gestation, lactation or both to elucidate if perinatal adaptations to a high fat/high sucrose 
diet makes the offspring more capable of dealing with a high fat diet later in life. We demonstrate 
that a dietary mismatch between pre- and post-natal life alters the phenotype in an obese prone 
rat model at weaning. Thus, exposure to a control diet in utero and a high fat/high sucrose diet 
during lactation cause more severe phenotypic alteration in the offspring at weaning than pups 
exposed to the high fat/high sucrose diet both in utero and during lactation. The same pattern is 
seen in the adult offspring after being challenged with a high fat diet for 6 weeks. However HFHS 
exposure during fetal life protected against hyperleptinemia in the adult offspring during the 
challenge. Additionally, offspring expose to high fat/high sucrose diet during lactation displayed a 
decrease level of inflammatory genes in the blood, which could indicated that perinatal HFHS 
exposure protect against the detrimental effects of high fat feeding leading to metabolic disease. 
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Resumé 
Antallet af overvægtige kvinder i den fødedygtige alder er drastisk stigende på globalt plan. Som 
følge heraf fødes flere børn af overvægtige mødre. Desværre, vil moderens forøgede indtag af fedt 
og sukker under graviditeten øget barnets risiko for at udvikle fedme, type 2-diabetes, hjerte-kar 
sygdomme og ikke-alkoholisk fedtlever, hvilket fører fedme og metabolisk dysfunktion videre fra 
generation til generation. Adskillige studier forsøger at belyse årsagen til at moderens metaboliske 
markører fører til metabolisk prægning i børnene; men, kost-induceret fedme er også forbundet 
med en kronisk lav inflammation. Ingen har endnu undersøgt rollen af denne inflammatoriske 
fænotype, men her viser vi, at fedme-induceret inflammation mindskes under graviditet i mus og 
derfor er mindre tilbøjelig til at påvirke den føtale programmering af metabolisk dysfunktion. I 
stedet antyder vi, at en tidlig forhøjet fedt-eksponering, forårsaget af moderens fedt-indtag, kan 
være vigtigere for langsigtet metabolisk prægning hos afkommet. Derfor undersøger vi effekten af 
et højt fedt og sukker indtag hos moderen under graviditet, diegivning eller begge, for at 
undersøge om perinatal tilpasninger til et højt fedt og sukker indtag gør afkommet bedre i stand til 
at håndtere en fedt-rig kost senere i livet. Vi påviser, at et misforhold mellem præ- og postnatal 
miljø ændrer fænotypen i en rottemodel, der er tilbøjelig til at udvikle fedme, ved fravænning. 
Således vil en eksponering for et kontrol kost i fosterlivet, men en kost rig på fedt og sukker under 
diegivning, forårsage mere alvorlige fænotypisk ændringer i afkommet ved fravænning, end unger 
udsat for forhøjet fedt og sukker i både fosterlivet og under diegivning. Det samme mønster ses i 
de voksne unger efter at være eksponeret for en fedt-rig kost i 6 uger. Dog beskytter 
eksponeringen af fedt og sukker i fosterlivet mod forhøjet leptin niveauer i de voksne unger, når 
de bliver fodret med en fedtholdig kost. Yderligere, unger der har diet ved en mor med højt fedt 
og sukker indtag viser et fald i udtryk af inflammatoriske gener i blodet, hvilket kan indikerede, at 
perinatal fedt og sukker eksponering beskytte mod de skadelige virkninger af en fedt-rig kost, der 
kan føre til metaboliske sygdomme.  
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“Nothing in biology makes sense except in the light of evolution” 
-Theodosius Dobzhansky, 1973 
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1. Introduction 
In nature, obesity occurs in Svalbard reindeers, seals and polar bears, which makes them capable 
of dealing with their harsh cold habitat1. Thus, for these animals, obesity is a survival strategy. In 
the human populations, however, obesity leads to metabolic dysfunction and diseases, which 
eventually shortens lifespan. Today, 65% of the world’s population lives in countries where 
overnutrition kills more people than undernutrition2 making obesity the biggest threat to human 
health.  Many initiatives have been made to elucidate the underlying mechanisms behind this 
global obesity epidemic. In the late 80’s, the first studies emerged that suggested that obesity and 
impaired metabolic function had origin in fetal development3. Since then, growing evidence has 
demonstrated that maternal overnutrition increases the risk of obesity and the metabolic 
syndrome in the offspring in adulthood4. Metabolic dysfunction is associated with a chronic low-
grade inflammatory phenotype5, but to our knowledge nobody has yet explored the role of 
obesity-induced inflammation in fetal programming of metabolic syndrome.   
 
The aims of this thesis were: 
1. To investigate how maternal obesity-induced inflammation is affected by pregnancy in 
mice.  
2. To investigate if maternal high fat/high sucrose (HFHS) diet during perinatal life affects the 
offspring’s metabolic and inflammatory phenotype in a rat model at weaning 
3. To investigate if maternal high fat/high sucrose (HFHS) diet during perinatal life affects the 
offspring’s metabolic flexibility in a rat model when challenged with a high fat diet in 
adulthood.  
 
The first part of this thesis focuses on the maternal phenotype and consists of a review (Chapter 2) 
and mouse study (Chapter 3). In the review, we surveyed the literature to set up a hypothesis 
regarding the role of maternal obesity-induced inflammation in fetal programming of the 
metabolic syndrome. In the mouse study, we investigated the effect of pregnancy on maternal 
obesity-induced inflammation in an established mouse model fetal programming.  
The second part of this thesis focuses on the offspring’s phenotype and consists of two studies 
performed in a rat model of maternal high fat/high sucrose feeding (Chapter 4-6). In the first 
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study, we explored the effect of maternal HFHS intake during gestation and/or lactation on the 
metabolic (Chapter 4) and inflammatory phenotype (first part of Chapter 6) in the young offspring 
terminated at weaning. In the second study, we investigated how the offspring’s metabolism 
(Chapter 5) and immune system (second part of chapter 6) coped with a high fat dietary challenge 
in adulthood after exposure to a maternal HFHS diet during gestation and/or lactation.  
 
Obesity and the metabolic syndrome 
Obesity has become a pandemic of the 21st century. Obesity and the development of the 
metabolic syndrome has been a heath concern in the western world for decades (Figure 1). Today 
the world is also experiencing a rise in the prevalence of obesity in developing countries. On a 
global scale, 1.4 billion people were overweight (BMI>25) in 2008, of those 500 million were 
considered obese (BMI>30)2. It is self-evident, that these numbers are alarming, but of more 
concern is the rise in obesity among children under the age of 5, especially in the developing world 
with 30 million overweight children2. Childhood obesity is a risk factor for development of the 
metabolic syndrome already before the onset of puberty6,7. The metabolic syndrome is defined as 
a cluster of symptoms; central obesity, hypertension, dyslipidemia (elevated triacylglyceride, TAG, 
and reduced high density lipoprotein (HDL)-cholesterol) and hyperglycemia, (Figure 2) which 
increase the risk of developing type 2 diabetes and cardiovascular disease (CVD)8. In clinic, 
metabolic syndrome is diagnosed when 3 out of the 5 criteria are present. Interestingly, waist 
circumference ratio is population- and country-specific, and it is speculated that genetic variations 
among ethnic groups might explain why Asian people tend to have an increased risk of diabetes at 
a lower BMI compared to Caucasians7,9. Currently, theories are being investigated, to elucidate the 
etiology of the obesity pandemic. In 1988, Barker and Osmond published a study that showed an 
inverse relationship between birth weight and hypertension later in life3. In 1992, Hales are Barker 
proposed a hypothesis, which suggested that early malnutrition could have long-term 
consequences and be linked to obesity and metabolic dysfunction in adulthood10,11.  
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Figure 1. Obesity tendency among adults in the US. Obesity has become a pandemic in the 21
st
 century, no longer 
only affecting the western world but also to a large extend the developing countries. The colour code indicates the 
percentage of the population that have a BMI > 30. From Centers for Disease Control and Prevention
12
 
 
 
Figure 2. Cut-off values for the five symptoms which constitutes the metabolic syndrome
8
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Metabolic syndrome   
The presence of 3 out of the following 5 symptoms would diagnose a patient with metabolic 
syndrome 
1. Elevated waist circumference (population- and country-specific definition) * 
2. Elevated triglycerides (≥150 mg/dl or ≥ 1.7 mM) 
3. Reduced HDL-cholesterol (<40 mg/dL or < 1.0 mM for men, <50 mg/dL  or 1.3 mM 
for women) 
4. Elevated blood pressure (Systolic ≥130 mm Hg and/or diastolic ≥85 mm Hg) 
5. Elevated fasting glucose (≥100 mg/dL or 5.6 mM) 
 
* The values for Europeans are ≥94cm for men, ≥80cm for women   
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Fetal programming of metabolic syndrome 
Fetal programming is define as a maternal stimuli or insult during a critical time of development 
(gestation or early life), which permanently affects the offspring’s physiology, structure or 
metabolism13. The initial research within fetal programming evolved around maternal 
undernutrition and protein restriction during pregnancy and many of the hypotheses regarding 
programming of metabolic dysfunction focus on maternal undernutrition. Recently, malnutrition 
due to overnutrition has been investigated as a maternal insult. To understand the framework of 
fetal programming research, an introduction to one of the first epidemiological studies involving 
maternal undernutrition and the hypothesises that arose is relevant. 
The historical background 
Famine in the Netherlands was a tragic consequence of World War 2, but it lead to a unique 
cohort of individuals that were exposed to undernutrition during pregnancy14. Children born 
during and after the Dutch famine demonstrated that uterine undernutrition lead to an increased 
prevalence of obesity, hypertension, CVD, impaired glucose tolerance and dyslipidemia14. 
Additionally, it was noticed that the different symptoms were linked to specific developmental 
stages, so that famine exposure in either the first or second trimester resolved in different 
metabolic phenotypes in the children15. In 1992, Hales and Barker explained these results by “the 
thrifty phenotype hypothesis” which suggested that poor nutrition during perinatal life has a 
detrimental effect on the offspring, leading to a higher risk of type 2 diabetes16 and the metabolic 
syndrome17.  In the wake of the thrifty phenotype hypothesis, Gluckman and Hanson hypothesised 
that a foetus is capable of “sensing” the environment surrounding the mother, and based on the 
maternal stimuli, predicts the post-natal environment. The foetus can then adapt its metabolism 
and physiology to ensure survival after birth (“predictive adaptive response”)18. E.g. if the offspring 
is exposed to undernutrition during fetal life, it can adapt a metabolic set point that is more 
suitable for a post-natal life with limited food availability to ensure survival19. Developmental 
plasticity has probably been an excellent strategy for survival in mammals through changing 
environments, but it has been suggested that metabolic disease might have arose due to a 
mismatch between the predicted environment and the actual post-natal life18,19.   
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Figure 3: The predictive adaptive response hypothesis.  The hypothesis states that a foetus is capable of adapting its 
metabolism, physiology or structure to ensure survival, by predicting the post-natal environment based on maternal 
stimuli during pregnancy. From Gluckman et al. 2007
19
 
Maternal obesity 
There is a clear inverse association between birth weight and the risk of developing obesity and 
the metabolic syndrome. However, the curve is not linear, it is U shaped, demonstrating that 
children born either small or large for gestational age have increased risk of metabolic 
dysfunction20. Elevated birth weight and exposure to maternal obesity during fetal life are equally 
strong predictors of the metabolic syndrome6 and several epidemiological studies have linked 
maternal obesity to an increased risk of obesity in the children21-23. In light of the increasing 
prevalence of obesity among women of childbearing age24, it is important to elucidate the 
mechanisms behind metabolic dysfunction in children exposed to maternal overnutrition to avoid 
further acceleration of the obesity pandemic. The effect of maternal obesity and high fat feeding 
on the metabolic imprinting of the offspring has been studied in-depth in various animal models. A 
brief overview of the various metabolic outcomes in the offspring is listed in table 1. Studies with 
relevance to results reported in this thesis are described in greater detail in the following chapters.   
Prenatal Postnatal
Deprived
Adequate
Fertilized 
egg
Match 
(healthy)
Match
(healthy)
Mismatch
(enhanced risk of 
metabolic dysfunction)
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Table 1. The effect of maternal obesity or high fat diets on the offspring’s risk of developing 
obesity and metabolic dysfunction 
Maternal  
phenotype 
Model Outcomes in the offspring 
Obesity Mouse hyperphagia25, ↑body  weight25-27, ↑adiposity25,27, ↑plasma leptin25,26,  
↑plasma insulin25,26, ↑blood glucose25, ↑plasma TAG25,  
impaired glucose homeostasis25, hypertension25, hepatic lipid 
accumulation26,27, hepatic inflammation and fibrosis26,27, reduced 
pancreatic beta-cell function28 
   
 Rat hyperphagia29, ↑body  weight 29-31, ↑adiposity29,30,32, ↑plasma 
leptin29,33,  
↑plasma insulin31,33, ↑blood glucose30,31, ↑plasma TAG30,31, ↑plasma 
FFA 29-31, Impaired glucose homeostasis29,30, hypertension32 
   
 Sheep ↑adiposity34, Impaired glucose homeostasis34,  
reduced pancreatic beta-cell number and function35 
   
High fat 
diets 
Mouse ↑body weight36, dyslipidemia36, hepatic lipid accumulation36,  
impaired glucose homeostasis36 
   
 Rat ↑body  weight37,38, ↑adiposity37,39,40, ↑plasma leptin37,38, ↑plasma 
insulin37,40, ↑blood glucose37, ↑plasma TAG, Impaired glucose 
homeostasis37,  
hepatic lipid accumulation39,40, hepatic inflammation38 
   
 Non-human 
primate 
↑adiposity41,42, hepatic lipid accumulation41 
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Since fetal imprinting persists into adulthood, it is speculated that “malprogramming” is linked to 
the genome. However, the fast development of the obesity epidemic suggests that the answer is 
not found within normal evolutionary adaptation. Instead it has been hypothesized that 
programming of metabolic dysfunction is linked to the epigenome, which fine tunes gene 
expression to a continuously changing environment without altering the underlying DNA 
sequence43.  
Epigenetics 
Epigenetic means “outside conventional genetics” and therefore covers the alterations in gene 
expression, which cannot be explained by the DNA sequence44. Monozygotic twins are two 
individuals that share the same genotype but have different phenotypes, as a result of different 
epigenomes45. The phenotypes in monozygotic twins are similar when they are young but 
differences start to accumulate as the twins grow older, since the epigenome is altered over the 
years46. The epigenome can adapt to environmental changes by modifying gene expression to 
optimize survival rate43,47, but the epigenetic pattern that is established during early development 
might be more stable than the alterations we accumulate after birth43. 
Mammalian epigenetics cover a range of modifications that can alter the structure of the DNA 
molecule without altering the sequence. DNA methylation and histone modifications have been 
the primary focus of research , but now studies on non-coding RNAs, like microRNAs, are 
emerging48 (Figure 4). Normally, DNA methylation occurs on a cytosine within a CpG dinucleotide 
(cytosine followed by a guanine in the DNA sequence), but a few studies have reported 
methylation outside CpG’s in embryonic stem cells49. The primary function of DNA methylation 
within promoter regions is gene silencing, and the degree of methylation often correlates with 
gene expression45. Hypermethylation blocks the DNA strand, which prevents the anchoring of DNA 
binding protein that initiates gene transcription44,45. Methylation patterns are also found in the 
introns and exons of genes, but the reasons for this are unclear, it might enhance rather than 
silence gene expression43. DNA is organized into nucleosomes and chromatins by wrapping around 
a histone complex. Modifications of the histones happen at the histone tails, and until now 
actylation of the lysine residue have been the primary focus. Modification of the histone tails 
alters the DNA availability; e.g. when the lysine residue is acetylated, the DNA is unwrapped from 
the histone complex and is therefore available for protein binding and transcription of the gene. 
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DNA methylation and histone modifications enhance or prevent gene expression by altering the 
transcription of the mRNA in the cell (transcriptional level). MicroRNA regulates gene expression 
differently than DNA methylation and histone modifications, via hybridizing to the complementary 
mRNA from a target gene which prevents translation into protein (translational level). 
 
 
Figure 4. Epigenetic regulation of gene expression. Epigenetic regulation alters the accessibility of the genes by 
modulating the DNA structure without changing the sequence. DNA methylation and modification of the histone 
complex are currently the most studied, but studies of noncoding RNA’s are emerging. From Milagro et al. 2013
48
 
 
Epigenetics, and in particular DNA methylation, play a central role in cell and tissue differentiation 
during fetal development and explains why all the different cells and tissues in an organism 
contain only one genotype, but innumerable phenotypes45. Within hours of fertilization DNA is 
stripped for methylations to make the fertilized egg pluripotent. Shortly after the implantation and 
throughout fetal development, the DNA is re-methylated giving rise to a variety of tissues and cell 
types.  A major part of the tissue-specific epigenome, which is established throughout fetal life, is 
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stable and heritable through mitosis, for example when a hepatocyte divides the daughter cell also 
develops into a hepatocyte. Epigenetic variations, as observed in monozygotic twins, arises as a 
consequence of the aging process and environmental exposures (nutrition, behaviour, 
pharmacological treatments)43. For instance, it has been shown that the estrogen receptor 
becomes hypermethylated with age50; the methylation pattern of the leptin promoter is altered by 
a high fat diet51; and physical inactivity reduces GLUT4 expression in skeletal muscle due to 
deacetylation of the histone complex43,52  
 
Epigenetics in the light of the predictive adaptive response 
As previously described, the predictive adaptive response is an evolutionary strategy that ensures 
optimal fitness in a range of environments via maternal stimuli. Epigenetic modifications are 
believed to play a key role in fetal adaptation and therefore also a central element when mismatch 
arises between prenatal and postnatal life47. Maternal undernutrition has been reported to affect 
hepatic metabolic function and pancreatic islet formation53. While maternal high fat feeding can 
hyperacetylate hepatic histones54, increase gluconeogenesis via epigenetic modifications of Pck155 
and alter leptin and adiponectin expression from adipose tissue via histone modifications56. Finally 
it has also been reported that children born with a low birth weight are less flexible in their 
metabolic adaptation via DNA methylation when challenged with overfeeding in adulthood57.  
Sookoian and colleagues58 have used a system biological approach to elucidate if maternal 
undernutrition and overnutrition share the same pathways when programming the offspring. 
Their model predicts that metabolic programming during maternal undernutrition targets gene 
involved with gene transcription, chromatin structure and DNA methylation, while maternal 
overnutrition is based on genes implicated in cellular control of glucose, lipid and lipoprotein 
metabolism and hormone activity. Additionally they suggest that exposure to overnutrition during 
fetal life is associated with metabolic programming of the liver, insulin resistance and ectopic lipid 
accumulation. Finally, their model demonstrated that an impaired liver phenotype (abnormal liver 
weight or hepatic steatosis) was a common denominator for both maternal under- and 
overnutrition58. This emphasizes the critical role of hepatic lipid and glucose metabolism in the 
development of metabolic syndrome in the adult offspring.   
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Lipid metabolism 
Dietary lipids are absorbed in the intestine. Short chain fatty acids are transferred directly to the 
liver via the portal vein59 (Figure 5) and the larger lipids (TAG, PL and sterols) are packaged into 
chylomicrons, transferred to the lymphatic system and eventually the blood circulation. The 
chylomicrons deliver lipids to adipose tissue and muscle via lipoprotein lipase (LPL) situated on the 
endothelial cell surface of the organs capillaries. TAG from the chylomicrons is hydrolyzed by LPL 
resulting in the release of free fatty acids (FFA) and diacylglycerides (DAG), which are transported 
into the cells via fatty acid transport proteins (CD36/FAT, FATP, FABP). When hydrolysis of TAG 
from the chylomicrons exceeds the fatty acid uptake, there is a spillover of lipids contributing to 
the pool of FFA in the blood. After delivering TAG to the muscle and adipose tissue the 
chylomicron remnant are transported to the liver, where they are cleared from the circulation. 
Therefore, the liver receives exogenous lipids from chylomicron remnants and from LPL spillover, 
but the majority of lipids, which are  trafficked through the liver, are endogenous lipids from de 
novo lipogenesis (DNL) (fed sate) and FFA released by the adipose tissue (fasting state). DNL is only 
elevated during the postprandial phase and accounts for 26% of the lipids found in the liver. 
Glucose is absorbed directly from the intestine to the liver via the portal vein and converted to 
acetyl-CoA via glycolysis and the oxidation of pyruvate60. Acetyl-CoA is further converted to 
Malonyl-CoA by acetyl-CoA carboxylase (ACACA). Acetyl-CoA and Malonyl-CoA constitutes the 
building blocks used in the formation of the fatty acid palmitate (C16:0), a reaction catalysed by 
fatty acid synthase (Fasn). Palmitate can be elongated by long chain fatty acid elongase 6 (ELOVL6) 
to stearic acid (C18:0), when double bonds are introduced by stearoyl-CoA desaturase 1 (SCD1) it 
then forms oleic acid (C18:1). Oleic acid is an important substrate in the formation of TAG, which 
are packed into very-low density lipoproteins (VLDL) and secreted from the liver. VLDL also 
delivers lipids to muscle and adipose tissue via LPL on the endothelial cells, similar to the 
chylomicrons. The release of TAG from VLDL increases the density of the lipoprotein creating 
smaller denser lipoproteins: intermediate density lipoproteins (IDL) and low density lipoproteins 
(LDL), which can be reabsorbed by the liver. Not all fatty acids can be synthesised from acetyl-CoA, 
since mammals are not capable of introducing double bonds beyond the 9th carbon. Linoleic acid 
(n-6) and α-linolenic acid (n-3) are therefore essential exogenous fatty acids for synthesis of a large 
range of lipids (Figure 6)    
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Figure 5. Lipid metabolism. Short chain fatty acids (SCFA) are absorbed straight to the portal vein and later the liver. 
Other dietary lipids are absorbed in the intestine and packaged in chylomicron, before they are released into 
circulation. LPL in adipose tissue and muscles releases FFA from the chylomicrons, but while the FFAs are absorbed by 
the muscle and adipose tissue, the chylomicron remnants are cleared by the liver. During feeding, the liver synthesises 
TAG from glucose by de novo lipogenesis. TAG is packaged in VLDL particles and secreted into circulation, which 
delivers FFA to the adipose tissue and muscles via LPL, like the chylomicrons. VLDL is converted to IDL and LDL as the 
TAG core decreases and LDL return to the liver for clearance. During fasting, DNL is inhibited and FFAs are mobilised 
from the lipolysis of TAG in the adipose tissue. The FFA are transferred to the liver, were it can be used for ATP 
production via β-oxidation or the formation of ketone bodies. DAG, diacylglyceride; FFA, free fatty acid; IDL, 
intermediate lipoprotein; LDL, low density lipoprotein; LPL. Lipoprotein lipase; MAG, monoacylglyceride; SCFA, short 
chain fatty acid; TAG, triacylglyceride; VLDL, very low density lipoprotein 
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Figure 6. Synthesis of long chain polyunsaturated fatty acids. Mammals are not capable of introducing double bonds 
beyond the 9
th
 carbon, which makes n-3 and n-6 fatty acids essential. Linoleic acid is the primary PUFA found in the 
western diet followed by α-linolenic acid
61
. Both of them can be metabolised to long chain PUFA and eicosanoid by 
the same enzymes. Eicosanoids from EPA are in general believed to be anti-inflammatory, while eicosanoids from 
arachidonic acid are believed to be inflammatory
61
. β-ox: β-oxidation, ELOVL2: fatty acid elongase 2, ELOVL5: fatty 
acid elongase 5, Δ5: Δ5-desaturase, Δ6: Δ6-desaturase. From Schmitz and Ecker 2008
61
. 
 
During the fasting state, lipids are returned to the liver from the adipose tissue. This process 
occurs when TAG is hydrolysed to DAG by adipose triglyceride lipase (ATGL). Then, DAG is 
hydrolysed to monoacylglycerides (MAG) by hormone sensitive lipase (HSL). Finally, MAGs are 
hydrolysed to FFA and glycerol by monoacylglycerol lipase (MGL)59,62. Both FFA and glycerol are 
released into the blood and reabsorbed by the liver, where the fatty acids are converted to acyl-
CoA. Acyl-CoA is catabolised into acetyl-CoA by β-oxidation in the mitochondria, which then can be 
used in the tricarboxylic acid (TCA) cycle and eventually ATP production, or for the generation of 
ketone bodies. The mitochondrial membrane is impermeable for acyl-CoA, so it is dependent on 
the carnitine transport system to enter the mitochondrial matrix. This is regulated by carnitine 
palmitoyltransferase 1 (CPT1) and the availability of carnitine63.  Very long chain acyl-CoAs (C>20) 
are toxic to the mitochondria, so they need shortening by β-oxidation in the peroxisomes 
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beforehand. This process is mediated by acyl-CoA oxidase (ACOX) and a multi-enzyme complex in 
the peroxisomes.  
Regulation of lipid metabolism 
Lipid metabolism is regulated in various ways to ensure that fatty acid oxidation is silenced and 
DNL is elevated during feeding, and vice versa during fasting. Secretion of insulin from the 
pancreatic beta cells in response to increased blood glucose during feeding stimulates DNL, so that 
excess glucose is stored as lipids. Additionally, insulin activates the transcription factor SREBP1c, 
which up-regulates the expression of Fasn, ACACA and SCD1 in DNL. Fasn and ACACA is also up-
regulated by the transcription factor ChREBP. When glucose levels rise, ChREBP is 
dephosphorylated and translocates from the cytosol to the nucleus. The increased DNL elevates 
levels of malonyl-CoA, which inhibit CPT1 and the delivery of acyl-CoA to the mitochondria, hereby 
shutting down oxidation in periods of excess nutrients. VLDL secretion from the liver is also 
decreased upon insulin stimulation to ensure that lipids are delivered to the muscle and adipose 
tissue, primarily from the chylomicrons in the postprandial phase. Insulin also inhibits hydrolysis of 
TAG in the adipose tissue, which decreases the availability of FFA for fatty acid oxidation in the 
liver. During fasting, insulin levels are low and the adipose tissue starts to shuttle FFA to the liver. 
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that are essential for 
optimal regulation of lipid metabolism. PPARα is found in hepatocytes, muscle, pancreas and 
kidney. It is activated by fatty acids, eicosanoids and fibrate, which results in increased uptake and 
oxidation of fatty acids63. PPARγ is primarily found in adipose tissue, where it increases insulin 
sensitivity and promotes fatty acid uptake and adipocyte differentiation. However, PPARγ is also 
found to a lesser extend in macrophages63, where it can induce an anti-inflammatory phenotype, 
which is important to maintain homeostasis in the adipose tissue (see below)64,65.  
Non-alcoholic fatty liver disease and dyslipidemia 
Non-alcoholic fatty liver disease (NAFLD) is believed to be the hepatic manifestation of the 
metabolic syndrome. When the balance between lipid uptake and utilization becomes impaired 
lipid accumulation in the liver occurs. Patients with NAFLD have increased DNL and VLDL secretion 
from the liver that results in dyslipidemia, characterized by elevated levels of circulating TAG 
and/or cholesterol. The trafficking of hepatic lipids in NAFLD is further elevated due to increased 
amounts of FFA being released from the adipose tissue. This is caused by a decreased insulin 
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action on the suppression of TAG hydrolysis. Simple steatosis is considered benign and 
accumulation of TAG might protect the liver against insulin resistance and the concomitant 
inflammation66. However, metabolic overload might not only cause TAG accumulation in the form 
of lipid droplets, it can also accumulate lipid intermediate products, since the various metabolic 
pathways often have a limited capacity; Peroxisomal β-oxidation increases when the capacity of 
mitochondrial β-oxidation is reached. This generates reactive oxygen species (ROS), non-complete 
oxidation of lipids in the mitochondrial β-oxidation that results in toxic lipids66,67 and palmitate 
that is shuttled into alternative pathways such as ceramide synthesis. This accumulation of by-
products can induce inflammation, liver injury and fibrosis, also known as non-alcoholic 
steatohepatitis (NASH). Kupffer cells (hepatic resident macrophages)68, regulatory T cells (Treg) 
and dendritic cells (DCs)69 normally maintain the non-inflammatory phenotype of the liver. With 
NASH development, immune cells (macrophages and neutrophils70) are recruited to the liver68, 
due to a Th1-skewed (pro-inflammatory) cytokine profile68. Various mechanisms have been shown 
to play a role in development of the inflammatory phenotype. Ibrahim and colleagues69 
demonstrated that the liver contains two distinct populations of DCs with either high (high-DC) or 
low (low-DC) lipid content. DC-low stimulates the proliferation of Treg and IL-10 production, which 
maintains a tolerogenic response in the liver. DC-high shows increased lipogenesis and ER stress, 
which lead to the production of pro-inflammatory cytokines (IL-12, IFN-γ, IL-6, TNFα, KC, MCP-1, 
RANTES, IL-1, IL-8). Additionally DC-high was capable of inducing proliferation of CD4+ and CD8+ T 
cells. Osteopontin is a matrix glycoprotein expressed by hepatocytes, macrophages and T cells, 
which plays a role in the production of pro-inflammatory cytokines in PBMCs, migration of 
monocytes/macrophages/DCs and in matrix degradation65,71,72. Osteopontin has been shown to be 
elevated in steatosis73 and osteopontin deficiency protects the liver against diet-induced 
steatosis72,74.  
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Obesity-induced inflammation 
The healthy link between metabolism and the immune system 
The immune system needs to mobilize large amount of energy during infections, and is therefore 
naturally linked to the metabolism. Bacterial and viral infections induce a Th1 immune response, 
which is characterized by activation of neutrophils, macrophages, DCs, B cells and T cells. The 
immune cells need nutrients when activated for; generation of reactive oxygen species from 
glucose via the pentose phosphate pathway, altering lipid composition in the cell membrane for 
phagocytosis of pathogens and antigen presentation, cytokine production and migration to the 
lymph nodes or site of infection64,65,75. All these mechanisms are generally fuelled by glucose and 
lipids and it is therefore necessary to direct nutrients towards the immune cells and away from 
storage. This is achieved by inducing insulin resistance in the insulin sensing organs, which in 
return increases gluconeogensis in the liver and lipolysis in the adipose tissue65.  The opposite is 
seen during infections with parasitic worms (helminth). Parasite infections are characterised by a 
Th2 response via an increase in eosinophils, which gives rise to increased insulin sensitivity instead 
of the decrease sensitivity observed in the Th1 response. This evolutionary combat strategy is 
beneficial since the parasite is dependent on the host nutrients to grow. By increasing insulin 
sensitivity, the nutrient availability is decreased and the parasite is therefore starved76. The 
immune system manipulates the metabolism during an immunological response, but the 
metabolism also utilizes immunological components to function. Muscles secrete IL-6, which 
enhance lipolysis and release FFA from the adipose tissue, to accommodate the increased energy 
consumption during exercise1,77. Finally, the immune system is important in tissue remodelling, 
playing a crucial role in adipose tissue expansion, due to excess nutrient intake (see below).  
Obesity-induced tissue inflammation 
Obesity is associated with hepatic lipid accumulation and steatosis, as previously described, but 
obesity-induced inflammation is not limited to the liver and can affect adipose tissue, pancreas1,5 
muscle78,79 and hypothalamus80. Inflammation in association with obesity was first described in 
adipose tissue81, and therefore the most studied (reviewed in the next section). The pancreas 
secretes insulin in response to elevated blood glucose. If basal insulin is increased due to a 
sustained hyperglycaemic diet, the pancreatic islets starts to produce the pro-inflammatory 
cytokine IL-1β, recruit macrophages and undergoes apoptosis (due to ER stress) to decrease 
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insulin secretion. It is hypothesized that the ER stress activates the NLRP3 inflammasome82 which 
generates IL-1β by caspase-11,5,83. The hypothalamus also produces pro-inflammatory cytokines 
(IL-6, TNFα and IL-1β)80 and undergoes apoptosis in rats fed a high fat diet84. It is speculated that 
hypothalamic inflammation leads to the insulin and leptin resistance observed in obese subjects, 
which impairs appetite regulation and exacerbate glucose intolerance1. Muscles are central insulin 
sensing organs, which secretes IL-6 during exercise and requires a proinflammatory response via 
NF-κB and JNK pathways for tissue repair and muscle regeneration after exercise1,85. However, 
inflammation and macrophage infiltration in the muscles is also associated with insulin resistance 
and obesity85. It is suggested that obesity-associated muscle inflammation is mediated by elevated 
levels of FFA, which promotes expression of proinflammatory cytokine (TNFα, IL-6 and MCP-1) in 
myocytes78,79,85. 
Adipose tissue inflammation 
Adipocytes collaborate with immune cells to maintain insulin sensitivity and tissue homeostasis of 
the adipose tissue in the lean state (Figure 7). Healthy adipose tissue is characterized by the 
presence of alternatively activated macrophages (M2), which are characterized by the expression 
of IL-10 and arginase-1(Arg-1)65,86. The M2 phenotype is orchestrated by cytokines secreted from 
eosinophils76, CD4+ Th2 cells (Th2)87, Treg88 and the newly identified “Natural helper cell”89 (NH 
cells), which also are present in adipose tissue.  Adipocytes90, eosinophils76 and Th2 cells produce 
IL-4 and IL-13 during homeostasis, the majority of which is secreted from the eosinophils76,89,90. 
Eosinophils are therefore important for suppression of the pro- and cellular inflammatory 
responses within the adipose tissue. Recently it was proposed that eosinophils are maintained in 
the tissue by the NH cells91. NH cells were identified by Moro and colleagues in 201092, and they 
are also known as nuocytes93, Innate helper type 2 cells94, and Innate Lymphoid type 2 cells95. 
They are widely distributed in mammalian tissues91,95 and have a function similar to the Th2 cells94. 
They secrete large amount of IL-5 and IL-13 upon stimulation with IL-33 in combination with IL-2 
and IL-2592. IL-33 is secreted from the adipocytes96 while IL-25 is produced by activated 
eosinophils and basophils97 and IL-2 is produced by CD4+ T cells and DCs98,99.  
  
As previously mentioned, inflammation is induced during tissue remodelling, which is necessary to 
store excess nutrients in the adipose tissue64. Adipocytes need to expand to deposit lipids during 
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sustained high fat feeding, but the adipocytes are surrounded by a extracellular matrix than needs 
to be broken down and re-build again after the expansion64,100. Infiltrating mast cells might be 
important for this remodelling, since they are associated with degradation and deposition of 
collagen by the release of proteases, IL-6 and IFN-γ64,101. If the tissue expands faster than the 
vasculature, the nutrient and oxygen supply will decrease (hypoxia) and angiogenesis is stimulated 
by the secretion of pro-angiogenic factors (VEGF) and pro-inflammatory cytokines from 
macrophages, which accumulates around the hypoxic site5,102. IL-33 produced by endothelial cells 
during obesity development has also been shown to stimulate angiogenesis103,104. IL- 33 might be 
increased due to elevated leptin secretion from the adipocytes104, but is also hypothesised to be 
an “alarmin” secreted from necrotic cells before they undergo apoptosis105 . Since IL-33 secretion 
normally results in accumulation of eosinophils91, it is speculated that endothelial cells release 
high amounts of IL-33 during angiogenesis to control the inflammatory response needed to 
enhance vascularisation. Apoptotic cells and cells death is common during hypertrophy and 
hyperplasia106. Dead adipocytes are surrounded by macrophages that engulf cell debris and the 
lipids that leak from the cells. These phenomena are called Crown Like Structures (CLS) and have 
been identified in obese adipose tissue107. The presence of CLS has been an important hallmark for 
identification of obesity associated adipose tissue inflammation throughout the literature. 
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Figure 7. Immunological phenotypes in adipose tissue in  lean and  obese states. Lean adipose tissue is characterized 
by M2 macrophages, eosinophils, Treg, Th2 and natural helper cells who maintain tissue homeostasis.  During 
development of obesity and insulin resistance, the macrophages differentiate into pro-inflammatory M1 
macrophages, which are mediated by infiltration of Th1, CD8
+
 T cells, B cells, neutrophils, mast cells and dendritic 
cells. Immune cell recruitment and inflammation are induced by the increased lipid turnover in the adipose tissue, 
which generates toxic lipids, ER stress, hypoxia, formation of reactive oxygen species and activation of the 
inflammasome.  Inspiration to the figures comes from Winer and Winer 2012
89
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Chronically elevated lipid deposition in the adipose tissue alters the adipocytes secretion profile 
(Figure 7). The adipocytes produce pro-inflammatory cytokines in obese adipose tissue (MCP-1, 
OPN, RANTES, IL-6 IL-1β and TNFa65,108-110), which in return recruits a number of different 
inflammatory immune cells. Neutrophils are recruited in an early transient phase and secrete 
neutrophil elastase, which degrades the insulin receptor substrate, hereby decreasing insulin 
signalling in the adipose tissue64,70.  B cells are also recruited in the early phase, but they stimulate 
IFN-γ secretion from Th1 and CD8+ T cells, which might be recruited by  secretion of the cytokine 
RANTES89,111,112.  Additionally, Th1 and CD8+ T cells also secrete IL-6 and TNFa upon activation89,106. 
The B cells also produce IgG2c whose primary target is GOSR1, which shuttles proteins from the ER 
to Golgi113.  Secretion of MCP-1 from the adipocytes recruits monocytes/macrophages that adapt 
a pro-inflammatory M1 phenotype (characterized by iNOS, IL-1β, IL-6, TNFα and IL-12, MCP-1 and 
RANTES expression5,89,106,112), due to the presence of pro-inflammatory cytokines (e.g. TNFa) in the 
tissue110. Because M1 macrophages play an essential role in adipose tissue inflammation, several 
studies have unsuccessfully tried to prevent the induction of macrophage infiltration by inhibiting 
MCP-1114,115. Osteopontin have been suggested as an alternative route, since neutralisation 
prevents both obesity-induced inflammation and insulin resistance74,116,117. Previously, the M1 
macrophages were identified by their expression of CD11c on the surface, but CD11c is also 
expressed on DCs and they have similar cytokine secretion patterns112. Stefanovic-Racic and co-
workers have demonstrated that DCs account for a large proportion of the CD11c+ infiltrating 
immune cells118. Only recently,  researchers have started to investigate the role of DC in the 
initiation of obesity-induced adipose tissue inflammation118,119 but DC are known to recruit and 
activate macrophages to the site of inflammation120. The presence of DCs are also positively 
correlated with insulin resistance119 and inhibition of the inflammatory pathway NF-κB in the DCs 
increase insulin sensitivity121,122. These studies provide evidence that DC play an important role in 
the development of obesity-induced inflammation and insulin resistance, but further research is 
needed to elucidate the underlying mechanisms.  
Many avenues have been explored to elucidate the initial mechanism responsible for obesity-
induced inflammation in adipose tissue. Obesity is associated with elevated lipolysis in the adipose 
tissue, which is known to recruit macrophages to engulf excess fatty acid release, hereby 
increasing lipid turnover in the tissue123. Inflammation might cause the increased lipolysis by 
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decreasing insulin sensitivity in the organ, in the attempt to avoid further expansion of the 
adipocytes62,89,100. But increased lipid turnover in both adipocytes and immune cells induce ER 
stress and the generation of ROS and toxic lipids, similar to the scenario in hepatic steatosis89,106. 
ROS124, ceramide125, cholesterol126 and saturated fatty acids124 can activate the NLRP3 
inflammasome, which produces IL-1β and IL-18 by caspase-1 activity that decreases insulin 
signalling in the tissue64,127. IL-1β is capable of activating the NF-κB and JNK signalling pathways, 
which upregulate the expression of various pro-inflammatory cytokines (TNFα, IL-1β and IL-6)5,128. 
Fatty acids might also be capable of activating the NF-κB pathway via the toll like receptors 
(TLRs)64, but Erridge and Samani planted a seed of doubt regarding this matter, when they 
published a study in 2009 showing that bovine serum albumin (BSA), that is used to get fatty acids 
into dilution,  often is contaminated with lipopolysaccharide (LPS), a potent activator of TLRs 129. 
When they used a LPS-free BSA, they discovered that saturated fatty acids did not directly 
stimulate TLR-dependent signalling, as previously thought129. LPS has also been suggested to play a 
role in the initiation of obesity-induced inflammation, since the intake of a high fat meal induces 
increased levels of circulating LPS (endotoxemia)130-132. Cani and colleagues have shown that 
endotoxemia cause obesity and adipose tissue inflammation in mice133. However, the 
endotoxemia hypothesis only deals with the increase in monocyte/macrophage recruitment to the 
adipose tissue and does not explain other alterations in the immune cell population. Moreover, 
the LAL assay, which are generally used to measure LPS, does not discriminate between various 
LPS types, which may be problematic since hexaacyl LPS has a higher inflammatory potential than 
pentaacyl and tetraacyl LPS134.  
 
To summarize, lean healthy adipose tissue is characterized by M2 macrophages, eosinophils, Treg, 
Th2 and natural helper cells, which during normal circumstances maintain tissue homeostasis.  
During development of obesity and insulin resistance, the adipose tissue becomes pro-
inflammatory probably mediated by lipotoxicity, ER stress, hypoxia, ROS formation and activation 
of the inflammasome as a result of the increased lipid turn over. The inflammatory adipose tissue 
is characterized by the presence of M1 macrophages, CD8+ T cells, Th1, B cells, neutrophils, mast 
cells and dendritic cells (Figure 7).  
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Animal experiments included in the thesis 
In the literature, a range of animal models have been used to investigate perinatal programming 
of metabolic syndrome (non-human primates, sheep and rodents)135. Rodents are extensively 
used in physiologic and metabolic research136, however, normal rodents have limitations; they 
have a strict appetite regulation, so it can be difficult to get them to overeat and become obese; 
they cannot develop cardiovascular disease and atherosclerosis; pups are born in litters and are 
very immature at birth compared to humans135,136. Today a range of obese prone rodent strains, 
which also develops hyperglycemia and whole body insulin resistance, have been developed 
commercially, so this limitation can be overcome strain selection137. The immature nature of the 
offspring at birth can be taken into account, when interpreting results related to perinatal 
programming in rodent models. Development of adipose tissue is important to point out, since it 
plays a critical role in the development of obesity and metabolic dysfunction; White adipose tissue 
develops in rodents in the postnatal period, while it develops in the third trimester in human138. 
Thus, postnatal effects on adipose tissue development in rodents lie within the prenatal 
development in humans.  
We chose to use rodents as a model, since they can develop the relevant metabolic phenotype for 
our studies (obesity, impaired glucose homeostasis, impaired lipid homoestasis and obesity-
induced inflammation), concurrent with a short life span which allow us to finalize the studies 
within the time frame of a PhD project. This thesis includes one mouse study conducted at 
Institute of Metabolic Sciences at University of Cambridge, UK, in collaboration with Dr. Susan E. 
Ozanne and two rat studies conducted at the Technical University of Denmark, DK. The common 
denominator for the animal studies is maternal high fat feeding and fetal programming of obesity 
and metabolic dysfunction. However, the aim of the mouse study was to phenotype the dams, 
while the rat studies investigate metabolic and immunological parameters in the offspring.  
Mouse study 
When studying immunological phenotypes, mouse models are the ideal choice. They have been 
extensively used in immunological research, so murine immune cell subsets are better 
characterized in the literature compared to rats. At Institute of Metabolic Science at University of 
Cambridge (UK), Dr. Susan E. Ozanne and colleagues have developed a maternal obesity mouse 
model in C57BL/6 mice, which leaves a metabolic imprint in the offspring, making them more 
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susceptible to obesity and metabolic dysfunction25. We were interested in studying if obesity-
associated inflammation was present in the dams of Dr. Ozannes model at the time of mating, and 
therefore potentially could cause some of the effects they have reported in the offspring. 
Additionally, we wanted to investigate how obesity-induced inflammation, if present before 
mating, was affected by pregnancy, since we hypothesized that a Th1 skewed obesity-induced 
inflammation would conflict with a Treg/Th2 skewed pregnancy (Chapter 2). 
 
Female mice were randomly assigned to a control or an obesogenic diet. After 6 weeks of feeding, 
blood was collected and the animals were left to recover for 2 days before 12 mice from each 
group were euthanized (blood and tissues were collected), while the remaining were mated. The 
pregnant dams and the unborn fetuses were euthanized on gestation day 18 (GD18), since we 
wanted to collect the placenta, which normally gets eaten by the dams straight after delivery 
(Figure 8). We also chose not to collect blood from the pregnant dams before termination, since 
stress from the blood sampling potentially could induce spontaneous labor and therefore prevent 
collection of the placenta. The outcomes of the study were an immunological phenotyping of 
monocyte activation in the blood and monocyte recruitment to various tissues in the dams before 
mating and on GD18. Additionally, we evaluated the animal’s adiposity, levels of circulating 
metabolic markers and ectopic lipid accumulation at the two time points (Chapter 3). 
 
Figure 8. Experimental setup of mice study 
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Rat studies 
Within Centre for Fetal Programming, who has partly founded this PhD stipend, we have tried to 
standardize our animal experiments to enable closer comparison of results from different studies. 
Rats are our preferred rodent model, but there are large individual variation in the outbreed rat 
strains137 and, as previously mentioned, normally rats do not become obese. So we chose an 
obese prone rat model from Charles River (Crl:OP-CD), hoping that the animals would be less 
restricted in their appetite when fed a high fat diet.  
 
Rat study 1 
Female obese prone rats were randomly assigned to a control diet or a high fat diet (60E%) 
supplemented with 15% sucrose water (HFHS). Since the typical human junk food diet consists of a 
combination of high fat food and sucrose sweetened beverage, and some data indicate that intake 
of sucrose as beverage has a more adipogenic effect, than sucrose in solid food 139, we have 
chosen a model mimicking these conditions. Female rats were maintained on the diets for 6 weeks 
before they were mated. All pregnant dams had normal deliveries, and all pups were weighed the 
day after birth. Female pups were euthanized and male pups were give identification marks and 
subsequently cross-fostered among the dams; control born pups were lactated by control dams 
(CC) or HFHS dams (CH) and HFHS pups were lactated by control (HC) or HFHS dams (HH). We 
chose to cross-foster the offspring after birth to be able to discriminate between prenatal and 
postnatal effects. Originally we wanted to euthanize half of the male offspring at weaning, and 
continue the remaining half on a control diet. However, the group sizes were smaller than 
expected (CC=15, CH=8, HC=9, HH=9), so we had to wean all male offspring on to the control diet 
at 4 weeks of age. The offspring were kept on the control diet for 16 weeks, a so called “re-
establishment” period, where we wanted to study if the altered metabolic phenotype, observed in 
the HFHS exposed offspring at weaning, could be recovered. Finally, the offspring were dietary 
challenged with a high fat (45E%) diet in adulthood from 20-26 weeks of age, which makes this 
experimental setup unique from previously published studies26,32,37. The purpose of our study was 
not only to investigate metabolic adapatability to a high fat diet in adulthood after perinatal HFHS 
exposure compared to the control group (Figure 9) The parametric outcomes of the study were 
levels of circulating metabolic markers over time and also adiposity and hepatic lipid accumulation 
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in the male offspring after the dietary challenge (Chapter 5). Additionally, we studied monocyte 
activation in the blood and monocyte recruitment to adipose tissue (Chapter 6).  
 
Figure 9. Experimental setup of rat study 1 
Rat study 2 
The offspring yield after the first round of mating was sparse, so we decided to re-mate the dams 
and repeat the cross-fostering experiment with the purpose of studying all male offspring in the 
second litters at weaning (Figure 10). After the first litters were weaned, the dams were left to 
recover before they were re-mated. Thus, the dams received the respective diets for 
approximately 17 weeks before they were mated the second time.  It is therefore not possible to 
make an exact comparison between the two rat studies, since the length of the maternal dietary 
intervention might be important for the magnitude of the metabolic imprinting in the offspring. 
The parametric outcomes of the study were levels of circulating metabolic markers, adiposity, 
hepatic lipid accumulation and composition in the male offspring at weaning (Chapter 4). 
Additionally, we studied monocyte activation in the blood and monocyte recruitment to adipose 
tissue (Chapter 6). 
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Figure 10. Experimental setup of rat study 2. 
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2.  The effect of maternal inflammation on fetal development and the risk 
of metabolic disease later in life. 
 
Camilla Ingvorsen, Susanne Brix, Susan E. Ozanne, Lars I. Hellgren 
 
Abstract. 
Maternal obesity during pregnancy is associated with increased risk of impaired metabolic function in the 
offspring. However, the obesity phenotype is complex and many factors can potential affect the metabolic 
imprinting in the offspring. Many studies have focused on elucidating the role of elevated metabolic 
markers in obese mothers, but diet-induced obesity is associated with chronic low-grade inflammation, 
suggesting that fetal programming due to maternal obesity, also could be causally linked to this 
inflammatory phenotype. Therefore, we have surveyed the literature to set up a hypothesis regarding the 
role of maternal obesity-induced inflammation in fetal programming of the metabolic syndrome. Nobody 
has yet investigated the role of obesity-induced inflammation in programming of metabolic syndrome in 
the offspring, so we are therefore restricted to the studies of acute inflammation from LPS injections, or, 
alternatively, we can be inspired from studies that investigate how other chronic low-grade inflammatory 
diseases, like autoimmune diseases, are affected by pregnancy. However obesity-induced inflammation is 
characterised by a Th1-driven immune response, a process that normally is suppressed via a Treg/Th2- 
skewed immune response during a normal pregnancy to avoid rejection of fetus. Thus, we speculated that 
there might be a conflict between maintaining a Th1 obesity-induced inflammatory response during a 
Treg/Th2-skewed pregnancy.   
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Introduction 
Obesity and metabolic disorders have become a global health concern in the 21st century, no 
longer only affecting the western world. Today we are experiencing a paradigm shift towards 
obesity being the biggest threat to human health, since 65% of the world population lives in 
countries were overweight kills more people than under-nutrition2. In 1992, Hales and Barker 
were the first to describe a hypothesis regarding programming of metabolic disease during fetal 
life11. Fetal programming is defined as maternal stimuli during pregnancy, which can have an 
effect on the offspring’s physiology, structure or metabolism that is maintained into adulthood. 
Many studies have shown that maternal obesity can lead to increased risk of adiposity26,30,140, 
glucose intolerance30,140, reduced beta-cell function28,  hypertension140,141, non-alcoholic fatty liver 
disease (NAFLD)26,41,142 and altered innate immunity27,143 in the offspring later in life. Obesity and 
metabolic dysfunction coexist with systemic low-grade inflammation and local inflammation in 
adipose tissue, liver144,145, muscle78,79 and hypothalamus80, suggesting that fetal programming due 
to maternal obesity, could be causally linked to this inflammatory phenotype. Metabolic and 
immunological regulations are closely linked together, since an efficient immune response 
requires that fluxes of  energy and metabolites are directed  towards  leukocytes  combat of 
pathogens75, in a manor so that metabolism can optimize nutrient availability and tissue 
remodelling via an inflammatory response100. Kosteli and colleagues123 showed that increased 
lipolysis in adipose tissue during weight loss promoted infiltration of adipose tissue macrophages 
probably via a concurrent secretion of monocyte chemoattractant protein 1 (MCP-1). Lipolysis is 
also increased during obesity development due to elevated basal lipolysis123, but the adipose 
tissue also has to expand and remodel to accommodate the need of storing excess nutrition146.  As 
a consequence of the obesity-induced hypertrophy and hyperplasia, the extracellular matrix must   
be broken down and rebuild , and a pronounced angiogenesis is required to avoid hypoxia,  while 
dead adipocytes need to be removed by macrophages147,148. This complex inflammation-induced 
tissue remodelling is partially coordinated through signalling via   pro-inflammatory cytokines.148. 
These local inflammatory events is part of a normal adaptation of the adipose tissue structure to 
situations of energy surplus, but , if the metabolic overload continues , the inflammatory 
phenotype will no longer only be local and transient, but instead become systemic and chronic. 
The inflammatory phenotype associated with obesity has been hypothesised to be the link 
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between obesity and metabolic diseases, such as development of type 2 diabetes and 
atherosclerosis. However, it is unclear how obesity triggers the chronic systemic low-grade 
inflammation, but several hypothesis have been suggested including lipotoxicity and ectopic lipid 
accumulation147, endotoxemia involving activation of monocytes due to enhanced 
lipopolysaccharide (LPS) leaking from the intestine133, ceramide-mediated activation of NLRP3 in 
the inflammasome125, foam cell formation like in cardiovascular disease as well as production of 
reactive oxygen species due to a stress response in the endoplasmatic reticulum (In depth reviews 
have previously been published on these hypothesis5,65,149-151). Regardless of the etiology of the 
chronic low-grade inflammation, a skew towards a type 1-driven inflammatory immunity is a core 
component. Th1-driven immunity is is characterized by CD4+ Th1 cells, CD8+ effector T cells and 
recruitment of inflammatory macrophages (M1-type)150 into the tissue, all being promoted via an 
activated innate immune system, involving dendritic cells and inflammatory monocytes. In the 
lean state, the adipose tissue has an anti-inflammatory phenotype dominated by the presence of 
regulatory T (Treg) cells, T helper cell (Th)2 cells, eosinophils and resident macrophages (M2-
type)106. This phenotype is maintained by IL-4 and IL-13 production from eosinophils and IL-10 
production from Tregs and resident macrophages106. But as obesity develops, these regulatory 
immune cells that normally maintain tissue homeostasis are gradually depleted, and the cytokine 
profile is skewed towards the production of pro-inflammatory cytokines (MCP-1,TNFa, IL-6, IL-1b, 
IL-18). Altogether, this profile comes along with the Type 1-driven inflammatory phenotype (CD4+ 
Th1 cells, CD8+ effector T cells and inflammatory macrophages (M1-type))150where the effector T-
cells are primed by IL-12p70-producing dendritic cells. How the switch to IL-12p70 production in 
dendritic cells is promoted in adipose tissues is still unresolved, but it is likely that it could involve 
endotoxemia, as endotoxins represent one agonist that triggers IL-12p70 production in dendritic 
cells via specific signalling pathways. IL-12p70 production is tightly controlled in dendritic cells, 
and therefore only very specific conditions will lead to amplification of the non-microbial/sterile 
promoted pro-inflammatory phenotype associated with obesity development.                                                                                
For the obesity induced maternal inflammation to affect the fetus, this can only occur if; 1) 
Maternal-derived inflammatory components such as cytokines or activated immune cells are 
transferred across the placenta, representing the maternal-fetal interface, and enters the fetal 
circulation (direct impact) or 2) Maternal inflammatory-derived components affect the placenta’s 
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capability of transferring other components such as nutrients or oxygen to the fetus (indirect 
impact). It is known that cytokines152 and maternal immune cells153 can be transferred across the 
placenta, and that cytokine exposure can alter placental perfusion rate154 (see below), but obesity-
induced inflammation is characterised by a Th1-driven immune response, as previously described, 
and this process is suppressed during a normal pregnancy155 (see below). Therefore, we speculate 
that there might be a conflict between a Treg/Th2 skewed pregnancy status in the mother and 
fetal transfer of a Th1-driven maternal obesity-induced inflammation that would, attenuate 
obesity-induced inflammation during pregnancy, and, hence, it´s impact on the fetus.   
 
Maternal immunity during pregnancy 
The immunological profile of pregnancy is firmly regulated from conception to delivery: Initially, 
implantation of the blastocyte in the earliest phase of pregnancy needs a strong activation of the 
innate immune system to repair the damaging events caused by breakage of the endothelial lining, 
invasion of the endometrial tissue and  establishment of a placental/fetal blood supply156. From 
early on, the semi-allogeneic fetus (paternal DNA and antigens) will also promote changes in the 
immunological phenotype towards a pro-inflammatory status, demonstrated by an increased 
leukocyte count in the blood and increased levels of C-reactive protein throughout pregnancy157. 
Further subtyping of the leukocytes present, shows that innate immune cells  (monocytes, 
neutrophils and plasmacytoid dendritic cells) are increased, while cells of the adaptive immune 
system are decreased  (B-cells and T cells)158,159 upon conception. In order to avoid rejection of the 
embryo, the maternal immune system needs to adapt the pro-inflammatory response to the 
pregnant state. This is achieved by skewing the immune response, initially via a Treg response and 
later on via promotion of a Th2 response (Figure 1A). Immediately after fertilization, human 
chorionic gonadotropin (hCG) is secreted, which will recruit Treg to the site of implantation160. 
After around 12 weeks of pregnancy, the hCG secretion decreases and the Th2 phenotype is then 
orchestrated by enhanced estrogen and progesterone levels that remain high until short before 
delivery. Both estrogen and progesterone have profound regulatory functions on immunity. 
Progesterone is produced by the placenta and the ovaries and progesterone receptors are found 
on mast cells, eosinophils, macrophages, dendritic cells and lymphocytes. Increased progesterone 
levels will induce the production of progesterone-induced binding factor (PIBF) in lymphocytes, 
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which will allow newly developed CD4+ T cells to differentiate into Th2 cells, secreting common 
Th2-derived cytokines (IL-4, IL-5 (and IL-10))155. This will decrease the Th1 response both at the 
maternal/fetal interface, but also systemically, as demonstrated by peripheral blood mononuclear 
cells (PBMCs) from pregnant woman showing increased secretion of IL-4 (Th2) and IL-10 (Treg), 
but decreased production of IL-2 (proliferation enhancer) and IFN-g (Th1)161. Estriol constitutes 
90% of the estrogens produced during pregnancy, and it interacts with T cells, B cells, neutrophils, 
monocytes/macrophages, NK cells and dendritic cells through estrogen receptors155,159. Upon 
binding, estrogen can reduce B-cell lymphopoiesis, which will decrease antibody production during 
infections159. Furthermore, estriol inhibits T cell migration and interacts with the NF-κB pathway 
by inhibiting the degradation of IκBα, which will decrease e.g. TNFα production and thereby result 
in diminished Th1 immunity. The Th1 phenotype and a pro-inflammatory environment are 
suppressed in the uterus until delivery, since spontaneous labor at term is dependent on a pro-
inflammatory Th1 switch to induce uterine contraction and expulsion of the fetus and placenta, 
however, presently the underlying mechanism behind this switch in immunity is incomplete156,162.   
 
Fetal immunity 
The maternal and fetal immune systems are closely linked, although the inter-linkage between the 
two seems to differ dependent on the time from conception. Maternal cells can cross the placenta 
and infiltrate fetal tissues and in response, the fetus develops tolerance to maternal antigens via 
generation of Treg153. Thus, although the fetal immune system is considered immature at birth, 
due to limited microbial exposures during fetal life, it starts to develop in the first trimester of 
human pregnancies163 (Figure 1B). Production of B cells, T cells and macrophages are already 
intiated a few weeks after implantation and  IgE production begins in the liver in the middle of the 
first trimester (8 weeks) of human pregnancy followed by lungs and the spleen (week 11). By the 
end of the first trimester the thymus cortex are also being formed and the bone marrow 
lymphopoesis and T-cell clonal expansion is initiated. In the middle of second trimester (week 19), 
IgM production is activated and by the end of the second trimester the differentiation and 
maturation of the immune cell compartment is complete. The immune system is capable of 
inducing an allergen- and microbe-specific antibody response already in the middle of the second 
trimester (week 23), which makes the fetus vulnerable to maternal inflammatory stimuli from this 
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time point onwards. However, the fetus is not capable of inducing a Th1-driven immune response 
before the very end of the third trimester (week 37)163, possibly due to an anti-inflammatory 
impact from maternal factors crossing the placenta.  
 
Figure 1. Maternal and fetal immunity. A. Implantation of the embryo causes an inflammatory response mediated via 
the innate immune system. Dendritic cells (DC), neutrophils (Neu) and monocytes (Mono) are increased during 
pregnancy, but to avoid rejection of the fetus, tolerance are induced via CD4
+
 Th2 cells (Th2) and regulatory T cells 
(Treg). The Treg/Th2 phenotype suppresses a pro-inflammatory Th1 phenotype until the end of gestation. A Th1 
response is induced at term to initiate contractions of the uterus and expulsion of the fetus and placenta, which is 
essential for a natural spontaneous labor. B. The fetal adaptive immune system is considered largely immature at 
birth, due to limited exposure to pathogens during pregnancy. However, the fetal immune system starts to develop 
already in the first trimester were macrophages (MΦ), B cells (B) and T cells (T) are the first to differentiate. At the end 
of the first trimester, the thymus cortex develops and T cell clonal expansion is initiated. During the second trimester, 
the fetus is capable of responding towards microbes, but the Th1 capacity is not acquired before the end of the third 
trimester. 
 
The Placenta - the maternal-fetal interface 
The placenta constitutes the maternal-fetal interface and functions to protect the fetus from 
rejection and exposure to maternal pathogens, concurrent with ensuring the fetal need for 
nutrients and oxygen164,165. Oxygen can diffuse across the placenta, and the supply is regulated by 
a decreasing gradient from maternal to fetal side, a process highly dependent on the thickness of 
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the placenta along with placental blood flow and metabolism164. Other essential components such 
as ions, amino acids and fatty acids reach the fetal circulation via protein-mediated transport 
across the maternal-fetal barrier164. The secretome of the placenta is very similar to that of 
adipose tissue and helps accommodate nutrient transfer to the fetus. Leptin and IL-6 are produced 
by placental cells while TNFa is produced by Hofbauer cells, the resident macrophages within the 
placenta166. During a normal pregnancy, the placenta produces TNFa during the last trimester with 
the formed TNFa being asymmetrically distributed to the maternal side167. It is hypothesized that 
TNFa can attenuate insulin sensitivity in maternal insulin-sensing organs, hereby shifting the flux of 
glucose and fatty acid to increased availability in the maternal blood stream166. Simultaneously, IL-
6 produced by placental cells induce fatty acid uptake and accumulation within the placental 
cells168. Thus, placental cytokine production diverts the nutrient flow away from the maternal 
storage compartments towards the fetus, presumably, to accommodate the increased fetal 
nutritional needs in later gestation.  
Several studies have focused on placental transfer of maternal cytokines to the fetus, but with 
inconclusive results. A study by Ashdown et al169 showed no TNFa, IL-1b or IL-6 in the fetal brain 
upon maternal LPS exposure on gestation day 18 in rats, whereas Oskvig et al170 showed elevated 
levels of all three cytokine in the fetal brain after maternal LPS exposure on gestation day 15 also 
in rats. The differences in the two findings might rely on different time points for maternal LPS 
exposure, as for instance IL-6 is transferred across rat placenta to a greater extent at mid-
gestation compared to late gestation152. A minimal transfer of IL-1a and TNFa across the placenta 
has also been shown in human placentas at term, while IL-6 seems to be transferred to a greater 
extent171.  These data shows that the placenta prevents and enhances transport of components 
differently during the early, mid and late trimester, perhaps due to a fluctuating need for provision 
of different nutritional and regulatory components during fetal development. This also implies 
that maternal inflammation affects fetal development differently at the different stages of 
pregnancy.  
 
Fetal outcome after exposure to maternal inflammation 
Maternal inflammation occurs naturally during pregnancy if bacterial and viral infections arise. 
During pregnancy, the mother is more susceptible to infections and the mortality and morbidity 
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rate is higher in the second and third trimester than in the first159. Preterm delivery can be a 
consequence of maternal infections172, and it has been shown that PBMCs from aborting mothers 
produce more Th1 cytokines (IL-2, IFNg, TNFa and TNFb) and less Th2/Treg cytokines (IL-4, IL-6 and 
IL-10) when stimulated with PHA (a mitogen that activates T-cells non-specifically) than PBMCs 
from normal pregnant mothers173.  
Injections of LPS in animal models (single or repetitive) have been used to investigate the effect of 
maternal inflammation on disease-risk in the offspring. Repetitive LPS injections in mice induce 
immune tolerance, meaning that repeated LPS challenge will induce a lower cytokine response 
and a down regulation of TLR4 expression on leukocytes compared to the initial challenge174. This 
also seems to be the case with prenatal exposure to LPS and repeated LPS challenges during 
postnatal life. Several studies have shown that maternal LPS exposure during late gestation in rats 
induces lower TNFa, IL-1b and IL-6 response in the offspring when challenged with LPS later in 
life175-178. But it also induced a decreased secretion of the anti-inflammatory cytokine IL-10176, 
which could indicate that maternal endotoxemia (high level LPS in blood circulation) results in an 
overall decreased reactivity towards LPS in offspring. A similar result was reported in a study done 
by Williams and co-workers179, where they investigated maternal LPS exposure during the 
periconceptional period where the zygote is formed. They showed that LPS tolerance in the 
offspring developed in a maternal dose-dependent manner. Increasing the maternal LPS dose 
resulted in progressively decreased immune response to LPS exposure in the adult offspring179. As 
previously described endotoxemia has been suggested to be important for the development of 
obesity, adipose tissue inflammation and type 2 diabetes133. Since offspring of LPS-exposed dams 
have a decreased endotoxemia response, the endotoxemia hypothesis suggests that offspring 
display decreased risk of obesity development and metabolic dysfunction in adult life. This is 
however not the case. Nilsson et al180 and Wei et al.181 reported that injection of LPS in pregnant 
rats during mid-gestation resulted in normal birth weight but increased body weight in the 
offspring at 11 weeks of age due to increased adiposity which correlated positively with circulating 
leptin levels. Food intake was also increased among the pups in both studies despite the elevated 
leptin level, which could indicate leptin resistance. The offspring exposed to LPS had normal 
glucose and insulin levels, but insulin sensitivity was decreased when estimated by euglycemic 
hyperinsulinemic clamp180 and also systemic arterial blood pressure was increased when 
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compared to the control born offspring181. What might be more important, than the actual LPS 
tolerance, is the decreased number of circulating neutrophils, monocytes and eosinophils also 
observed in the offspring exposed to pre-natal endotoxemia178. As earlier described, the insulin 
sensitive, non-inflamed adipose tissue is characterized by a large number of eosinophils that 
produce IL-4, a cytokine that is necessary to sustain the anti-inflammatory M2-phenotype in 
tissue-resident macrophages. Contrarily, loss of eosinophils leads to infiltration with inflammatory 
macrophages, and reduced insulin sensitivity76,182. It is therefore noteworthy, that maternal LPS-
induced inflammation during pregnancy has been observed to cause reduced number of tissue-
resident eosinophils in the airways of the adult offspring182, while no data exist on adipose tissues. 
If this also occurs in adipose tissue in the offspring from mothers suffering from sub-clinical 
inflammation, they could be primed to a higher risk of adipose inflammation and, hence, 
metabolic dysfunction.  
 
Endotoxemia may also impact on the function of the placenta, since LPS injections every 12 hour 
during late gestation in rats increased placental macrophage infiltration along with decreased 
placental perfusion rate 154. Placental macrophage infiltration and reduced placental function were 
hypothesized to be caused by an increase in IL-1 levels, since administration of the IL-1 receptor 
antagonist half an hour prior to LPS injection protected the animals from an LPS-induced increase 
in numbers of infiltrating macrophages and a reduction in placental perfusion capacity154.  Some of 
the characteristics in prenatally LPS-exposed offspring are also reported to be imprinted by 
prenatal exposure to cytokines alone. Prenatal exposure to TNFa or IL-6 (cardinal cytokines also 
produced after LPS exposure) results in increased body weight and adiposity in the offspring, and 
IL-6 exposure by itself, furthermore, results in decreased glucose uptake (i.e. decreased glucose 
tolerance), while no change in food intake was observed between cytokine-exposed and -control 
offspring183. Interestingly, a lack of pre-natal IL-6 also results in increased body weight and 
adiposity, increased leptin levels and decreased glucose tolerance184,185. 
 
All these studies using animal models of LPS injections induce maternal cytokine levels that mimic 
that of infections, and are therefore substantially higher than the cytokine levels present during 
obesity-induced inflammation. Obesity-associated low grade inflammation might affect the fetus 
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during pregnancy, but to our knowledge nobody has yet investigated if chronic low-grade 
inflammation associated with obesity will affect fetal development or how a maternal Th1-skewed 
phenotype is affected by pregnancy. To fill the gap, we are therefore restricted to the studies of 
acute inflammation from LPS injections, cited above, or, alternatively, we can be inspired from 
studies that investigate how other chronic low-grade inflammatory diseases, like autoimmune 
diseases, are affected by pregnancy (Figure 2). 
 
 
Figure 2. Impact of pregnancy on inflammatory status. Maternal inflammation happens naturally during infections 
and preterm labor. Besides the naturally-occurring inflammation, various animals models of maternal inflammation 
(A) have been developed that are mainly based on injections with LPS from Gram-negative bacteria, or injection with 
specific pro-inflammatory cytokines (IL-6, TNFa). The common denominator for these studies are that they focus on 
maternal inflammation levels that are normally present during infections. Obesity-induced inflammation is 
characterized by lower levels of inflammatory cytokines compared to infectious levels, so alternatively we might get a 
better idea of the fetal programming potential from maternal obesity-induced inflammation by studying other low 
grade inflammatory diseases like psoriasis, rheumatoid arthritis and multiple sclerosis (B) and the effect on neonatal 
immunity. 
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Pregnancy has a positive effect on low-grade inflammatory diseases 
Although we lack data on the impact of pregnancy on obesity-induced inflammation, data exists 
that describes the maternal inflammatory profiles in chronic low-grade inflammatory diseases. 
From these data, it is evident that the disease burden is reduced during pregnancy in several of 
them. In multiple sclerosis patients, relapse rates are decreased during pregnancy, with a 
following increase in rates after birth186. The same is seen in psoriasis patients187,188, and in 
patients with rheumatoid arthritis189. Based on this, we hypothize that obesity-induced 
inflammation may improve during gestation, as observed for other low-grade inflammatory 
diseases, and that the programming of metabolic disease in offspring, observed with maternal 
obesity, might be mediated by changes in nutritional or hormonal components rather than being 
due to placental transfer of pro-inflammatory mediators. To address this issue, we recently 
investigated how gestation in an obese mouse model, with known effect of metabolic outcome in 
the offspring, affected obesity-induced inflammation at gestational day 18 (Ingvorsen et al, 
submitted). The study showed that macrophage infiltration in adipose tissue and liver was 
reversed in obese dams after 18 days of gestation to the levels seen in controls, concomitant with 
a normalization of pro-inflammatory cytokines in the blood. Additionally the obese dams had a 
normal macrophage count in the placenta. However, local tissue inflammation, like we know it 
from adipose tissue, liver and muscle, has been reported in the placenta of obese mothers in 
humans190 and non-human primates191. The placental inflammation is characterized by increased 
infiltration of inflammatory macrophages with maternal origin and increased expression levels of 
pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β)190-192. Additionally, increased plasma levels of C 
reactive protein (CRP) and IL-6 has also been reported in obese pregnant women190,192,193 
alongside with the presence of adipose tissue inflammation192. Thus, the obesity-induced 
inflammation is not completely reverse by preganancy in obese women, like we have reported in 
the obese mice model. However,  based on the immune-skewing that take place during pregnancy 
and the improvement of clinical symptoms observed in other inflammatory-disesaes during 
pregnancy, we hypothesize that the inflammation is  less pronounced during pregnancy and that a 
direct transfer of inflammatory mediators might not play a strong direct role in programming of 
metabolic dysfunction in the offspring. Instead, we can speculate that increased cytokine levels 
and the increased cytokine production and secretion from the placenta would result in increased 
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insulin resistance in the maternal insulin sensing organs via TNFa166,167 and an increased fatty acid 
uptake via IL-6168, like described above. The inflammation would therefore have an indirect effect 
on the fetus by increasing the flow of lipids to the fetus. In human neonates the size of abdominal 
adipose tissue and hepatocellular lipid content is strongly correlated to maternal BMI 194 and it has 
also been shown in non-human primates and rodents that offspring from obese mothers have 
increased hepatic triglyceride and ceramide accumulation41 (Ingvorsen et al, submitted, Chapter 
3), which is the hepatic manifestation of metabolic syndrome195. Because hepatic lipid metabolism 
plays a central role in  development of metabolic syndrome, an alteratered metabolix flux of iipids 
in the liver already at birth could initiate a long-time metabolic trajectory that makes the offspring 
more vulnerable to dyslipidemia and metabolic dysfunction later on in life.  
 
Concluding Remarks 
Although we lack experimental data on whether chronic exposure to sub-clinical levels of 
inflammatory mediators in the mother are involved in metabolic programming of the offspring of 
obese mothers, the available literature on symptoms of other inflammatory diseases during 
pregnancy, date on exposure to acute inflammation through LPS injection and observations of 
increased macrophage infiltration of the placenta in obese mother give us some leads on the role 
of maternal inflammation. Pregnancy reduce the clinical manifestation of chronic-inflammatory 
diseases, indicating that pregnancy per se, can counteract an inflammatory phenotype, whereas 
exposure to an inflammatory environment (i.e. LPS-injections) during fetal development will 
program the offspring towards a metabolic phenotype similar to what is observed in offspring 
from obese mother.  In this context, the observed reduction in tissue eosinophils in the offspring 
warrants particular attention, since this might be a mechanism that increases the susceptibility to 
future development of adipose inflammation. Future research in this area should also focus on the 
role of cytokines produced by infiltrating macrophages in the placenta on regulation of fatty acid 
flux to the fetus and whether the observed increased ectopic lipid load in the fetus/newborn leads 
to a persistent programming of lipid metabolism that can drive future development of metabolic 
diseases.  
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3.  Gestation reverses obesity-induced inflammation in a mouse model of 
fetal programming 
 
Camilla Ingvorsen, Anna Hammerich Thysen, Denise Fernandez-Twinn, Pernille Nordby, Kristian 
Fog Nielsen, Susan E Ozanne, Susanne Brix, Lars I. Hellgren 
 
Abstract 
Objective. Maternal obesity is associated with increased risk of metabolic dysfunction in the offspring. It is 
not clear which physiological aspects of the obese state causes this metabolic programming. Obesity causes 
many metabolic changes but also chronic low-grade inflammation. We therefore investigated if low-grade 
inflammation was present in obese dams compared to controls dams at gestation day 18. 
Methods. Female mice were fed either a standard chow diet or a highly palatable obesogenic diet for 6 
weeks prior to conception. Mice were either euthanized before mating (n=12 in each group), or euthanized 
on gestation day 18 (n=8 in each group). Blood and tissues were collected for analysis. 
Results The consumption of the obesogenic diet increased body weight and decreased insulin sensitivity 
prior to conception, while there was no difference between the groups at gestation day 18. Local 
inflammation was assayed by macrophage count in adipose tissue and liver. Macrophage count in the 
adipose tissue was increased significantly by the obesogenic diet, and the hepatic count also showed a 
tendency to increased macrophage infiltration prior to gestation. This was further supported by a 
decreased population of monocytes in the blood of the obese animals, which suggested that monocytes are 
being recruited from the blood to the liver and adipose tissue in the obese animals. Gestation reversed this 
infiltration such that obese dams showed a lower adipose tissue macrophage count at the end of gestation 
compared to pre-pregnancy obese mice and there was also no longer a tendency to increased hepatic 
macrophage count. Placental macrophage count was also similar in the two groups. 
Conclusion At gestation day 18, obese dams were found not to have increased macrophage infiltration in 
placenta, adipose tissue and liver compared to lean dams, despite an incipient infiltration before gestation. 
Thus, the obesity-induced inflammation was reversed during gestation 
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Introduction 
Maternal obesity before and during pregnancy increases the risk of metabolic disorders, such as 
obesity, hyperphagia, hypertension, non-alcoholic fatty liver disease and insulin resistance in the 
offspring25,26. The maternal cues programming offsprings metabolism are still unknown, but 
inflammatory mediators produced in the mother due to the obesity-induced low-grade chronic 
inflammation could be causative agents. This inflammatory state is characterized by increased 
infiltration of immune cells into white adipose tissue and the liver, as well as enhanced levels of 
pro-inflammatory cytokines, such as TNF- -6196. Administration of inflammatory cytokines 
to pregnant rodents, at levels reflecting infections, such as prenatal exposure to TNF- -6, 
results in increased bodyweight and adiposity in the offspring and exposure to IL-6 furthermore 
resulted in decreased glucose uptake175-177,183. However, there is yet no data on the effects of fetal 
exposure to the sub-acute levels seen in obesity-induced low-grade inflammation. Although it is 
well established that excessive adiposity induces low-grade inflammation, pregnancy is 
characterized by local anti-inflammatory skewing of the immune response, to avoid rejection of 
the fetus197,198. Therefore, extrapolating the interpretation of experimental data from non-
pregnant subjects to the situation during pregnancy might be misleading.  
Various hypotheses have been raised to explain why excess adiposity is associated with sub-
clinical inflammation; two recent models are the endotoxemia- and the lipotoxicity hypotheses. 
According to the endotoxemia hypothesis, recruitment of monocytes to adipose tissues is initiated 
through lipopolysaccharide (LPS)-mediated activation of circulating monocytes, via a TLR4- and 
CD14-dependent mechanism, that propagates the inflammatory phenotype131-133.  This hypothesis 
is supported by observations that obese subjects have increased levels of circulating LPS133,199.  
However, it has been shown that neutrophils70,200, mast cells101 and also T-cells111 infiltrate the 
adipose tissue, coincident with a depletion of eosinophils, prior to monocyte infiltration. Due to 
these drastic alterations of the tissue-localized leukocyte compartment during obesity 
development, the endotoxemia hypothesis is unlikely to explain all these changes. The lipotoxicity 
hypothesis alternatively suggests that the triglyceride storage capacity of adipocytes becomes 
limiting, causing ectopic lipid accumulation and formation of lipotoxic intermediates that impairs 
metabolic function and induces an inflammatory phenotype in the tissue147. Furthermore, adipose 
tissue expansion alters the adipokine expression profile, which, among other effects, results in 
45 
 
increased leptin and monocyte chemotactic protein-1 (MCP-1) production, which initiate 
migration and cytokine release of monocytes and neutrophils109,201.  
Regardless of the aetiology of obesity-induced inflammation, maternal obesity-induced 
inflammation during gestation might cause programming effects in the offspring, leading to 
metabolic impairment, but it requires that the low-grade inflammation is not counter-balanced by 
the gestationally-induced anti-inflammatory response. To gain insight into the gestational 
influence on obesity-induced inflammation and its impact on the fully-matured fetus, we have first 
determined the level of obesity-associated inflammation in a commonly used mouse model of 
obesity-induced fetal-programming of metabolic dysfunction26,140, and then focused on the effect 
of inflammation and maternal obesity on ectopic lipid deposition in the offspring at gestational 
day 18. 
 
Materials and methods 
Animal experiment 
All studies were approved by the local Ethics Committee and conducted according to the Home 
Office Animals (Scientific Procedures, UK) Act 1986. The animal model used has been described in 
detail by Samuelsson et al. 2008. However it should be noted in this previous study offspring of 
second pregnancies were studied where in the current study it is the first pregnancy that is being 
characterized. In brief, female C57BL/6 mice at weaning were fed a regular chow diet (3% fat 
(w/w), RM1, Special Diets Services, Witham, UK) (n=20) or a highly palatable obesogenic diet 
consisting of a high fat pellet diet (22% fat (w/w), 824053, Special Diets Services, Witham, UK) 
supplemented with sweetened condensed milk (Nestle, Croydon, UK) (n=21) (Supplementary 
figure 1). After 6 weeks on the diets, 12 mice in each group were euthanized by rising CO2 
concentrations, followed by immediate cardiac puncture; tissues were collected and treated as 
further described below. Blood plasma samples were  stored at -80°C until analysed. The 
remaining mice were mated and euthanized on gestation day 18 (GD18), along with the unborn 
fetuses, followed by tissue and blood plasma sampling (lean n=8, obese n=9). Before and during 
gestation the dams were weighed weekly and body fat was evaluated by time-domain nuclear 
magnetic resonance (Bruker minispec LF series, Bruker Optik GmbG, Ettlingen, Germany).  
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Blood stimulations and identification of monocytes in blood by flow cytometry 
Blood for profiling of monocyte numbers, TLR4 and CD14 expression levels and for stimulation 
with LPS was collected 2 days before the animals were euthanized. It was collected from the 
saphenous vein in heparin coated tubes and stained with CD45-PE, CD11b-FITC, CD14-PerCP-Cy5.5 
and TLR4-APC (eBiosciences) for 30 minutes at 4°C followed by lysis of red blood cells with FACS 
lysing solution (BD Biosciences). Samples were subsequently analysed by flow cytometry on a FACS 
Calibur (BD Biosciences). The remaining blood was diluted 10 fold in complete media (RPMI-1640 
with 1% penicillin and streptomycin and 1% L-glutamine) and stimulated for 24h with 500 ng/mL 
LPS (E. coli O111:B4, InvivoGen) or complete media. After stimulation, supernatants were 
collected for TNF-α analysis (Meso Scale Discovery TNF-α kits and Meso Scale Selector Imager 
6000) according to manufacturer’s instructions. The cells were collected for flow cytometry 
analysis, and analysed as described for the whole blood. Monocytes were gated as shown in 
supplementary figure 2.  
 
Blood glucose and plasma parameters 
Blood glucose was analysed by a glucometer (AlphaTRAK, Abbott Animal Health, Illinois, USA) on 
blood collected from the tail vein after 4 hours of fasting. Plasma triglycerides were analysed on a 
Cobas Mira Plus with a Horiba ABX Pentra kit (Montpellier, France). Plasma MCP-1, insulin and 
leptin were analysed on a Meso Scale Selector Imager 6000 with Meso Scale Discovery kits 
according to manufacturer’s instructions.  
 
Adipocyte size 
Parametrial adipose tissue was fixed in 4% PFA immediately after sacrifice, dehydrated in 
industrial methylated spirit (IMS), cleared in xylene and embedded in paraffin before being cut 
into 5 µm sections and stained in Mayer’s Haematoxylin (Pioneer Research Chemicals) and 1% 
Eosin (Pioneer Research Chemicals). Slides were evaluated on a light microscope using Cell^P 
software program to calculate adipocyte area. All adipocytes in one image were measured and 3 
images from each animal were analysed. On average 445 adipocytes from control animals and 279 
from obese were quantified. Areas smaller than 200 µm2 were not considered adipocytes.  
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Lipid analysis 
The livers were snap-frozen in liquid N2 and stored at -80°C
 until analysed. Total lipids were 
extracted from maternal livers, fetal livers and placentas, as earlier described in Pedersen et al202 
with the exception that the following internal standards were added prior to extraction: 2H- 
ceramide (N-palmitoyl(d31)-D-erythro-sphingosine (Avanti Polar Lipids, Alabaster, AL, US) and 
sphingomyelin (N-palmitoyl(d31)-D-erythro-sphingosylphosphorylcholine (Avanti Polar Lipids)), 
pentadecanoic acid, di-pentadecanoy-sn-glycerol, tri-pentadecanoylglycerol (all Larodan Fine 
Chemicals)  and β-sitostanol (Sigma-Aldrich). The total lipid extract was fractionated ion Strata 
NH2 cartridges  (Phenomenex). The cartridges were rinsed and activated with 2x 1000 µL heptane, 
samples were applied in 200 µl CHCl3 and consecutively eluted with 2x 2.0 ml  CHCl3:2-propanol 
(2:1, v:v) (elutes neutral lipids) and 5.0 ml 2% acetic acid in diethylether (elutes FFA). The neutral-
lipid fraction was dried down, re-dissolved in 200 µl CHCl3 and applied to a new NH2 cartridge and 
further fractionated into cholesterol esters, TAG and a fraction containing cholesterol, DAG and 
ceramide through elution with 2x 2.0 ml hexane (cholesterolesters), 2x 1.0 ml 
hexane:CHCl3:ethylacetate (100:5:5 (TAG) and 2x 2.0 ml CHCl3:2-propanol (2:1). The fractionation 
method is a combination of the methods of Kaluzny 203, Burdge et al.204 and Bodennec et al205 and 
have been validated in-house through spiking of authentic samples with synthetic lipids. 
Triacylglycerols were analysed as earlier described202, using GC-FID. The fraction containing 
cholesterol and ceramide was analysed using LC-MS as described in Supplemental Materials.  
 
Histology 
Placenta and liver from female mice and fetuses were fixed in 4% PFA and incubated in 30% 
sucrose over night before being cut in 7 µm frozen sections. Slides were washed in 60% 
Isopropanol, stained with Oil Red O (Sigma, St. Louis, MO, US) and counterstained with Mayer’s 
Haematoxylin (Sigma, St. Louis, MO, US) to detect lipid accumulation within the various tissues.  
 
Immunohistochemistry 
Liver, Parametrial adipose tissue, placenta and fetal livers were fixed in 4% PFA, dehydrated in 
ethanol, cleared in xylene and embedded in paraffin before being cut into 5 µm sections. All 
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sections were dewaxed in xylene and rehydrated in ethanol. Antigens were retrieved by 
proteinase K (Qiagen, Hilden, DE), followed by blocking of endogenous peroxidases with 0.3% 
hydrogen peroxide for 30 minutes. Slides were then incubated with 10% rabbit serum (Vector 
laboratories, Peterborough, UK) added avidin (Vector laboratories) to block endogenous biotin for 
40 minutes, followed by incubation with a primary rat anti-mouse F4/80 antibody (liver, placenta 
and fetal liver: BM8, Abcam, 1:200 dilution; adipose tissue: Cl:A3, AbD Serotec, 1:150 dilution) 
added biotin (Vector laboratories) and incubated for 2 hours. Slides were then incubated with a 
biotinylated rabbit anti-rat IgG antibody (1:200 dilution) for 1 hour (Vector laboratories) followed 
by treatment with ABC reagent (Vector laboratories) for 30 minutes and developed with a DAB 
reagent (Vector laboratories). Slides were finally counterstained with Mayer’s haematoxylin 
(Sigma). Liver macrophage infiltration was measured by counting all macrophages in six images 
obtained at 10x magnification. Macrophage infiltration in adipose tissue was measured by 
counting all adipocytes and macrophages in six images taken at 10x magnifications and a 
macrophage-to-adipocyte ratio was calculated. Placenta samples were analysed by counting all 
F4/80 positive cells in a placental cross-section. The liver is involved in formation and development 
of blood cells during the perinatal period, where resident macrophages form erythroblastic islets 
with other blood cells206. This complicates macrophage count in the fetal liver, so instead 
macrophage accumulation was quantified by estimating the area with F4/80-positive stain. Images 
were obtained at 20x magnification and 4 images from each fetal liver were quantified by the 
“color segmentation” plug-in in ImageJ (http://imagej.en.softonic.com/)  
 
Statistical analysis 
Data are presented in boxplots with whiskers that represent 5-95 percentiles. Not all data 
followed a Gaussian distribution or had equal variance among groups, therefore the gestation and 
diet effects were analysed by a permutated 2-way ANOVA in the lmperm package in R 
(http://www.r-project.org/), as described by Anderson, 2001207. Post hoc-tests were performed as 
a pair-wise comparison between groups by a two sample permutation test in the coin package in 
R207. Effects were considered significant when p<0.05. 
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Results 
We characterized the metabolic status of non-pregnant female mice after 6 weeks feeding of an 
obesogenic diet and then on gestation day 18 (GD18). 
Weight gain and adiposity upon 6 weeks of obesogenic diet and effects of gestation. 
Female mice on an obesogenic diet gained more weight and had higher adiposity than mice on the 
control diet from 2 weeks of feeding (Fig. 1A, 1C). After 6 weeks, the obese mice had higher body 
weights (lean: 22.9g±1.57, obese: 26.7g±3.5, p<0.001), increased adiposity (Fig 1C, p<0.001), larger 
parametrial adipose tissue depots (Fig 1E, p<0.01), and larger adipocytes compared to the lean 
mice (Fig 1F-G, p<0.001). The two groups had similar weight gain from conception (Fig. 1B). On 
GD18, the obese mice still had increased total adiposity (p<0.05) and larger parametrial adipose 
tissue depots (p<0.05) (Fig 1D-E). Gestation had no effect on adipocyte size. The obesogenic diet 
did not affect liver weight after 6 weeks of feeding nor at GD18, however, the liver almost doubled 
in weight in both diet groups during gestation (control: from 0.81g±0.11 to 1.73g±0.19, obese: 
from 0.94g±0.35 to 1.58g±0.17) (Fig 1E). We observed no effect of maternal obesity on placental 
weight, fetal body weights, fetal liver weights or the liver-to-body weight ratios (Fig 2A-D).  
 
Maternal metabolic parameters in blood 
Fasting blood glucose levels were not different between diet groups after 6 weeks or at GD18 (Fig 
3A). However, the obesogenic diet resulted in increased fasting insulin levels after 6 weeks on the 
diet (p<0.05). Fasting insulin levels were increased as an effect of gestation only in lean dams 
(p<0.01), and, notably, there was therefore no significant difference between insulin levels in the 
two groups at GD18 (Fig 3B, p=0.34). Leptin was elevated in the obese animals both at week 6 and 
on GD18, although leptin levels also increased in the control mice with gestation (Fig 3C, p<0.05). 
The levels of triglycerides in the plasma were unaffected by diet, but gestation had a significant 
lowering effect in both groups (Fig 3D, p<0.05) 
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Figure 1. Maternal characteristics. Maternal weight gain prior to gestation (A) and at Day 18 of gestation (B) in lean 
(solid line and open box) and obese (broken line and grey box) female mice. Their percentage fat mass was 
determined by TD-NMR prior to (C) and during gestation (D) and parametrial fat pads and livers were weighed at post-
mortem (E). Finally the parametrial adipose tissue was sectioned and H&E stained (G) to evaluate the adipocyte size 
(F). Open boxes/broken lines : lean dams, shaded boxes/solid lines: dams fed obesogenic diet. Boxes show the 25-75 
percentile and whiskers the 5-95 percentile. In A, C and D, data are given as mean ± std. dev.  At week 6, prior to 
conception n=12, and on gestation day 18 n=8 in lean and n=9 in the obese group.  *p<0.05, **p<0.01, ***p<0.001, 
ns- non significant.   
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Figure 2. Fetal characteristics.  On gestation day 18, dams were euthanized and placenta and fetuses was removed 
and weighed (A and B respectively). Livers from foetuses were also removed and weighed (C) and a liver to body ratio 
was calculated (D). Open boxes lean, grey boxes obese. All pups from a single dam were considered as a single natural 
replicates, so the average weight of placenta, fetuses, fetal livers and the average fetal liver to body ratio from each 
dam are presented (lean n=8, obese n=9). ns non significant. 
 
 
Figure 3. Metabolic markers in plasma. At week 6 and on gestation day 18, blood was collected after a 4-hour fast 
from animals fed chow (white boxes) or an obesogenic diet (grey boxes). Blood glucose levels (A) were measured in 
whole blood from the tail vein and insulin (B), leptin (C) and triglycerides (D) were analysed in plasma obtained from 
blood collected by cardiac puncture. *p<0.05, **p<0.01, ***p<0.001 
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Lipid accumulation in maternal liver, placenta and fetal liver. 
The obesogenic diet had no effect on liver weight or on hepatic lipids after 6 weeks of feeding. 
However, at GD18 the diet significantly increased hepatic TAG accumulation compared to lean 
dams (p<0.01)(Fig 4A, 4C accumulation).  Hepatic ceramide level was also not affected by the 
obesogenic diet at week 6, while gestation increased the levels in both groups (p<0.0001 for 6 
week vs. gestation day 18). At GD18 this increase was attenuated in obese dams, which now had 
lower hepatic ceramide than lean dams (Fig 4B, p<0.05). Interestingly, both diet and gestation 
altered the distribution between different ceramide species. Gestation tended to increase the 
concentration of C16 and C18-species, while the obesogenic diet increased the amount of 
ceramide-species with sphinganine as long-chained base (PCA analysis in Supplemental Fig. 3).  We 
found no differences in triglyceride or ceramide concentrations in the placenta (Fig 4D-F), however 
the fetuses from obese dams had higher hepatic triglyceride (p<0.05) and borderline increased 
ceramide levels (Fig 4G-I, p=0.06), but no difference in ceramide-species composition (not shown).  
Based on all metabolic parameters, it was apparent that the obesogenic diet used in this model of 
fetal programming induced significant changes in overall metabolic parameters prior to mating, 
but also in fetuses analysed at GD18. We proceeded thereafter to characterize the level and 
influence of gestation on inflammation. 
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Figure 4. Hepatic and placental lipid accumulation.  Lipids were extracted from maternal and fetal liver, as well as the 
placenta, and TAG content was analysed. A) TAG content in maternal liver; B) Ceramide content in maternal liver; C) 
Lipid accumulation in maternal liver determined Oil-Red O staining; D) Placental TAG content; E) Placental ceramide 
content; F) Lipid accumulation in placenta determined with Oil Red O staining G) TAG content in fetal livers; H) Hepatic 
ceramide levels in foetuses; I) Lipid accumulation in fetal liver stained with OilRed O. p<0.05, **p<0.01, ***p<0.001, 
ns non significant 
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Figure 5. Macrophage infiltration in adipose tissue, liver and placenta. Mice were euthanized and adipose tissue (A & 
B), liver (C & D), placenta (E& F) and fetal liver (H) were collected, fixed and stained with an antibody targeting a 
macrophage surface marker (F4/80). Macrophages were counted in adipose tissue (A), liver (C) and placenta (E), but 
during the perinatal period macrophages form erythroblastic islets with other blood cells in the liver, which obstruct a 
macrophage count.  It was therefore only possible to estimate the F4/80 positive stained area in the fetal livers (G), 
which were done by the “color segmentation” plugin in ImageJ. p<0.05, ns non significant 
 
  
m
at
e
rn
al
 h
e
p
a
ti
c
m
ac
ro
p
h
ag
e
 c
o
u
n
t
week 6 GD18
0
200
400
600
800
1000
diet p=0.06
p=0.07
m
at
e
rn
al
 a
d
ip
o
se
 t
is
su
e
m
a
cr
o
p
h
ag
e
 c
o
u
n
t/
 a
d
ip
o
cy
te
week 6 GD18
0.0
0.5
1.0
1.5 diet p<0.05
gestation p<0.05
* *
p=0.05
p
la
ce
n
ta
l
m
a
cr
o
p
h
a
ge
 c
o
u
n
t
lean obese
0
100
200
300
400
500 ns
F4
/8
0
-p
o
si
ti
ve
 a
re
a
in
 f
e
ta
l l
iv
e
r 
(%
)
lean Obese
0
10
20
30
ns
m
a
te
rn
a
l h
e
p
a
ti
c
m
a
cr
o
p
h
a
ge
 c
o
u
n
t
week 6 gestation
0
200
400
600
800
1000
diet p=0.06
p=0.07
m
a
te
rn
a
l a
d
ip
o
se
 t
is
su
e
m
a
cr
o
p
h
a
ge
 c
o
u
n
t/
 a
d
ip
o
cy
te
week 6 gestation 
0.0
0.5
1.0
1.5 diet p<0.05
gestation p<0.05
* *
p=0.05
p
la
ce
n
ta
l
m
a
cr
o
p
h
a
ge
 c
o
u
n
t
lean obese
0
100
200
300
400
500 ns
F4
/8
0
-p
o
si
ti
ve
 a
re
a
in
 f
e
ta
l l
iv
e
r 
(%
)
lean Obese
0
10
20
30
ns
m
a
te
rn
a
l h
e
p
a
ti
c
m
a
cr
o
p
h
a
ge
 c
o
u
n
t
week 6 gestation
0
200
400
600
800
1000
diet p=0.06
p=0.07
m
a
te
rn
a
l a
d
ip
o
se
 t
is
su
e
m
a
cr
o
p
h
a
ge
 c
o
u
n
t/
 a
d
ip
o
cy
te
week 6 gestation 
0.0
0.5
1.0
1.5 diet p<0.05
gestation p<0.05
* *
p=0.05
p
la
ce
n
ta
l
m
a
cr
o
p
h
a
ge
 c
o
u
n
t
lean obese
0
100
200
300
400
500 ns
F4
/8
0
-p
o
si
ti
ve
 a
re
a
in
 f
e
ta
l l
iv
e
r 
(%
)
lean Obese
0
10
20
30
ns
C
E
G
A
55 
 
Levels of macrophage infiltration in maternal liver and adipose tissue, placenta and fetal liver 
Adipose tissue macrophages were enhanced in obese mice prior to gestation (p<0.05, Fig 5A, B), 
while liver macrophage counts tended to be higher upon 6 weeks on the obesogenic diet (p=0.07) 
(Fig 5C, D). Interestingly, macrophage counts were equalized in obese and lean dams at GD18 both 
in adipose tissue (Fig 5A, D) and the liver (Fig 5C, D) and there were no difference between the 
groups in placenta (Fig 5E, F) and fetal livers (Fig 5G, H).   
 
Gestational effects on monocyte recruitment and activation propensity  
Since we found increased macrophage infiltration in adipose tissue (and tendencies in liver) 
following 6 weeks of obesogenic diet consumption, we studied the general recruitment of blood 
monocytes into tissues by MCP-1. MCP-1 was elevated in the obese mice at week 6, although only 
borderline significant (p=0.07), but like the hepatic macrophage count, this tendency was not 
observed at GD18 (Fig 6A). The levels of plasma MCP-1 correlated significantly with parametrial 
adipose tissue mass (Fig. 6B) implying a link between circulating MCP-1 levels and adiposity. 
Concomitant with the enhanced plasma MCP-1, there was a decrease in the number of blood 
monocytes in obese mice at week 6 (Fig 6C, p<0.05) supporting the idea that monocytes were 
being recruited to the tissues at this time-point (Fig 5A and C). At GD18, no differences were 
observed in plasma MCP-1 levels (Fig. 6A), blood monocyte counts (Fig 6C) or adipose tissue 
macrophage counts (Fig 5A) between obese and lean dams. However, blood monocyte numbers 
increased two-fold during gestation independent of diet (Fig 6C).  
To investigate if blood monocytes were pre-activated by endotoxemia, we measured the 
expression of CD14 and TLR4 on monocytes from freshly drawn blood. The results show that the 
obesogenic diet resulted in a highly significant reduction in the expression of TLR4 (Fig 6C; p<2x10-
16) and tended to decrease CD14 (Fig 6D, p=0.06) when analysed by 2-way ANOVA. These effects 
were most pronounced at GD18, where there were significant differences (p<0.05) between 
control and obese dams. This implies that monocyte function might be regulated by obesity during 
gestation. 
To test whether the lower TLR4 expression level was indicative of LPS-tolerance due to chronic 
endotoxemia, we stimulated the blood with LPS for 24 hours. If LPS-tolerance is induced, we 
would expect TLR4 expression levels and also secreted TNF-α to be less up-regulated upon ex vivo 
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LPS stimulation 208. Notably, the LPS stimulation resulted in an equal up-regulation of TLR4 and 
CD14 in both diet groups (Fig. 6F, G, p=0.27 and p=0.80, respectively), and TNF-α secretion was 
also similar (Fig 6H), suggesting no apparent LPS pre-activation of blood monocytes in vivo. The 
lower TLR4 expression in gestating obese mice (Fig 6D) did not influence their ability to become 
activated by LPS. 
 
Figure 6. Monocyte recruitment and activation in blood. Blood was collected and monocyte recruitment investigated 
by analyses of plasma MCP-1 levels (A). Plasma MCP-1 levels were correlated with adiposity among the obese animals 
at week 6 (B, p<0.05), which could indicate increased monocyte recruitment to the tissues. Monocytes in the blood 
were identified by flow cytometry (CD45
+
 CD11b
high
) and the abundance of monocytes (C) along with their surface 
expression of CD14 (D) and TLR4 (E) were analysed. Blood was also stimulated with 500ng/mL LPS for 24 hours to 
investigate the change in surface expression of CD14 (F) and TLR4 (G) and secretion of TNF-α into the supernatants 
(H). *p<0.05, **p<0.01, ***p<0.001, ns non significant. Lean, week 6 n=21; obese, week 6 n=22; lean, gestation day 18 
n=8, obese, gestation day 18 n=9 
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Discussion 
Maternal obesity is a risk factor for metabolic dysfunction in the offspring25,26. Obesity and adipose 
tissue expansion induces many metabolic changes, but also a low-grade inflammatory phenotype. 
Both metabolic and inflammatory components might play a key role in the impaired metabolic 
programming in offspring.  However, since gestation induces an anti-inflammatory state in order 
to avoid rejection of the fetus, both pro- and anti-inflammatory cues are in play in the obese 
mother. In order to understand the potential role of inflammatory-signals in this metabolic 
programming, it is important to determine to what extent metabolic inflammation is attenuated 
by gestation in models of offspring metabolic programming by maternal obesity. Therefore, we 
determined both the inflammatory and metabolic state in the mothers prior to pregnancy and at 
the end of gestation using a mouse model of maternal obesity with well-described negative 
metabolic implications for the offspring140,209. 
 
Obesity-associated inflammation and metabolic impairment is induced after 6 weeks of obesogenic 
feeding 
In this model, 6 weeks of feeding on a high-fat diet supplemented with condensed milk prior to 
mating induced an obese phenotype in the dams with increased body weight, increased adiposity 
and decreased insulin sensitivity, as reflected by an elevated insulin level to maintain a normal 
glycemia. Obesity development was associated with increased macrophage infiltration in the 
parametrial adipose tissue and a tendency to increased macrophage infiltration in the liver. 
Hepatic macrophage infiltration has previously been reported to be associated with hepatic lipid 
accumulation and ceramide is known to induce an inflammatory phenotype195, however our data 
indicate that obesity-induced hepatic inflammation can occur prior to changes in the lipid content, 
since no significant increases in liver triglycerides or ceramide were observed at this time point. 
The data from the macrophage count was supported by a tendency to increased levels of MCP-1 in 
the blood. This cytokine is produced as a result of an early adipocyte response to high fat intake210, 
which activates circulating monocytes and mobilizes them to a site of inflammation211. 
Furthermore, the number of circulating monocytes was also reduced in the obese dams prior 
gestation, indicating that the increased concentration of MCP-1 provoked recruitment of 
circulating monocytes from the blood into tissues. Altogether, our data indicates that obesity-
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induced tissue inflammation is initiated upon 6 weeks on obesogenic diet, and thus prior to mating 
for first pregnancy in this model. 
Since the metabolic-endotoxemia hypothesis proposes that obesity leads to a chronic LPS-
exposure, and thereby induces relative tolerance in target cells208, we investigated if the LPS-
driven activation of monocytes differed between the two groups. In the blood, circulating LPS is 
bound to LPS-binding protein (LBP) and activates monocytes through a TLR4/MD2/CD14-
dependent mechanism. CD14 is secreted from the monocytes and binds to LBP, which allows LPS 
to interact with MD2 on the monocyte surface, and then form a complex with TLR4. LPS first binds 
the MD2 receptor and then finally the TLR4 receptor to activate the production of inflammatory 
cytokines via the NF-κB and IRF3-signalling pathway212-214. Although our data showed a strongly 
significant reduction in TLR4 expression and a tendency (p=0.06) to reduced CD14 expression on 
the blood monocytes of obese dams, their response to stimulation with LPS for 24 hours was 
similar to that of the lean dams, therefore suggesting there was no endotoxemia/LPS tolerance215. 
Thus, although the reduced TLR4 and CD 14 expression could be interpreted as an adaptation to 
chronic LPS-exposure, this did not result in functional LPS-tolerance.  
 
Effect of gestation on obesity-induced inflammation and metabolic impairment.  
The main objective of our study was to investigate how obesity-induced inflammation is affected 
by gestation in a well-described model of metabolic programming25. Dams fed the obesogenic 
diets had higher fat mass and circulating leptin levels at GD18, but despite this, our data showed 
that all tendencies towards obesity-induced inflammation were normalized during gestation. We 
found no change in hepatic or placental macrophage count on GD18. This is in contrast to previous 
findings by Challier et al 2008, who reported increased macrophage accumulation in human 
placenta from obese mothers190. However, our data is consistent with other studies, which have 
reported that pro-inflammatory-related diseases such a multiple sclerosis, rheumatoid arthritis 
and psoriasis are improved during pregnancy. Additionally, pregnant women have been shown to 
be more susceptible to infections such as influenza, due to the suppression of the pro-
inflammatory immune system, and that persistent infections, like malaria, during pregnancy 
increases the risk of abortion and preterm delivery, because the body is no longer capable of 
sustaining the anti-inflammatory state (reviewed in Robinson and Klein155). Despite the anti-
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inflammatory properties of gestation, this study cannot rule out that the inflammatory state at the 
time of embryonic implantation potentially could have programming effects on offspring.  
However, while gestation skews the systemic immune-response towards an anti-inflammatory 
direction, it has been shown that maternal obesity dramatically increases fetal exposure to lipids.  
Zhu and colleagues reported increase lipid transport to the fetus in obese ewes216 and McCurdy 
and co-workers have reported that a maternal high fat diet resulted in lipid accumulation in fetal 
liver of non-human primates41. Although we found no lipid accumulation or any sign of increased 
inflammation in the placenta after the relatively short pre-gestational time on the obesogenic diet, 
we did observe increased accumulation of triglycerides and ceramides in fetal livers. Gestation 
increased ceramide levels in maternal livers in both groups, but, unexpectedly, this increase was 
less pronounced in livers from obese mothers, resulting in a significantly higher hepatic ceramide 
level in lean dams compared to obese dams. These data could indicate that maternal obesity is 
associated with increased transfer of ceramides from the mother to the fetus. Since it is well 
established that ceramides inhibit signalling from the insulin receptor217, it is also noteworthy, that 
ceramide accumulation in the livers of the lean dams occurred concomitant with reduced systemic 
insulin sensitivity during pregnancy, manifested as increased fasting insulin. In order to optimize 
nutrient flow to the fetus, maternal insulin sensitivity is normally reduced during pregnancy218. 
Whether the observed hepatic ceramide accumulation is part of this normal metabolic adaption to 
pregnancy requires further study. Besides attenuating insulin receptor signallling, ceramide is also 
a highly potent inducer of apoptosis 219 220. Therefore, ceramide accumulation in skeletal muscles, 
the liver or the heart, has been linked to development of type 2 diabetes and increased risks for 
cardiac failure219-221. 
The model of developmental programming used in this study is more susceptible to development 
of metabolic diseases and cardiac dysfunctions later in life140,209,222. If the higher tissue ceramide 
content in the fetuses reflects persistent alterations in ceramide metabolism, this could explain 
the observed increased incidence and earlier onset of metabolic diseases in pups from the obese 
mothers.  
In conclusion, in this study we found no evidence that fetal programming of metabolic dysfunction 
in mice born by obese dams is driven by sub-clinical inflammation during gestation. On the 
contrary, data supports a model in which gestation induces an anti-inflammatory skewing of the 
60 
 
immune system and an attenuation of the metabolic inflammation induced by the obesogenic 
diet. Since the mice in our study were in an early phase of the inflammatory development prior to 
mating, this model will not answer if gestational anti-inflammatory effects are able to reverse 
more pronounced pro-inflammatory states. However, the obesogenic diet caused increased 
ectopic deposition of TAG and ceramide in the fetal liver prior to birth. Hence the results indicate 
that ectopic lipid deposition, rather than maternal inflammation, may provide a mechanism for 
the increased susceptibility to metabolic diseases later in life in this model of developmental 
programming.  
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Supplemental materials 
Materials and methods 
Liver and placenta lipid analysis 
Total lipids was extracted from maternal and fetal livers as well as from the placentas, as earlier 
described204  with the exception that following internal standards was added prior to extraction: 
2H-labelled ceramide (N-palmitoyl(d31)-D-erythro-sphingosine (Avanti Polar Lipids, Alabaster, AL, 
US) and sphingomyelin (N-palmitoyl(d31)-D-erythro-sphingosylphosphorylcholine (Avanti Polar 
Lipids, Alabaster, AL, US)), pentadecanoic acid, di-pentadecanoy-sn-glycerol, tri-
pentadecanoylglycerol (all Larodan Fine Chemicals, Malmö, SE)  and β-sitostanol (Sigma-Aldrich, 
St. Louisn MO, US). The total lipid extract was fractionated into four fractions: 1) triacylglycerols 
(TAG), 2) diacylglycerols, ceramides and cholesteroles 3) free fatty acids, and 4) phospholipids, on 
500 mg Strata NH2 cartridges (Phenomenex, Torrance, CA). The cartridges were activated with 2 × 
1000 µL heptane, samples was applied in 200 µL CHCl3 and consecutively eluted with 2 × 2.0 mL  
CHCl3:2-propanol (2:1, v:v) (elutes neutral lipids), 5.0 mL 2% acetic acid in diethylether (elutes FFA) 
and 4.0 mL methanol (elutes phospholipids). The neutral-lipid fraction was dried down with N2 
flow, re-dissolved in 200 µL CHCl3 and applied to a new NH2 cartridge and further fractionated into 
cholesterolesters, TAG and a fraction containing cholesterol, DAG and ceramide through elution 
with 2 × 2.0 mL hexane (cholesterolesters), 2 × 1.0 mL hexane:CHCl3:ethylacetate (100:5:5) (TAG) 
and 2 × 2.0 mL CHCl3:2-propanol (2:1). The fractionation method is combination of the methods of 
Kaluzny203, Burdge et al.204 and Bodennec et al205 and have been validated in-house through 
spiking of authentic samples with synthetic lipids, and analyzed on GC-FID and UHPLC-HRMS as 
described below. The FFA, TAG and PL fractions  was analyzed by  GC-FID as earlier described204. 
 
UHPLC-HRMS 
Samples were analysed by Ultra High Performance Liquid chromatography-high resolution mass 
spectrometry (UHPLC-HRMS) on a maXis G3 quadrupole time-of-flight mass spectrometer (Bruker 
Daltonics, Bremen, Germany) equipped with an electrospray ionization (ESI) ion source. The mass 
spectrometer was connected to an Ultimate 3000 UHPLC system (Dionex, Sunnyvale, CA). 
Separation of 1 µL samples were performed at 70°C on a Agilent ZORBAX Rapid Resolution HD 
300SB-C3 100 × 2.1 mm ID, 1.8 µm column (Agilent Technologies, Santa Clara, CA) using a linear 
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gradient of (A) water (buffered with 20 mM formic acid) and (B) iso-propanol/acetonitrile (20:80 
v:v) at a flow of 0.4 mL min-1 starting from 35% B and increasing to 100% in 15 min, remaining at 
100% B for 4 min. MS was performed in ESI+ with a data acquisition range of 10 scans s-1 at m/z 
1001000. The MS was calibrated using the HPC algorithm on sodium formate automatically 
infused before each run, providing a mass accuracy of <2 ppm. 
Extracted ion chromatograms of the [M+H]+ ions (± 0.001 m/z) for all target peaks were 
constructed using Target Analysis (Bruker). The target lipid compounds were identified by the 
retention time and accurate masses (± 1.2  ppm). The sum of the peak areas of the [M+H]+, 
[M+Na]+ and [M+H−H2O]
+ ions were used for quantification. Ceramide masses were determined 
based on standard-curves constructed from N-palmitoyl-D-erythro-sphingosine (C16:0 ceramide), 
N-lignoceroyl-D-erythro-sphingosine (C24:0 ceramide) and N-nervonoyl-D-erythro-sphingosine 
(C24:1 ceramide). Response factors for other ceramide species were interpolated based on the 
difference in response to these three ceramide species. 
 
 
 
Supplementary figure 1. Experimental setup. Female mice at 5 weeks of age was assigned to either a chow diet or a 
highly palatable obesogenic diet consisting of a high fat pellet diet supplemented with sweetened condensed milk. 
After 6 weeks on the diets, 12 mice from each group were euthanized and the remaining was mated up and 
euthanized on gestation day 18. 
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Supplementary figure 2. Gating strategy to identify monocytes in fresh blood by flow cytometry. Monocytes were 
identified first as CD45
+
, then according to the forward scatter and side scatter and finally as CD11b
high
. 
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Supplementary figure 3. Effects of pregnancy and the obesogenic diet on hepatic ceramide composition. Hepatic 
ceramides were analysed as described in material and methods and data were analysed using principal component 
analysis. In the names of the ceramide species in the loading plot is the first number describing the number of carbons 
in the molecule and the number after the colon the number of double bonds.  
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4. Effect of maternal high fat/high sucrose intake during gestation and/or 
lactation on metabolic markers of hepatic lipid metabolism 
 
Camilla Ingvorsen, Lars I. Hellgren 
 
Abstract 
Background: Maternal high fat intake or obesity predisposes the offspring to a higher risk of developing 
metabolic diseases. It is however not clear if pre- and postnatal exposures have similar effects on adiposity 
and hepatic lipid metabolism in the young offspring. 
Method: Rat dams were exposed to a high fat/high sucrose (HFHS) diet for 17 weeks prior to mating and 
during pregnancy. After birth was the male offspring cross-fostered, creating four groups differing in 
dietary exposure in utero or during lactation; control diet during both periods (CC), HFHS diet during both 
periods (HH), control diet during pregnancy but HFHS during lactation (CH) or viceversa (HC). At weaning 
was the pups euthanized, and metabolic markers in plasma were assayed, together with hepatic lipid 
composition and gene expression related to hepatic fatty acid metabolism. 
Results: Pups born by control-fed dams but exposed to HFHS-diet during developed most pronounced 
adiposity, while pups born by HFHS-fed dams seemed to be partially protected from the effect of the high 
energy diet during lactation. A mismatch between maternal diet during pregnancy and lactation also led to 
accumulation of free fatty acids in the liver. The prenatal HFHS exposure did cause a very strong inhibition 
of FADS1 and FADS 2 gene expression, indicating a decreased capacity of synthesis of long chained 
polyunsaturated fatty acids from the dietary C18 polyunsaturated fatty acids. 
Conclusion: Intake of energy dense diet during lactation has most severe effects in offspring that have not 
been exposed to this diet in utero. The prenatal exposure had however very pronounced effects on 
expression of genes involved in synthesis of polyunsaturated fatty acids. 
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Introduction  
Obesity and the associated metabolic disorders have become a worldwide epidemic and as a 
consequence, an increasing number of children are born by obese mothers 4,223.  From different 
animal models, as well as from human epidemiological studies, we know that maternal obesity 
and/ or high fat intake during pregnancy leads to increased risk of obesity, type-2 diabetes, 
hyperlipaemia, hypertension and non-alcoholic fatty liver disease (NAFLD) 4. Exposure to maternal 
obesity and/or high fat diet during fetal life have been shown to cause very early dysfunctions in 
lipid metabolism manifested as increased hepatic fat accumulation in fetuses from mice  and 
Japanese macaques (Ingvorsen et al submitted 41 ), as well as in human neonates 194,224. In human 
neonates, hepatocellular lipid content was shown to be significantly correlated to maternal pre-
pregnancy BMI 194.  Thus, already at the time of birth do these children suffer from aberrant 
hepatic lipid metabolism, leading to increased hepatic steatosis, with potential trajectories 
towards metabolic diseases later in life. In most studies the maternal diets during pregnancy have 
also been maintained throughout lactation, but it is known that exposures during various critical 
windows during fetal and post-natal development results in different phenotypic outcomes 14,225. 
In 2007, Gluckman, Hanson and Beedle described the predictive adaptive response hypothesis, 
which states that offspring are adapted to an expected environment during fetal life to ensure 
optimal survival for the offspring after birth. But if the environment turns out differently than 
predicted, then a mismatched phenotype occur, that can lead to increased risk of metabolic 
diseases 19. Although some studies have addressed the issue on whether mismatch between high 
energy diet exposure in fetal and neonate life might have particular negative impact 26,226, as 
suggested by the hypothesis on predictive adaptive response 227, we lack information on how such 
a mismatch affects hepatic lipid composition and metabolism.  
Hepatic steatosis is per se considered a benign and reversible condition, but it is often linked to 
accumulation of lipotoxic intermediates, such as ceramide and free fatty acids (FFA) 228. Since 
ceramides attenuate insulin signaling, induce apoptosis, can cause formation of reactive oxygen 
species and are involved in inflammatory development in the liver 229, increased ceramide 
accumulation has been suggested to be a major factor involved in the progress from the benign 
NAFLD, to the much more malign state, non-alcoholic steatohepatitis (NASH) 229. Increased hepatic 
concentration of both saturated and monounsaturated free fatty acids also attenuate hepatic 
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insulin-receptor signaling 230, indicating that early metabolic programming of the balance between 
FFA and TAG concentrations in the liver might affect hepatic insulin sensitivity. Thus, only 
considering effects on hepatic TAG levels, but not these bioactive intermediates can be misleading 
in evaluating metabolic risks of the offspring to nutritionally challenged mothers. The aim of this 
study is therefore to determine how a maternal intake of a cafeteria type diet, high in fat and 
sucrose, prior to and during gestation, as well as during lactation affects accumulation and 
composition of hepatic lipids, the expression of genes involved in hepatic lipid and fatty acid 
metabolism and how these factors are related to the metabolic outcome at weaning. By using a 
cross-fostering model, we are able to distinguish between effects induced during gestation and 
lactation. Because of the problems in distinguishing between effects of difference in adiposity and 
direct dietary effects in obese rodent-models, we have developed a model in which the high 
fat/high sucrose intake do not lead to increased obesity in the dams, compared to intake of chow. 
Since the typical human junk food diet consists of a combination of high fat food and sucrose 
sweetened beverage, and some data indicate that intake of sucrose as beverage has a more 
adipogenic effect, than sucrose in solid food 139, we have chosen a model mimicking these 
conditions.  
 
Materials and methods 
Animal experiment 
Female obese prone rats (strain: OP-CD, Charles River, Kingston, United States) 8 weeks of age, 
were fed a high fat/high sucrose (60E% fat, D12492, Research Diets, Brogaarden, Denmark, 
supplemented with 15% sucrose water) or a control diet (10E% fat, D12450B, Research Diets, 
Brogaarden, Denmark) for 17 weeks. After 17 weeks of feeding, the female rats were mated by 
strain-matched male rats, what were fed a standard maintenance diet prior to mating (Altromin, 
Brogaarden, Denmark). At the end of gestation all the dams had natural deliveries. Female pups 
were euthanized the day after birth and blood and tissues were collected and treated as further 
described below. The male pups were cross-fostered the day after birth among dams on either 
control or HFHS diet, which resulted in 4 male offspring groups; born by control dams and lactated 
by control dams (CC), born by control dams and lactated by HFHS dams (CH), born by HFHS dams 
and lactated by control dams (HC) and born by HFHS dams and lactated by HFHS dams (HH). Litters 
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were standardized to 4-6 pups pr dam and dams were maintained on the respective diets during 
mating, gestation and lactation. After 4 weeks of lactation the male offspring were euthanized 
along with the dams. Blood and tissues were collected and treated as further described below. 
 
Weighing and blood sampling 
Dams were weighed and blood was collected from the tail vein after an overnight fast before 
gestation and after weaning. Offspring was weighted at birth and weekly throughout gestation. 
Blood was collected from the offspring non-fasted at day 1 by decapitation, and blood from 2-3 
pups was pooled for plasma generation. At 4 weeks of age, the male offspring was fasted for 4 
hours before blood from the tail vein were collected for blood glucose analysis. Then the offspring 
were anaesthetized with a ketamin/xylazine cocktail (200mg/kg body weight ketamin and 
10mg/kg body weight xylazine) and blood was collected by cardiac puncture for generation of 
plasma.  
 
Blood glucose and plasma parameters 
Blood glucose was analysed by a glucometer (On Call Plus, ACON laboratories, San Diego, United 
States). Plasma triglycerides were analysed on a Cobas Mira Plus with a Horiba ABX Pentra kit 
(Montpellier, France). Plasma insulin and leptin were analysed on a Meso Scale Selector Imager 
6000 with Meso Scale Discovery kits according to manufacturer’s instructions (Meso Scale 
Discovery, Rockwille, United States). Insulin and blood glucose measurements were used to 
calculate a qualitative insulin sensitivity check index (QUICKI), 1/(log(insulin) + log(glucose)) 231. 
 
Lipid analysis of mother’s milk and the offspring’s liver 
Stomachs from the female offspring at day 1, containing mother’s milk, were collected and snap-
frozen in liquid nitrogen and stored in -80◦ until analysis. The stomachs were divided into 2 pieces, 
one piece for protein extraction and 1 piece for lipid extraction. 
Proteins were extracted from mother’s milk by homogenizing half the content from a stomach into 
100µL of water containing a protease inhibitor, followed by 2 minutes of centrifugation at 
20.000xg. The supernatants were analyzed for leptin content on a Meso Scale Selector Imager 
6000 with a Meso Scale Discovery kit according to manufacturer’s instructions (Meso Scale 
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Discovery, Rockwille, United States) 
 
Lipid were extracted from the milk-bolus by the Folch method 232, after addition of 
trinonadecanoyl as internal standard and mQ-H2O to obtain the required ratio between 
CHCl3:MeOH:H2O (8:4:3) in the final extract. Fatty acid content and composition in the final lipid 
extract was analyzed as have been described 202. 
The livers were snap-frozen in liquid N2 and stored in -80
◦ until analysed.  Lipids were extracted 
using the Folch procedure, in the presence of internal standards for FFA, TAG and PL as has been 
described 202, in addition ceramide with C17:1 long-chained base (Avanti Polar Lipids, Alabaster, 
AL, US) was added as internal standard for ceramide quantification, prior to extraction. One 
aliquot of the lipid extract was used for PL, TAG and FFA analysis as described 202, and one aliquot 
used for quantification of ceramide, as described in Drachmann et al. 233, but using the above 
mentioned C17:1 ceramide as internal standard.. 
 
Histology 
Liver from the offspring were immediately fixed in 4% PFA until usage. Before the tissues were cut 
into 7µm frozen sections, they were left in 30% sucrose over night. Slides were washed in 60% 
Isopropanol, stained with Oil Red O (Sigma, St. Louis, MO, US) and counterstained with Mayer’s 
Haematoxylin (Sigma, St. Louis, MO, US) to detect lipid accumulation. 
 
RT-qPCR 
Liver samples was collected from female offspring at day 1 and male offspring after weaning and 
stored in RNAlater at 4°C for 24 hours and then at -80 until RNA extractions. RNA was extracted by 
a RNeasy kit (Qiagen) according to manufacturer’s instructions and converted to cDNA by a High 
Capacity cDNA Reverse Transcription kit (Invitrogen). Quantitative PCR was run on an 7900HT Fast 
Real-time PCR system (Applied Biosystem) with a Taqman Fast Universal PCR master mix (Applied 
Biosystems) and primers and probers for target genes from Integrated DNA Technologies (Iowa, 
United States) (Table 1). 
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Table 1: Primers for qPCR, 5’ FAM is the reporter signal from all the probes and 3’ Iowa Black FQ/ZEN is quencher  
Gene Forward primer Reverse primer Probe 
lpl  GCTTGTCATTCTCAGTTCCAGA  CCAAGAGAAGCAGTAAGATGTACC  CGCTCTCAG ATGCCCTACAAAGTATTCC  
atgl  CCAACGCCACTCACATCTAC  GCTTCCGAGCCTCCTTG  ATAATGTTGGCACCCGCTTCGC  
hsl  CTACAGGACTATGTCACGCTA  CTCGTTGCGTTTGTAGTGTTC  CTTCCAGTTCACACCTGCCATCCG  
chrebp  CCAGTAATTACCCTCCAAGACAA  GAGAGCCTGGTACATTCAGTATG  CAGATGAGCACCGGAAACCTGAGG  
srebf1  GAAGCGGATGTAGTCGATGG  GCTACCGTTCCTCTATCAATGAC  TTATTCAGCTTTGCCTCAGTGCCCA  
ucp1  GTCCCTAAGACACCTTTATACCT  CTAGCAGACATCATCACCTTCC  CCTGGCCTTCACCTTGGATCTGA  
cpt1a  AAAGTCAAAGAGCTCCACCTG  TGTCCAAGTATCTTGCAGTCG  CCTCCATGGCTCAGACAATACCTCC  
fasn  GCTGATACAGAGAACGGATGAG  GCGAGTCTATGCCACTATTCTG  AATGTCACGCCTTGCTCCTTGC  
cd36  CAATGAGTAGGTCTCCAACCG  TGCTCTTCCTTGATTCTGCTG  TGAGAATGCCTCCAAACACAGCCA  
ccaca  CATCTCTAACTTCCTTCACTCCTT  TGCCGAGTCACCTTAAGTACA  AGTCCTTCCTGCTCACACACTTCTG  
acox  GAACTTGATTCTGAACGACCCA  CACTCTTCTTAACAGCCACCT  TTCCTCACTCGAAGCCAGCGTT  
fads1  TGCTGCCTCTCTACTTCCA  GAAGACACGAACATAGAAGCTGA  AAGTCCACCCATTTCTTCCGCTGA  
fads 2  AAGACTGCTGAGGACATGAAC  TGCCGAAGTACGAGAGGAT  AGGCGATGCTTTCCATGACGATGA  
scd1  GATCTTCCTCATCATTGCCAAC  CGTGTGTCTCAGAGAACTTGT  TCCAGAACGATGTGTATGAATGGGCC  
elovl5  CCTGCTGTCTCTCTACATGTTC  CACCAGAGGACACGAATAACC  TTCCCACACACCTGTCACCAACTC  
b2m  CCAGATGATTCAGAGCTCCATAG  ACCGAGACCGATGTATATGCT  CCTGGGACCGAGACATGTAATCAAGC  
gapdh  GTAACCAGGCGTCCGATAC  GTTCTAGAGACAGCCGCATC  ATCCGTTCACACCGACCTTCACC  
 
Statistical analysis 
Not all data followed a Gaussian distribution or had equal variance among groups, so pre-natal 
effects at day 1, was evaluated by a two-sided two sample permutation test in the “coin” package 
in R (http://www.r-project.org/)207. Pre-natal and post-natal effects at weaning were analyzed by a 
permutated 2-way ANOVA in the “lmperm” package in R as described by Anderson (2001)207. Post 
test were performed as a pair-wise comparison between groups by a two-sided two sample 
permutation test and the p-values adjusted for multiple testing by the Holm method. Effects were 
considered significant when p<0.05. 
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Results 
Maternal metabolic phenotype 
Female rats were fed at control or a HFHS diet for 17 weeks prior to mating. During the 17 weeks 
of feeding, the rats on the HFHS diet had no increased weight gain when compared to the control 
fed rats, despite having a net energy intake that was 1.25 fold higher than the control diet (438 
kJ/d vs. 342 kJ/d, Table 2).  Also blood glucose, plasma insulin, leptin, TAG and insulin sensitivity, 
estimated by the QUICKI index, were similar between the two groups prior to mating (Table 3). 
There was neither difference in weight gain during gestation or litter size among the two groups. 
After lactation, the dams on the HFHS diet had similar body weight and weight of total fat pads 
when compared to the control fed dams. Also blood glucose, plasma insulin, leptin, TAG and 
insulin sensitivity (QUICKI) were similar between the groups after lactation, although there was a 
tendency toward increased leptin (p=0.06) and decreased plasma TAG (p=0.07) in the HFHS group.  
There was neither any difference in the total fat (Table 4) nor leptin content in the milk from the 
two groups (data not shown). There were however, significant differences in the fatty acid 
composition of the milk. Thus, while the endogenously synthesized monounsaturated palmitoleic 
(C16:1n-7) and cis-vaccenic acid (C18:1n-7) constituted 10 percent of total fatty acid in the control 
dams, they only constituted 5 percent in the HFHS fed dams (p<0.05). The milk-bolus from HFHS 
fed dams also contained considerably less fatty acids with a chain length  of 8 to 14 C (p<0.05), but 
more stearic acid (C18:0) (p<0.05) (Figure 1A).  To determine if these differences could be 
explained by the fatty acid composition in the two diets, we calculated the difference in percental 
distribution between the fatty acids in the milk-bolus and the diet (Figure 1B). These data show 
that the reduction in the monounsaturated n-7 FA and myristic acid, is due to reduced bio-
enrichment in the HFHS-dams, but that there is no difference in bio-enrichment (the difference 
between the percental contribution of the specific fatty acid in the milk fatty acid fraction, 
compared to the diet) of stearic acid between the two groups. Due to the extremely low levels of 
medium chained fatty acids in the diet ( <0.3% of total FA), bioenrichment could not be calculated. 
Figure 1A and B also show that there were no differences in the PUFA concentration in the milk, 
despite the relative higher level of both n-6 and n-3 PUFA in the control diet, but a larger intake in 
mass of PUFA, in the HFHS-diet.  
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Table 2: Macronutrient  and fatty acid composition of the two diets (high fat/high sucrose is based on 
bith food and sucrose-sweetened drinking water) .  
 
Control 
High fat/ 
high sucrose 
Protein E%  20 11 
Carbohydrate E%*  70 57 
Sucrose E%*  35 50 
Fat E%  10 32 
Fat intake (g/d)  0.65 ± 0.08 3.8 ± 0.6 
Carbohydrate intake (g/d)  10.4 ± 1.5 16.7 ± 1.8 
Protein intake (g/d)  2.96 ± 0.4 2.81 ± 0.5 
Energy intake (kJ/d)  342± 49 438 ± 39 
Myristic acid (C14:0)  0.9 ± 0.0 1.2± 0.0 
Palmitic acid (C16:0)  15.9 ± 0.0 20.2± 0.0 
Palmitoleic acid (C16:1D
9
)  0.8 ± 0.0 1.5± 0.0 
Stearic acid (C18:0)  7.6 ± 0.0 10.8± 0.0 
Oleic acid (C18:1D
9
)  27.6 ± 0.0 34.8 ± 0.0 
cis-Vaccenic acid  ((C18:1D
7
)  1.7 ± 0.0 2.1± 0.0 
Linoleic acid (C18:2D
9,12
)  39.3 ± 0.0 25.0 ± 0.0 
α-Linolenic acid (C18:3D
9,12,15
)  4.3 ± 0.0 1.8 ± 0.0 
w-6/w-3 ratio  9.2 ± 0.0 14.6 ± 0.0 
Ratio C16:0/C18:0  2.1± 0.0 1.9 ± 0.0 
* In HFHS the sum of consumed food and water with sucrose are reported. Fatty acid data are given as percent of 
total fatty acids  and are average ± range of duplicate determination.   
 
Table 3. Physiological data on the dams before mating and when euthized after lactation.  Data are 
given as average± stdev. N for control = 7 n for HFHS = 3  
 
Control  
High fat/  
high sucrose  
p-value  
Weight gain before mating (g)  124 ± 9  126 ± 16  ns 
Weight gain during gestation  (g)  132 ± 16  119 ± 8  ns 
Litter size  11.3 ± 1.0  10.0 ± 1.4  ns 
Body weight when euthanized (g)  352 ± 12  351 ± 15  ns 
Total weight of fat pads when euthanized (g)  26.6 ± 5.0  30.9 ± 9.1  ns 
Glucose before gestation  (mM)  4.63 ± 0.77  4.13 ± 0.68  ns 
Glucose when euthanized (mM)  3.74 ± 0.78  4.37 ± 0.74  ns 
TAG before gestation  (mM)  1.05 ± 0.24  1.07 ± 0.30  ns 
TAG when euthanized  (mM)  0.97 ± 0.23  0.66 ± 0.15  p= 0.07  
Insulin before gestation  1.46 ± 0.58  1.12 ± 0.19  ns 
Insulin when euthanized  1.36 ± 0.32  2.23 ± 1.08  ns 
QUICKI index before gestation  0.29 ± 0.02  0.30 ± 0.01  ns 
QUICKI index when euthanized  0.30 ± 0.02  0.28 ± 0.01  ns 
Leptin before gestation  3.12 ± 0.97  4.05 ± 1.36  ns 
Leptin when euthanized  4.54 ± 1.43  7.07 ± 2.19  p= 0.06  
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Metabolic phenotype at birth 
All pups were weighted the day after birth and the female pups were euthanized. Pups from HFHS 
dams tended to be slightly lighter (p = 0.06) than the control-pups, and female pups were 
significantly smaller than male (p<0.01) (Figure 1C).  The female pups born by HFHS dams had 
significantly smaller livers than the pups from control fed dams (p<0.05, Figure 1D), and the liver 
to body-weight ratio was borderline significant (p=0.052, data not shown). There was no 
difference in the mass of brown adipose tissue (BAT) or heart (Figure 1D). Although the maternal 
HFHS intake only had very small effects on maternal weight, and no significant effect on fat pad 
size, it had substantial impact on metabolic markers at birth (Figure 1E). Hence, HFHS pups had 
1.25-fold increased blood glucose (p<0.05), although there were no differences in insulin level, 
five-fold increased plasma leptin (p<0.05) and plasma TAG concentration in the HFHS group was 
only 28 percent of the concentration in control pups (p<0.05) (Figure 1E).  
 
 
Table 4. Fatty acid compostion in milk bolus received from the stomach of the euthanized female pups.  Data 
are given as average ± stdev mg*g
-1
. N for control = 6 (each n is average of two pups from one dam), N for HFHS 
=  3 .  
 
Control  
High fat/  
high sucrose  
p-value  
Medium chained-fatty acids ( C8:0+C10:0+C12:0)  0.46 ± 0.22  0.09 ± 0.07  P<0.05  
Myristic acid (C14:0)   3.36 ± 0.33  2.38 ±0.07  P<0.05  
Palmitic acid (C16:0)  62.6 ± 7.8  56.3 ± 3.1  ns  
Palmitoleic acid (C16:1D
9
)  13.9 ± 2.2  5.91 ± 1.08  P< 0.05  
Stearic acid (C18:0)  8.86 ± 1.07  12.7 ± 1.2  P< 0.05  
Oleic acid (C18:1D
9
)  85.5 ± 10.6  89.9 ± 7.2  ns  
Cis-vaccenic acid (C18:1D
7
)  10.4 ± 1.1  6.41 ± 0.69  P<0.05 
Linoleic acid (C18:2D
9,12
)  31.8 ± 6.7  39.0 ± 3.25  ns  
α-linolenic acid (C18:3D
9,12,15
)  1.07 ± 0.03  1.10 ± 0.25  ns  
Arachidonic acid  (C20:4D
5,8,11,14
)  12.1 ± 1.5  13.8 ± 0.8  ns  
Eicosapentanoic acid (C20:5D
5,8,11,14,17
)  0.83 ± 0.11  0.84 ± 0.01  ns  
Docosapentanonic acid  (C22:5D
4,7,10,13,16
)  0.78 ± 0.15  0.52 ± 0.17  p= 0.06  
Docosapentanonic acid  (C22:5D
7,10,13,16,19
)    0.94 ± 0.13  0.95 ± 0.04  ns  
Docosahexaenoic acid (C22:6D
4,7,10,13,16,19
)  1.49 ± 0.14  1.36 ± 0.28  ns  
Total fatty acids  243 ± 34  242 ± 19  ns  
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 Figure 1. Weight, metabolic parameters at the day after birth and fatty acid composition in mother’s milk. A) 
Weight of male and female pups from dams fed control-diet (open bars) and high fat/high sucrose diet (HFHS) (closed 
bars). Data are given as average ± std. dev. N for male control pups were 27 and female control pups 32, n for male 
HFHS were 19 and females 12. B) Organ weight in female pups at birth. Otherwise as in A. C) Metabolic plasma 
parameters in the pups at birth, otherwise as A.  D) Fatty acid composition in the milk bolus retrieved from the 
stomach of female pups the day after birth. Data are normalized to the concentration of each fatty acid in milk from 
the control mothers and are given as average ± std. E) Enrichment of the different fatty acids in mother’s milk, 
compared to the percentage of each fatty acid in the two diets. A value of 1, represents that the percental 
contribution of the fatty acid in mother’s milk equal its percental contribution in the diets.  
 * = p<0.05, ** = p<0.01 
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Hepatic lipid metabolism in female offspring at birth 
The pups from HSHF-fed dams had on average only one third as high hepatic TAG concentration as 
the control pups (4.62 vs. 14.94 mg/g) at birth (Figure 2A). The reduced hepatic lipid levels was 
also manifested in a less pronounced reduction in ceramide, while there were no differences in 
FFA or PL content (Figure 2 B-D).  The maternal HFHS diet caused substantial alterations in the FA-
composition of the hepatic lipids in the newborn pups, compared to the control diet.  Figure 2E 
show that hepatic phospholipids from the HFHS-pups were depleted in palmitoleic (almost 50% 
decrease, p<0.05) and cis-vacceninc acid (20% decrease, p<0.05) compared to the control pups, 
thus a similar pattern to what we observed in the milk. In the PUFA fraction, there was a skewing 
towards the initial steps in the biosynthesis of the n-6 long-chained PUFA (LC-PUFA) in the HFHS-
pups. Thus, they had significantly higher levels of linoleic acid (C18:2n-6) (1.4 fold increase, 
p<0.05) and di-homo- -linoleic acid (C20:3n-6) (1.2 fold increase) but reduced levels of the end 
product in this pathway, docosapentaenoic acid (C22:5n-6) (25 % reduction, p<0.05), while there 
were no difference in the concentration of arachidonic acid (C20:4 n-6). A similar tendency was 
seen in the n-3 LC-PUFA, were an average reduction in n-3 docosapentaenoic acid with 30 % was 
borderline significant (p=0.07) (Figure 2E).  
 
The increase in the FA representing the earlier steps and decrease in the final product of the 
transformation of the dietary linoleic acid to LC-PUFA, could either be due to the composition of 
the FA transferred over the placenta, or to altered hepatic FA metabolism in the fetuses. 
Therefore, we analyzed the FA-composition in plasma from the dams after they were euthanized 
(Figure 2F), as well as the gene expression for the enzymes involved in n-7 MUFA (stearoyl-CoA 
desaturase I (SCDI) and LC-PUFA synthesis (FADS1, FADS2, ELOVL5) (Supplementary figure 1), in 
fetal livers. The maternal plasma fatty acid composition, showed the same pronounced decrease 
in n-7 MUFA (Figure 2F), as we observed in the milk bolus (Figure 1A) and the fetal hepatic PL 
(Figure 2E). There was no significant difference between the two groups in the relative content of 
PUFA, in the maternal plasma (Figure 2F). None of the assayed genes was statistically significantly 
differently expressed in the HSHS born pups, although SCD1 was borderline increased (p=0.06) 
(Supplemental figure 1).  
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Figure 2. Hepatic lipids and fatty acid composition in the female pups the day after birth.  A) Hepatic lipid 
composition (A- D) as well as the fatty acid composition in hepatic phospholipids (E) and fatty acid composition of 
total lipids in maternal plasma at weaning (F). In E  and F data are normalized to the percental contribution of each 
fatty acid to the total fatty acid pool in the pups born by control mothers.  
N for control pups were 12 and for HFHS pups 6. N for dams in figure D was 4.  
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Figure 3. Body weight, organ weight and metabolic plasma markers at 4-weeks of age.  A-B) Growth curves (A) and 
weight-gain (B) for the pups during lactation. ** = pre-natal effect p<0.01, *** = prenatal effect p<0.001, $$ = post-
natal effect p<0.01, $$$ = post-natal effect p<0.001 C-E)  Organ weights at 4-weeks of age. F-H) Fasting blood glucose, 
fasting plasma insulin and the derived QUICKI values,; I) Plasma leptin levels and J) Plasma TAG concentrations.  
* = p<0.05, ** = p<0.01, *** = p<0.001 between the connected groups.  
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Weight of offspring during lactation 
After birth, the male offspring were cross-fostered, meaning that control- and HFHS-born pups 
were lactated by either control (CC, HC) or HFHS dams (CH, HH). The pups were weighted weekly 
and at 1 week of age, pups born by HFHS dams (HC, HH) had lower body weight than the control-
born groups (CC, CH) (pre-natal effect, p<0.01), independent of the diet of the lactating dam 
(Figure 3A). This pre-natal effect was maintained throughout lactation (p<0.01 at week 2, p<0.01 
at week 3, p<0.001 at week 4), but at 3 and 4 weeks of age the pups lactated by HFHS dams had 
increased body weights compared to the control lactated pups (post-natal, p<0.01 and p<0.001 
respectively). The total weight gain during lactation was decreased in the HFHS-born pups (HC, 
HH) compared to the control born (CC, CH) (pre-natal, p<0.01), but the weight gain were increased 
in HFHS-lactated pups (CH, HH) compared to control-lactated pups (CC, HC) (post-natal, p<0.0001) 
(Figure 3B). Hence only weight-gain in the CH group was significantly higher than in the groups 
lactated by control dams.  
 
Metabolic status at weaning 
HFHS born pups had decreased adipose tissue mass compared to the control-born pups (pre-natal, 
p<0.0001), but lactation by HFHS dams increased adiposity to a larger extent than lactation by 
control dams (post-natal, p<0.0001) (Figure 3C). Thus, epididymal fat pads were largest in the CH 
group (0.574g ± 0.09), followed by the HH group (0.451g ± 0.08), then the CC group (0.248g ± 0.04) 
and finally the HC group (0.205g ± 0.03) (Figure 3C). The same pattern was seen on the weight of 
the liver; pre-natal exposure to HFHS diet decreased the weight (p<0.01), while post-natal 
exposure to HFHS during lactation increased the weight (p<0.001), resulting in significantly larger 
livers in the CH pups compared to CC pups (Figure 3D), also when calculated as percent of 
bodyweight (data now shown). There were no pre-natal effect on the weight of the hearts, but 
pups lactated by HFHS dams had increased heart weights compared to the control lactated pups 
(p<0.0001) (Figure 3E). 
Blood glucose was measured in blood from the tail vein before the animals were anaesthetized. 
Glucose levels were significantly increased in the groups representing a mismatch between 
pregnancy and lactation, the CH and the HC groups (p<0.01 and p<0.05, respectively), when 
compared to the control (CC) group (Figure 3F). Plasma insulin levels were increased in the HFHS 
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lactated pups (post-natal, p<0.0001, Figure 3G). It is noteworthy that this was not the case in the 
HC group, despite the increased glucose level. HFHS-lactated pups also had a decreased insulin 
sensitivity, shown by a decrease in QUICKI value (post-natal, p<0.001) (Figure 3H), and increased 
plasma leptin levels (post-natal, p<0.0001) (Figure 3I). Plasma TAG was decreased in the CH group 
compared to the control (CC) group (p<0.001), this was the only effect seen on plasma TAG (Figure 
3J). 
 
 
 
Figure 4. Hepatic lipid accumulation and composition.  The livers from the animals sacrificed at 4 weeks of age were 
Oil Red O stained (A=CC, B=CH, C=HC, D=HH) to visualize lipid accumulation and the concentration of specific lipid 
classes were chemically analyzed (E-H). The fatty acid composition of hepatic phospholipids and free fatty acids were 
analyzed by principal component analysis, and the derived principal component 1 (PC 1) and 2 (PC 2) were tested for 
significant variation between the treatments (I-L). Since the PCA analysis indicated an altered production of long-
chained PUFA from C18-PUFA, we calculated their ratio in phospholipids and free fatty acids (M-N). Otherwise as in 
figure 3 
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Lipid composition and lipid metabolism in male offspring at weaning 
At four weeks of age, HFHS-lactated pups have increased hepatic lipid-levels, as seen in the oil-red 
O staining (Figure 4 A-D) and in the results from the chemical analysis of hepatic TAG (post-natal, 
p<0.0001) (Figure 4E). The hepatic phospholipid (PL) content was also significantly affected by the 
dietary treatments, the CH pups had an increased concentration of PL compared to CC and HC 
(p<0.05 vs. CC and HC, and p<0.08 vs. HH) (Figure 4F). Unexpectedly, hepatic ceramide levels were 
decreased with about 20 % (post-natal, p<0.001) in animals lactated by HFHS mothers, compared 
to the control lactated pups (Figure 4G).  There was an interaction between the pre-natal and 
post-natal exposure in the effect on hepatic free fatty acid concentration, with a tendency to 
increased free fatty acids in the CH-group (p=0.07) and a significant increase in the HC groups 
p<0.05) (Figure 4H).  
In order to detect potential changes in the total fatty acid composition of the glycerolipids, we 
performed principal component analysis on these data sets (Supplemental figure 2 for score and 
loading plots), and tested the derived principal components for treatment effects. For PL and TAG, 
separation along the first principal component, which explained 62 (PL, supplementary 2A-B) and 
78 (TAG, supplementary 2C-D) percent of the variation in the data, was driven by the postnatal 
treatment (p<0.0001). However, separation along the second principal component, explaining 11 
(PL) and 12 (TAG) percent of the variation, was significantly affected by the prenatal treatment 
(p<0.05 and p<0.01 for PL and TAG, respectively) (Figure 4I-J for PL, data not shown for TAG). 
While the postnatal intervention had a dominating role in determining the TAG and PL fatty acid 
composition, this was not the case for the free fatty acids. For the free fatty acids, both pre- and 
postnatal treatments had strongly significant effects (p<0.0001 for both) effects on PC 1, as well as 
a  significant interaction (p<0.01, Figure 4K). This was in particular driven by the separation of the 
HC group, from the other three groups along PC 1 (Supplemental figure 2 E-F). Only the post-natal 
treatment had significant effects on PC 2, although a significant treatment interaction effect and a 
significant difference between CC and HC (p<0.05) indicates that the pre-natal exposure to the 
HFHS-diet affected the response to the post-natal control diet s (Figure 4L). From the loading plots 
for PL and TAG, it is evident that the first endogenous product in the n-6 pathway, α-linolenic acid 
(C18:3n-6), have strong impact on the distribution along PC 2, and among the major fatty acids, 
C18:2 n-6 and C20:4 pulls the samples apart along this axis. Since this indicate that the 
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biotransformation of the dietary derived C18-PUFA to C20 and C22 was affected by the prenatal 
treatment, we calculated the ratios between the long-chained (C20 and C22) and C18 PUFAs, as a 
measure of the efficacy in the PUFA biosynthetic pathway. The efficacy was decreased by both 
pre- and post-natal exposure to the HFHS diet, as seen in Figure 4M for PL (a similar result was 
seen in TAG, data not shown) and Figure 4N for free fatty acids.  
 
To assay whether the increased amount of hepatic FFA in the pups that had been exposed to a 
dietary mismatch (HC & CH), was due to transcriptional up-regulation of hepatic fatty acid uptake, 
fatty acid synthesis or reduced β-oxidation, we analyzed mRNA levels for the rate-limiting 
enzymes, as well as the transcription factors, controlling these processes (Figure 5A-F). The results 
show that the hepatic metabolism was transcriptionally adapted to the increased fatty acid load in 
the HFHS-lactated pups, but dietary mismatch did not alter transcriptional regulation of these 
genes. Thus, postnatal HFHS-exposure caused increased expression of the fatty acid transporter 
CD36 (p<0.0001), reduced expression of genes involved in fatty acid synthesis (FAS, p<0.001) and 
acetyl-CoA carboxylase (ACACA, p<0.01) and a slight increased expression of genes for enzymes 
controlling mitochondrial and peroxisomal β-oxidation (Cpt1a, p<0.05 and ACOX, p<0.05). In the 
pups lactated by HFHS-dams, Srebf1 was also increased (p<0.001). 
 
We also determined the expression of the genes involved in synthesis of LC-PUFA, the desaturases 
FADS1 and FADS 2 as well as the elongase ELOVL5. Expression of both FADS1 and FADS2 were 
significantly reduced by the pre-natal, but not by the post-natal HFHS exposure (Figure 5G-H). 
However, ELOVL5 was up-regulated by the postnatal HFHS exposure and, strikingly, the gene 
expression of SCD1, was almost totally inhibited in animals lactated by HFHS-fed dams (Figure 4I-
J). Hence, pups lactated by control dams had 60-fold higher expression of SCD1 (Figure 4I).  
To get an integrated quantification of the parameters related to metabolism and hepatic lipids, we 
performed a PCA analysis in which we combined the general metabolic data and hepatic liver 
masses (Figure 6). The resulting score-plot show that the postnatal effect is driving the separation 
along PC1 (p<0.0001), but that there are a strong interaction factor (p0<0001), caused by the 
separation of that the CH-group from the HH group (CH vs HH p<0.05), showing that the metabolic 
parameter in CH group deviates most from the control-animal (Figure 6).   
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Figure 5. Expression of genes related to hepatic fatty acid metabolism. mRNA level of  related to fatty acid uptake 
(A),  fatty acid synthesis (B-D), β-oxidation (E-F), PUFA desaturation (G-H), MUFA synthesis (I) and elongation of PUFA 
(J) was quantified using RT-qPCR. Otherwise as in figure 3. 
 
Lipid metabolism in adipose tissue at weaning 
Altered dynamics in adipose fatty acid metabolism and release of fatty acids could explain the 
increased level of FFA in the mismatched groups, therefore we investigated expression of genes 
coding for the enzymes responsible for fatty acid flux in the epididymal adipose tissue (Figure 7). 
The pups that had been exposed to HFHS during lactation had increased mRNA levels of 
lipoprotein lipase (LPL), adipose triglyceride-lipase (ATGL) and hormone-sensitive lipase (HSL) 
compared to control exposed pups (post-natal, p<0.05 for all three genes). The level of mRNA for 
ATGL was furthermore decreased in epididymal adipose tissue in pups born by HFHS-fed dams 
(pre-natal, p<0.05), while no effects of the pre-natal exposure were seen on LPL and HSL. ChREBP 
was also increased in HFHS lactating pups (post-natal, p<0.05), but no effect were seen of the 
mRNA level of Srebf1. UCP-1 mRNA levels were decreased in HFHS born pups (pre-natal, p<0.01), 
whom also showed increased mRNA level of Cpt1a (pre-natal, p<0.05). There were no pre-natal or 
post-natal effects on the mRNA level of Fasn. 
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Figure 6. Principal component analysis of the combined phenotypic parameters.  A PCA was performed, loading 
body weight, metabolic plasma parameters and the hepatic concentration of the different lipids. A) Score-plot, B) 
Loading plot. C-D) PC1 and 2 for the different groups. Otherwise as in figure 3.   
 
 
Figure 7. Gene expression of genes related to fatty acid flux in epididymal white adipose tissue.  
mRNA for genes involved in adipose fatty acid uptake (A), TAG hydrolysis (B-C) , fatty acid oxidation (D and E) and fatty 
acid synthesis (F-H) were analyzed using RT-qPCR.  
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Discussion 
Exposure to a maternal high energy diets during gestation and lactation increases the risk of 
metabolic dysfunction in the offspring later in life and causes changes in hepatic lipid metabolism 
in the offspring that are evident already at birth. However, less is known on whether changes in 
maternal diets during lactation can reverse these changes, or whether a dietary mismatch 
between pregnancy and lactation will worsen the metabolic consequences. This study uses a 
maternal HFHS dietary rat model and reports acute effects in the male offspring at weaning. 
Furthermore, the offspring has been cross-fostered during lactation, which made it possible to 
investigate matched (CC and HH) and mismatched (CH and HC) predictive adaptive responses in 
the offspring. 
 
The maternal HFHS dams used in this study had similar body weight, blood glucose, plasma insulin 
levels, insulin sensitivity, leptin and TAG levels as the control-fed dams. Thus, the effects reported 
in the offspring were primary caused by dietary pre- and post-natal exposure, and not maternal 
metabolic changes or obesity, which can develop during HFHS feeding. 
At birth, the male and female pups born by HFHS dams tended (p=0.06) to have decreased body 
weight as well as reduced liver weight. Along with a tendency to growth retardation, the HFHS 
offspring had increased blood glucose and plasma leptin levels, while no effect on insulin levels 
were seen. It is important to note that control and HFHS dams had almost identical protein 
intakes, the tendency to lower weight in the HFHS-born pups can therefore not be explained by 
protein restriction. Additionally the HFHS pups had decreased plasma TAG levels and decreased 
levels of hepatic TAG and ceramide.  
 
HFHS-weaned pups had an increased body weight compared to the control-lactating offspring at 3 
weeks of age. We suspect that this weight gain was caused by the pup’s natural dietary changes 
around 2-3 weeks of age, where their primary nutritional intake no longer is dominated by the 
mother’s milk. At 3 and 4 weeks of age the CH group was significantly heavier than the control 
(CC) group, potentially due to the combination of exposure to a control diet during fetal life and 
HFHS diet during lactating, which both increased the offspring’s body weight. The increased body 
weight was caused by elevated adiposity in the HFHS weaned offspring, but the CH offspring had 
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larger epididymal fat depots than any of the other groups, including the HH group. This result 
indicates that adiposity is controlled by a predictive adaptation in fetal life, potentially through a 
higher energy expenditure in the HH group than in the CH group. Additionally, the HC group also 
had decreased epididymal fat depots compared to the CC group. This data support that a 
mismatch between the predicted adaptive response during fetal life and the actual post-natal 
environment are important in determining adiposity.  
 
The observed reduced birth and liver weight as well as the reduced hepatic and plasma lipid levels 
at birth in pups from high energy-fed dams is in accordance with the finding by Zhang et al (2011) 
in pups born by rat dams fed a chocolate and high fructose beverage diet 39 and  Krasnow et al 
(2011) in pups born by high fat fed C57/bl5 mice dams 234. In the latter study, the authors also 
analyzed body composition of the neonates, showing that pups from HF-fed dams had more body 
fat, than the control pups. This indicate that, at least in a mouse-model, the observed effects on 
hepatic and plasma lipids is not due to reduced placental energy transfer, but rather altered fat 
distribution and metabolism, pointing toward a reduced capacity for lipid storage in the fetal liver 
as a target for this programming.  
A comparison of the maternal plasma fatty acid composition with the fatty acid composition in 
hepatic phospholipids in the newborn pups (Figure 2E and F), also indicates that the fetal fatty acid 
metabolism is affected by the maternal HFHS-diet. Thus, while there were no difference in plasma 
PUFA composition between the dams, there is a very pronounced skewing toward incorporation 
of the shorter chained, less unsaturated, PUFA (i.e increased C18:2 n-6 and decreased 
incorporation of C22:5 n-6) in the HFHS-born pups. This indicates that synthesis of the long-
chained PUFA from the dietary C18-precursors is hampered in the HFHS-born pups.  Synthesis of 
long-chained PUFA takes place through desaturation and elongation of the dietary essential fatty 
acids, linoleic and α-linolenic acid. The desaturation is catalyzed by the Δ5- and Δ6-desaturase 
(FADS1 and FADS2, respectively), and elongation by the elongase ELOVL5 235,236. In the rodents, as 
well as in humans, FADS1 and 2 are localized in close proximity in a gene-cluster, and gene 
expression is to a large extent controlled by the same factors, were in particular dietary PUFA 
intake have strong inhibitory effects on their expression 237.  Analyses of mRNA levels for these 
enzymes in the liver at birth did not show any significant differences in their expression, although 
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average FADS1 mRNA level was substantially lower than for the control animals  (Supplemental 
figure 1), but at weaning, a very strong inhibitory effect of the prenatal high energy diet was 
evident on the FADS-genes. Thus in both the HC and HH groups was average mRNA level for FADS1 
only 50% of what was found in pups born by chow-fed dams, and the expression of FADS2 was 
similarly down-regulated in the HFHS-born pups, although not to the same extent (figure 5G and 
H). This is partly in accordance with recent findings, that in rat mothers, increasing intake of butter 
during pregnancy and lactation, programs a reduced expression of FADS2 but not FADS1 in the 
offspring at 2.5 month of age, through increased methylation of several sites in the promoter 
region of the FADS2 gene 238. However, in addition to the findings by Hoile and co-workers, our 
data shows that it is the prenatal, but not post-natal exposure to the high energy-diet that 
programs FADS expression-pattern. It should however be noted, that interpretation of these 
results is not straightforward. Although the HFHS-diet in present study contained a lower 
concentration of linoleic and α-linolenic acid, than the control diet, the high fat fed dams in our 
study, as well as in the by Hoile et al, have had a higher intake of PUFA than the low fat fed 
controls. Hence, in our study was the average PUFA intake among the HFHS-fed dams 1.0 g/day 
and in the control dams 0.27 g/day and in the study by Hoile et al. had the HF fed dams 6 times 
higher absolute PUFA intake, than the low fat fed. Thus, we cannot exclude that it is the higher 
absolute PUFA intake, rather than high fat intake, that cause the programming. In our study, the 
changes in expression of FADS and EVOVL5 only resulted in minor changes in the fatty acid 
composition of hepatic lipids at weaning, but it cannot be excluded that the in utero programming 
of hepatic FADS expression will lead to lower PUFA supply to the tissues later in life, as for 
example seen as a reduced C20:4 n-6/C18:2 n-6 ratio in hepatic lipid at 90 days of age in pups born 
and lactated by cafeteria-diet fed dams in a study by Bouanane et al. 239 and a reduced C20:4 n-6 
and C22:6 n-3 concentrations in hepatic PL in the earlier mentioned study by Hoile and co-workers 
238.   
 
In all analyzed samples; mother’s plasma mother´s milk, neonate livers and livers at 4 week of age, 
the concentration of the n-7 unsaturated monounsaturated fatty acids were downregulated. 
(figure 1A-B, figure 2E-F and supplemental figure 2). The n-7 monounsaturated fatty acids are 
synthesized from palmitic acid by stearoyl-CoA desaturase I (SCDI), and while this expression of its 
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gene tended to be up-regulated in the liver of the newborn dams, it was almost fully inhibited in 
the livers of the 4 week old pups that had been lactated by HFHS-fed dams. Hepatic SCD1 
expression is down-regulated by increased PUFA-load and by leptin, but up-regulated by insulin 
240.  Thus, the most likely explanation for the observed 60-fold decrease in SCD1 expression in the 
HFHS-lactating pups is their increased leptin levels. As further discussed below, the reduction in 
synthesis of palmitoleic acid (C16:1 n-7) in the HFHS-lactated pups, might have metabolic 
implications. 
 
It is also noteworthy that the phenotype with increased blood glucose without a concomitant 
compensatory rise in insulin seen at birth in the HFHS-born female pups (Figure 1E), also is evident 
at 4 weeks of age in pups that have been cross-fostered to control mothers during lactation (HC 
group in Figure 3F and G). This suggests that fetal exposure to a high fat/high sucrose diet, without 
maternal obesity, cause relatively persistent alteration of glucose homeostasis, which is not 
reversed by a normal diet during lactation. This could indicate altered β-cell function already at 
birth, manifested as reduced glucose-induced insulin secretion. It was earlier shown that islets 
isolated from 9-month old rats born by dams fed high fat diet had reduced glucose-induced insulin 
secretion, although this was not manifested as an altered fasting glucose:insulin ratio, as we see in 
present study 241, and in a recent study, newborn mice born by high fat fed dams had almost 50 % 
reduced β-cell mass at birth, compared to pups born by control dams 242.  However, as seen by the 
raised fasting insulin (figure 3G) and the QUICKI data in figure 3H, exposure to the high energy diet 
in both pre- and post-natal life cause most severe effects on insulin sensitivity in the pups at 
weaning.   
 
While there were only subtle differences in the PUFA-composition of the hepatic lipids at 4 weeks 
of age, the effects on the content of the different lipid classes were more pronounced. Thus, as 
seen in many other studies, lactation from the HFHS-fed dams, cause pronounced increase in 
hepatic TAG, but also a decrease in ceramide levels that have not been reported elsewhere. In 
utero exposure to the HFHS-diet did not have any impact on these effects. While the post-natal 
effect on TAG concentrations was expected, the reduced ceramide levels was surprising, since 
ceramide synthesis is induced by excess palmitic acid 243, which the HFHS-diet is expected to 
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supply. However, in a recent study, it was suggested that the hepatocytes rapidly secrets excess 
ceramide, when ceramide synthesis is induced by fatty acid oversupply, as a protective mechanism 
against its lipotoxic effects 244. Thus, an up regulation of hepatic ceramide secretion, could 
potentially explain the observed decrease in hepatic ceramide in the pups-lactating from HFHS-fed 
dams.  The mismatch between maternal diet during gestation and lactation altered hepatic lipid 
composition, in a way that has not been earlier reported. Thus, being born by control-fed and 
being lactated by HFHS-fed dams, caused an increase in total PL per mass liver in the CH group and 
both HC and CH pups had increased FFA, although only the effect in the HC-group reached 
significance. Since the amount of PL is a proxie for membrane area, this indicates that 
ultrastructural changes leading to a larger membrane area per mass liver (for example smaller cell-
size or increased area of intra-cellular membrane systems) have taken place. Based on the 
available data, we cannot explain this effect, and to the best of our knowledge, it has not been 
reported elsewhere.  The increase in hepatic FFA is potentially important, since in the liver, FFA 
reduce signaling from the insulin receptor 230, potentially by inducing hyperactivity of protein 
phosphatase 2A 245. Additionally, saturated fatty acids induce endoplasmic reticulum stress and 
they function as precursor for synthesis of other lipotoxic intermediates such as acyl-CoA, 
diacylglycerol and ceramides 246. The gene expression pattern for the assayed genes responsible 
for hepatic fatty acid uptake (CD36), synthesis (FAS, ACACA and SREBF1) or fatty acid oxidation 
(Cpt1a and ACOX), did not reveal any transcriptional regulation that could explain the increased 
FFA concentration in the mismatched groups, all these genes was regulated by the postnatal 
HFHS-exposure, in a way that would decrease hepatic fatty acid load. The gene-expression analysis 
of the enzymes involved in fatty acid flux in the adipose tissue did show that the CH group had 
increased expression of lipoprotein lipase, and tended (p=0.054)  to have an increased expression 
of the adipose triglyceride lipase (ATGL). Since LPL catalyze the extracellular hydrolysis of TAG that 
is required for uptake of fatty acids to adipose tissue, and ATGL catalyze the rate-limiting step in 
hydrolysis of TAG required for release of fatty acid from adipose tissue, this could indicate that HC-
pups had an increased fatty acid turn-over in the epididymal adipose tissue (figure 7), but these 
data do not explain the increased FFA concentration in the liver of pups exposed to dietary 
mismatch.  
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Although we found pronounced effects of the post-natal maternal diets, there was no difference 
in fat or leptin content in the mother´s milk from HFHS or chow-fed dams. This is in  contrast to 
finding in other studies 247. It shall however be noted, that dams in present study had similar 
adiposity, while the dams in the study by Franco et al. were more obese than the control dams, 
which might explain the discrepancies in results. Furthermore, in present study we were only able 
to sample colostrum, we can therefore not conclude anything on the milk composition later on in 
lactation. There were however substantial differences in the milk fatty acid composition that 
might be relevant for the metabolic effects in pups lactated by HFHS dams, which cannot be 
explained by the maternal dietary FA-composition. As seen in figure 1A, milk from HFHS-fed dams 
contained substantially less n-7 monounsaturated and medium-chained (C8 – C14) fatty acids.  The 
medium-chained FA is synthesized in the mammary gland and the mammary fatty acid synthesis is 
down-regulated when the mother has high levels of circulating lipids 248. Medium chained fatty 
acids, in contrast to longer fatty acids, are to a large extent absorbed via the portal veins directly 
to the liver, where they are oxidized by a carnithine-independent pathway 249.  This is in contrast 
to the longer fatty acids, that are absorbed via the chylomicron-pathway and are systemic 
circulated before being taken –up by the liver as chylomicron remnants. Thus, the reduced levels 
of MCFA in the milk from HFHS-dams will lead to reduced hepatic exposure to fatty acids in the 
very early life in pups lactating from these mothers. Although speculative, this might mean that 
these pups are less primed for hepatic fatty acid oxidation during the postnatal developmental 
window which could cause reduced fatty oxidation later in life. The decrease in palmitoleic acid 
observed not only in mother´s milk, but in all lipid samples in this study, could also have 
consequences for metabolic regulation in the pups. In rodents, it has been suggested that 
palmitoleic acid function as lipokine, increasing muscle insulin sensitivity and suppressing hepatic 
steatosis in mice 250. Furthermore, chronic administration to palmitoleate reduces insulin 
resistance and hepatic lipid accumulation, as well as increases satiety and increase the release of 
appetite-reducing hormones in rats, when compared to other similar FA 251,252.  Thus, the drastic 
reduction in its intake in the pups from the HFHS-dams, as well as the reduced synthesis from 
palmitic acid due to the strong inhibition of SCD1 during lactation, could skew the metabolic 
regulation toward a phenotype with reduced insulin sensitivity and increased hepatic lipid load, 
and could therefore partly explain the observed reduced insulin sensitivity, measured as decrease 
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QUICKI value, and increased hepatic TAG levels, in the HFHS-lactating pups.  
 
In figure 6, we summarize the results using a PCA analyzing, and the most important result from 
this is that a dietary mismatch between the control diet in utero and the maternal high fat/high 
sucrose intake during lactation, cause more severe phenotypic alteration in the studied metabolic 
parameters at weaning than when the pups have been exposed to the HFHS-diet both in utero and 
during lactation, as seen in figure 6. This is in good accordance with the predictive adaptability 
hypothesis, indicating that epigenetic adoptions occur in utero, that predisposes the fetuses to, in 
this case, the exposure to a diet with high energy diet after birth.  The loading plot shows that it is 
the increase in weight, leptin and phospholipid level that are the primary drivers for this 
separation.   
To conclude, we have in this study shown that that maternal high fat/high sucrose feeding during 
gestation and lactation have partly different effects on metabolic parameters and on hepatic lipid 
status at weaning in rat pups. The prenatal exposure has a very strong inhibitory effect on 
expression on FADS1 and 2, while a mismatch between pre- and postnatal diet cause increased 
level of hepatic free fatty acids.  
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Supplementary material  
 
Supplementary figure 1. Fatty acid composition of triacylglycerols in the liver at the day after birth.  Data are 
normalized to the percental contribution of each fatty acid to the total fatty acid pool in the pups. Open symbols = 
control pups, closed symbols = pups born by HFHS-mothers. N for control pups were 12 and for HFHS pups 6. 
 
 
Supplementary figure 2. Principal component ananlysis of the fatty acid composition in hepatic phospholipids, 
triacylglycerols and free fatty acids at four weeks of age.  Upper panel show score plots and the lower panel the 
loading plots. 
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5. The impact of maternal pre- and post-natal intake of high fat/high 
sucrose diet on metabolic adaptability to a high fat diet in adult rat 
offspring 
 
Camilla Ingvorsen, Lars I. Hellgren 
Abstract 
Objective Maternal high fat feeding during gestation and lactation is associated with increased adiposity, 
decreased insulin sensitivity and elevated hepatic lipid accumulation. The phenotype is particular 
pronounced when the offspring have been exposed to a control diet during pregnancy and then transferred 
to an obesogenic diet after birth, possible due to the mismatch between the pre- and post-natal 
environment. Low birth weight is associated with reduced metabolic flexibility and adaptation when 
challenge with a high fat diet, but it is not known whether exposure to high energy diets during gestation 
and/or lactation have similar effects, or whether this will improve their capacity to metabolically cope with 
the high fat challenge, in accordance with the predictive adaptability hypothesis. Therefore we have 
investigated if rats exposed to maternal high fat/high sucrose diet during gestation and/or lactation have 
impaired metabolic adaption when challenged with a high fat diet in adulthood. 
Methods Female obese prone rat were fed a control (C) or a high fat/high sucrose diet (HFHS) for 6 weeks 
prior to mating. Female offspring were euthanized and characterized at birth. Male offspring were cross-
fostered on complementary diet during lactation, after which they were weaned on to a control diet from 
4-20 weeks of age followed by 6 weeks of high fat feeding, and subsequently euthanized and characterized.  
Results The dietary challenge increased body weight in all offspring, however HFHS lactated offspring had 
elevated adiposity and plasma leptin levels compared to C lactated offspring. Additionally, the leptin level 
was decreased in the HFHS born offspring, which indicates that they might be protected against 
hyperleptinemia during the dietary challenge. Insulin sensitivity was altered to the same extend in all 
groups during the dietary challenge and there were found no alteration in plasma TAG. The weight of the 
liver was elevated during the challenge probably due to accumulation of hepatic triacylglycerides. Prenatal 
HFHS exposure increased the hepatic concentration of free fatty acids, and if the offspring additionally 
were postnatal HFHS exposed the accumulation was even higher. These alterations could not be explained 
by changes in mRNA levels of genes involved with hepatic lipid metabolism. Hepatic ceramide content was 
surprisingly decreased by the dietary challenge.  Hepatic phospholipid content was not affected by the 
dietary challenge but HFHS lactated offspring showed elevated levels which indicated ultrastructural 
changes in the hepatocytes.  
Conclusion Maternal intake of a HFHS diet during pregnancy and lactation alters the metabolic response to 
a high fat diet in the adult offspring. In particular leptin secretion and accumulation of hepatic free fatty 
acids was affected 
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Introduction 
Obesity and metabolic dysfunction are rapidly increasing in children, which later in life enhances 
the risk of severe metabolic disease 253.  Maternal obesity during pregnancy, which also is an 
escalating problem,  might account for a part of the explanation, since it is known to enhance the 
risk of obesity, type-2 diabetes, cardio-vascular disease and non-alcoholic fatty liver disease in the 
offspring later in life 4,254,255. Animal studies have shown that pups exposed to maternal obesity 
during gestation and lactation have increased adiposity, decrease insulin sensitivity and  elevated 
hepatic lipid accumulation, which can develop into non-alcoholic fatty liver disease (NAFLD).  
Additionally, increased hepatic mRNA levels of inflammatory cytokines and fibrogenesis have been 
reported 26,32,36,140. This impaired metabolic phenotype is particular pronounced, if the offspring 
has been prenatally exposed to a control diet and then transferred to an obesogenic environment 
after birth 26,32. It has been suggested that maternal obesity is necessary for metabolic imprinting 
in the offspring 256, but several studies have subsequent contradicted this finding by showing that 
maternal high fat feeding alone can affect the offspring 37,39,41. 
Maternal obesity or high fat feeding during pregnancy alter lipid metabolism in the offspring and 
increases hepatic lipid accumulation, which can develop into non-alcoholic fatty liver disease 
(NAFLD), already at birth in mice (Ingvorsen et al, submitted, Chapter 3), non-human primates 41 
and human neonates 194,224. Thus, these children suffer from impaired hepatic lipid metabolism 
from perinatal life, leading to increased hepatic fat accumulation, with potential trajectories 
towards metabolic diseases later in life.  NAFLD is considered benign, but it is often linked to 
accumulation of toxic lipids, such as ceramide and free fatty acids (FFA) 228. Ceramide is known to 
attenuate insulin signaling, induce apoptosis, cause formation of reactive oxygen species (ROS) 
and induced inflammation in the liver 229, while in particular saturated FFA also reduce signaling 
from the insulin receptor and cause endoplasmic reticulum stress in hepatocytes 230,246. Thus, both 
ceramide and free fatty acids has been suggested to play a pivotal role in the progression from 
benign NAFLD towards the more malign state, non-alcoholic steatohepatitis (NASH) 229,246. The 
early effects on hepatic lipid accumulation persist in the young adult rodents 26,257 alongside with 
increased hepatic inflammation and hyperinsulinemia, even when they have been fed a control 
diet after weaning 26. While studies in human subjects by Brøns and colleagues have shown that 
healthy young males born with low birth weight has less metabolic flexibility when challenged 
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with a high fat diet 258, and therefore display limited metabolic adaptations in response to dietary 
challenges 57, nothing is known on whether similar reduced metabolic adaptability are manifested 
in subjects exposed to overnutrition in utero and/or during lactation. Therefore we have 
investigated if perinatal maternal intake of a high fat/high sucrose diet during gestation and/or 
lactation influences the capability of the offspring to deal with a high fat load as adults, with 
particular focus on hepatic lipid metabolism. Since the typical human junk food diet consists of a 
combination of high fat food and sucrose sweetened beverage, we have chosen a rat model 
mimicking these conditions.  
 
Materials and methods 
Animal experiment 
Female obesity-prone rats (strain: OP-CD, Charles River, Kingston, United States) 8 weeks of age, 
were fed a high fat/high sucrose (60E% fat, D12492, Research Diets, Brogaarden, Denmark, 
supplemented with 15% sucrose in the drinking water) or a control diet (10E% fat, D12450B, 
Research Diets, Brogaarden, Denmark) for 6 weeks prior to conception. After 6 weeks of feeding, 
the female rats were mated by strain-matched male rats, what were fed a standard maintenance 
diet prior to mating (Altromin, Brogaarden, Denmark). At the end of pregnancy all the dams had 
natural deliveries. Female pups were euthanized the day after birth. Blood glucose was analysed 
on all female pups, but plasma were generated by pooled blood from 2-3 pups. Tissues were 
collected and treated as further described below. The male pups were cross-fostered at day 1 
among dams on either control or HFHS diet, which resulted in 4 male offspring groups; born by 
control dams and lactated by control dams (CC), born by control dams and lactated by HFHS dams 
(CH), born by HFHS dams and lactated by control dams (HC) and born by HFHS dams and lactated 
by HFHS dams (HH), (Figure 1). The dams were maintained on the respective diets during mating, 
gestation and lactation. After 4 weeks of lactation the male offspring were weaned onto a chow 
diet (Altromin, Broggarden, Denmark) until 20 weeks of age, after which they were challenged 
with a high fat diet (45E% fat, D12451, Research diets, Brogaarden, Denmark) for 6 weeks before 
they were euthanized. Only half of the CC group were transferred to the dietary challenge, so a 
pure control was maintained (control diet during gestation, lactation and the challenge period). 
This resulted in 5 groups of male offspring after the challenge; CCC, a pure control and 4 groups 
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challenged with the high fat diet (CCH, CHH, HCH, HHH). Tissues and blood was collected and 
treated as further described below. 
 
Figure 1. Experimental setup. Female obese prone rats were fed a conventional (control)  diet or a high fat/high 
sucrose (HFHS) diet for 6 weeks prior to mating (N as displayed in the figure). All dams had spontaneous deliveries and 
female offspring were euthanize at weaning. Male offspring were cross-fostered so control born pups were lactated 
by control (CC) or HFHS dams (CH), while HFHS born pups were lactated by control (HC) or HFHS (HH) dams. All 
offspring were weaned onto a control diet for 4-20 weeks age, after which they were challenge with a high fat diet for 
6 weeks and subsequently euthanized (N as displayed in the figure). 
 
Weighing and blood sampling 
Dams were weighed weekly and blood was collected from the tail vein before gestation after an 
overnight fast. Offspring was weighted at birth and every week from 2 weeks of age. Blood was 
collected from female pups the day after birth by decapitation. Additionally blood was collected 
from the tail vein of male offspring at weaning after 4 hours of fasting and again at 11, 20 (before 
challenge) and 26 weeks of age (after challenge) after overnight fasting. 
 
Blood glucose and plasma parameters 
Blood glucose was analysed by a glucometer (On Call Plus, ACON laboratories, San Diego, United 
States). Plasma triglycerides were analysed on a Cobas Mira Plus with a Horiba ABX Pentra kit 
(Montpellier, France). Plasma insulin and leptin were analysed on a Meso Scale Selector Imager 
6000 with Meso Scale Discovery kits according to manufacturer’s instructions (Meso Scale 
Discovery, Rockwille, United States). Insulin and blood glucose measurements were used to 
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calculate a qualitative insulin sensitivity check index (QUICKI), 1/(log(insulin) + log(glucose)) 231. 
 
Liver lipid analysis 
The livers were snap-frozen in liquid N2 and stored in -80
◦ until analysed.  Lipids were extracted 
using the Folch procedure, in the presence of internal standards for FFA, TAG and PL as has been 
described 259, in addition ceramide with C17:1 long-chained base (Avanti Polar Lipids, Alabaster, 
AL, US) was added as internal standard for ceramide quantification, prior to extraction. One 
aliquot of the lipid extract was used for PL, TAG and FFA analysis as described 259, and one aliquot 
used for quantification of ceramide, as described in Drachmann et al. 233, but using the above 
mentioned C17:1 ceramide as internal standard. 
 
RT-qPCR 
Liver samples was collected from female offspring at day 1 and male offspring at 26 weeks of age 
and stored in RNAlater at -80 until RNA extractions. RNA was extracted by a RNeasy kit (Qiagen) 
according to manufacturer’s instructions and converted to cDNA by a High Capacity cDNA Reverse 
Transcription kit (Invitrogen). For quantitative PCR, target genes were amplified with Taqman Fast 
Universal PCR master mix (Applied Biosystem) and primer and probe from Integrated DNA 
Technologies (Iowa, United States) (Suppl. Table 1) on a 7900HT Fast Real-time PCR system 
(Applied Biosystem). 
 
Statistical analysis 
Not all data followed a Gaussian distribution or had equal variance among groups, so the pre-
natal, post-natal and challenge effects were analyzed by a permutated 2way (before the dietary 
challenge) or 3way ANOVA (after the dietary challenge) in the “lmperm” package in R 
(http://www.r-project.org/), as described by Anderson (2001)207. Post test were performed as a 
pair-wise comparison between groups by a two sample permutation test in the “coin” package in 
R 207 and the p-values from the two sample tests were adjusted for multiple testing by the Holm 
method. Effects were considered significant when p<0.05. 
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Results 
Maternal metabolic phenotype 
Female obese prone rats were fed a HFHS or control diet for 6 weeks prior to conception. During 
the 17 weeks of feeding, the rats on the HFHS diet had no increased weight gain when compared 
to the control fed rats, despite having a net energy intake that was 1.25 fold higher than the 
control diet (438 kJ/d vs. 342 kJ/d, Table 1). Before the dams were mated, there were found no 
differences in weight gain, blood glucose levels, plasma insulin, leptin, triglyceride or insulin 
sensitivity (estimated by the QUICKI index) between the two groups (Table 2). The two groups also 
had similar gestational weight gain and litter size. 
 
Table 1: Macronutrient  and fatty acid composition of the two diets (high fat/high sucrose is based on 
bith food and sucrose-sweetened drinking water) .  
 
Control 
High fat/ 
high sucrose 
Protein E%  20 11 
Carbohydrate E%*  70 57 
Sucrose E%*  35 50 
Fat E%  10 32 
Fat intake (g/d)  0.65 ± 0.08 3.8 ± 0.6 
Carbohydrate intake (g/d)  10.4 ± 1.5 16.7 ± 1.8 
Protein intake (g/d)  2.96 ± 0.4 2.81 ± 0.5 
Energy intake (kJ/d)  342± 49 438 ± 39 
Myristic acid (C14:0)  0.9 ± 0.0 1.2± 0.0 
Palmitic acid (C16:0)  15.9 ± 0.0 20.2± 0.0 
Palmitoleic acid (C16:1D
9
)  0.8 ± 0.0 1.5± 0.0 
Stearic acid (C18:0)  7.6 ± 0.0 10.8± 0.0 
Oleic acid (C18:1D
9
)  27.6 ± 0.0 34.8 ± 0.0 
cis-Vaccenic acid  ((C18:1D
7
)  1.7 ± 0.0 2.1± 0.0 
Linoleic acid (C18:2D
9,12
)  39.3 ± 0.0 25.0 ± 0.0 
α-Linolenic acid (C18:3D
9,12,15
)  4.3 ± 0.0 1.8 ± 0.0 
w-6/w-3 ratio  9.2 ± 0.0 14.6 ± 0.0 
Ratio C16:0/C18:0  2.1± 0.0 1.9 ± 0.0 
* In HFHS the sum of consumed food and water with sucrose are reported. Fatty acid data are given as percent of 
total fatty acids  and are average ± range of duplicate determination.   
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Table 2. Physiological data on the dams before mating.  Data are given as average± stdev. N for control = 6; n for 
HFHS = 5  
 Control  High fat/  
high sucrose  
p-value  
Weight gain before mating (g)  70 ± 14  77 ± 19  ns 
 Weight gain during gestation  (g)  72 ± 12  68 ± 8  ns 
Litter size  8.3 ± 3.1  8.0 ± 2.5  ns 
Glucose   (mM)  4.25 ± 0.73  4.34 ± 0.86  ns 
Insulin (ng/mL)  0.58 ± 0.19  0.67 ± 0.23  ns 
QUICKI  (AU)  0.33 ±  0.02  0.32 ± 0.02  ns 
Leptin (ng/mL)  5.78 ± 2.20  8.16 ± 6.07  ns 
TAG   (mM)  0.96 ± 0.38  1.31 ± 0.44  ns 
 
 
 
Figure 2. Metabolic phenotype of female offspring at birth. A. The birth weight of male and female offspring. B. 
Blood glucose and plasma levels of insulin, leptin and TAG in female offspring at birth. C. Hepatic lipid concentrations 
of triacylglycerides (TAG), free fatty acids (FFA), phospholipids (PL) and ceramide (cera) in neonate female offspring. * 
p<0.05, *** p<0.001 
 
Metabolic phenotype of female offspring at birth 
All pups were weighed the day after birth and the female pups were euthanized. Female pups 
weighed less than males (p<0.001), but both male and female pups born by HFHS fed dams had a 
lower birth weight than pups born by control fed dams (p<0.001), (Figure 2A). Tissues from the 
female pups were harvested and weighed and the organ to body ratio was calculated to account 
for the lower birth weight in the HFHS pups. The weight of the liver as percent of body weight did 
not differ between the groups (C=3.73 % ± 0.45, H=3.48 % ± 0.52, p=0.10). Blood glucose were 
elevated in the HFHS pups (p<0.05) and plasma TAG were decreased (p<0.05) compared to the 
control pups, while no changes were found in insulin and leptin levels, (Figure 2B). Lipids were 
extracted from fetal livers, and pups born by HFHS dams had decreased hepatic FFA (p<0.05) and 
tended to decreased ceramide concentrations (p=0.05) compared to control born pups, while no 
effect were seen on TAG and PL content (Figure 2C).  
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Figure 3. Body weight and weight gain of male offspring. A. Growth curve of male offspring during lactation, re-
establishment and the challenge period. B. Weight gain during lactation, where the offspring were cross-fostered to 
dams on complementary diets. C Weight gain during the re-establishment period from 4-20 weeks of age, where the 
offspring were fed a conventional diet. D Weight gain during the challenge period, where the offspring were fed a high 
fat diet. * p<0.05, ** p<0.01, *** p<0.001, ns non significant. 
 
Body weight of male offspring  
Male pups were cross-fostered the day after birth, so that control born pups were lactated by 
control dams (CC) or HFHS dams (CH) and HFHS pups were lactated by control dams (HC) or HFHS 
dams (HH). Pups lactated by HFHS dams gained more weight than the control lactated dams until 
weaning (postnatal effect p<0.001) (Figure 3A and 3B). During the re-establishment period from 4- 
20 weeks of age, when all offspring were fed a control diet, there were no difference in weight 
gain between the groups, (Figure 3A and 3C). However, since the HFHS-lactated offspring had 
elevated body weights compared to control-lactated at weaning (CC= 54±1g ; CH= 74±7 g; HC= 
52±4 g ; HH=73±9 g;  postnatal effect p<0.001), the HFHS lactated pups remained heavier until 20 
weeks of age (CC= 526±40 g; CH= 556±15 g; HC= 514±31 g, HH= 565±19 g; postnatal effect 
p<0.01). The same pattern were seen when the offspring were challenged with a 45E% fat diet 
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from 20-26 weeks of age; all groups receiving the dietary challenge (CCH, CHH, HCH, HHH) had 
similar elevated weight gain (challenge effect p<0.001) (Figure 3A and 3D). Thus, the offspring 
exposed to the HFHS diet during postnatal life (CHH and HHH) were heavier at 26 weeks (CCC= 
563±43 g; CCH= 646±15 g; CHH= 666±45 g; HCH= 617±18 g; HHH= 664±22 g, postnatal p<0.01), 
due to a persistent elevated body weight from weaning. 
 
Plasma parameters in male offspring 
Blood samples were collected after weaning (4 weeks of age), during the re-establishment period 
(11 weeks of age) and also before (20 weeks of age) and after (26 weeks of age) the dietary 
challenge. Blood glucose and plasma insulin were analysed and a QUICKI value were calculated to 
evaluate insulin sensitivity. There were no difference in insulin sensitivity among the groups 
before the dietary challenge, which decreased the insulin sensitivity to the same degree in all 
groups compared to the control (CCC) group (challenge effect p<0.01) (Table 3). Plasma leptin was 
increased in the HFHS lactating offspring at weaning (postnatal effect p<0.001), which was 
maintained until 11 weeks of age (postnatal effect p<0.001). At 20 weeks of age, the leptin levels 
were re-established in the HH groups and therefore equivalent to the control group (CC), but there 
was a tendency to a remained elevated leptin level in the CH groups (p=0.07). The dietary 
challenge increased leptin levels in all groups (challenge effect p<0.01). Additionally, offspring 
lactated by HFHS dams had an elevated leptin level after the challenge compared to control 
lactated offspring (postnatal p<0.05) and control born offspring also displayed increased leptin 
levels compared to HFHS born offspring at this time point (prenatal p<0.05). Hence, the HCH group 
did not reach a significant higher leptin level compared to the CCC group at 26 weeks. (CCC vs CCH 
p<0.05, CCC vs CHH p<0.05, CCC vs. HHH p<0.05, Table 3), since exposure to HFHS prenatally and 
control diet postnatally both caused decreased leptin levels after the dietary challenge. Plasma 
TAG was also elevated in the HFHS lactated pups at weaning (postnatal effect p<0.01) and the HC 
group had the lowest concentration, which was significantly lower than for the HH-group (p<0.05, 
Table 3). At  11 weeks of age, there were no differences in TAG levels between the groups. At 20 
weeks of age, plasma TAG level were again significantly higher in the HFHS-lactated offspring 
(postnatal p<0.01), but only the HH group had a significant increased elevated TAG level compared 
to CC (p<0.05). The dietary challenge had no overall effect on plasma TAG concentration 
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(challenge effect p=0.76), but after the challenge HFHS lactated offspring had higher TAG 
concentrations (postnatal effect p<0.01), this was in particular evident in the CHH group, 
(pre:postnatal p<0.01), despite normalisation of the TAG level in the HHH group after the 
challenge (Table 3). 
 
Table 3.  Circulating metabolic markers in male offspring at weaning (4 weeks of age), at 11 weeks of age and 
before (20 weeks of age) and after (26 weeks of age) a high fat dietary challenge.  Data are given as average± 
stdev. N for the groups as in Figure 1.  
  
CCC CCH CHH HCH HHH Pre-
natal 
Post- 
natal 
Inter-
action 
Challenge 
Blood 
glucose  
Weaning  
1.00 ± 
0.10  
1.01 ± 
0.11 
1.06 ± 
0.16 
0.97 ± 
0.05 
p= 0.75 p= 0.18 p= 0.10 
 
 
Week 11  
1.00 ± 
0.10  
0.99 ± 
0.12 
1.05 ± 
0.23 
0.98 ± 
0.13 
p= 0.43 p= 0.36 p= 0.60 
 
 
Before 
challenge  
1.00 ± 
0.13  
0.93 ± 
0.06 
1.00 ± 
0.13 
1.00 ± 
0.17 
p= 0.39 p= 0.69 p= 0.49 
 
 
After 
challenge  
1.00 ± 
0.17 
1.19 ± 
0.17 
1.06 ± 
0.10 
1.15 ± 
0.19 
1.09 ± 
0.11 
p= 0.78 p= 0.12 p= 0.50 p< 0.05 
Insulin  Weaning  
1.00 ± 
0.58  
0.68 ± 
0.25 
0.83 ± 
0.33 
1.03 ± 
0.32 
p= 0.48 p= 0.71 p= 0.11 
 
 
Week 11  
1.00 ± 
0.31  
0.78 ± 
0.27 
1.20 ± 
0.92 
1.00 ± 
0.33 
p= 0.28 p= 0.75 p= 1.00 
 
 
Before 
challenge  
1.00 ± 
0.56  
1.11 ± 
0.86 
0.89 ± 
0.70 
1.16 ± 
0.49 
p= 0.96 p= 0.31 p= 0.84 
 
 
After 
challenge  
1.00 ± 
0.31 
2.22 ± 
0.72 
2.16 ± 
1.14 
2.49 ± 
1.34 
3.69 ± 
2.64 
p= 0.27 p= 0.31 p= 0.21 p= 0.18 
QUICKI  Weaning  
1.00 ± 
0.10  
1.03 ± 
0.04 
1.00 ± 
0.07 
0.98 ± 
0.04 
p= 0.32 p= 1.00 p= 0.34 
 
 
Week 11  
1.00 ± 
0.04  
1.04 ± 
0.06 
1.01 ± 
0.12 
0.99 ± 
0.03 
p= 0.51 p= 0.96 p= 0.64 
 
 
Before 
challenge  
1.00 ± 
0.06  
1.02 ± 
0.08 
1.07 ± 
0.14 
0.99 ± 
0.06 
p= 0.64 p= 0.71 p= 0.22 
 
 
After 
challenge  
1.00 ± 
0.06 
0.89 ± 
0.05 
0.91 ± 
0.07 
0.89 ± 
0.06 
0.86 ± 
0.06 
p= 0.47 p= 0.61 p= 0.28 p< 0.01 
Leptin  Weaning  
1.00 ± 
0.33  
1.40 ± 
0.42 
1.17 ± 
0.46 
1.65 ± 
0.62 
p= 0.12 p<0.001 p= 0.75 
 
 
Week 11  
1.00 ± 
0.20  
1.43 ± 
0.31 
0.89 ± 
0.21 
1.43 ± 
0.35 
p= 0.78 p <0.001 p= 0.38 
 
 
Before 
challenge  
1.00 ± 
0.19  
1.40 ± 
0.41 
1.15 ± 
0.28 
1.05 ± 
0.11 
p= 0.55 p= 0.10 p< 0.01 
 
 
After 
challenge  
1.00 ± 
0.30 
1.73 ± 
0.38 
2.35 ± 
0.67 
1.61 ± 
0.61 
1.77 ± 
0.33 
p< 0.05 p< 0.05 p= 0.17 p< 0.01 
TAG  Weaning  
1.00 ± 
0.38  
1.07 ± 
0.41 
0.65 ± 
0.16 
1.28 ± 
0.39 
p= 0.40 p< 0.01 p< 0.05 
 
 
Week 11  
1.00 ± 
0.19  
1.03 ± 
0.17 
1.01 ± 
0.21 
1.11 ± 
0.29 
p= 0.58 p= 0.36 p= 0.84 
 
 
Before 
challenge  
1.00 ± 
0.21  
1.24 ± 
0.23 
1.10 ± 
0.28 
1.46 ± 
0.34 
p= 0.11 p< 0.01 p= 0.29 
 
 
After 
challenge  
1.00 ± 
0.26 
0.86 ± 
0.19 
1.34 ± 
0.39 
1.01 ±  
0.23 
1.01 ± 
0.11 
p= 0.84 p< 0.01 p< 0.01 p= 0.76 
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Organ weight and adiposity after 6 weeks challenged with a high fat diet. 
All animals were euthanized at 26 weeks of age, after the 6 week dietary challenge. Epididymal, 
visceral and perirenal adipose tissue depots were removed and weighed and adiposity was 
evaluated by calculating the total adipose tissue mass to body weight ratio. The dietary challenge 
increased adiposity in all groups (challenge effect p<0.001), but HFHS lactated offspring had a 
higher degree of adiposity than the control lactated pups (postnatal effect p<0.05, Figure 4A). The 
liver weight was increased after the dietary challenge (challenge effect p<0.05), but prenatally 
HFHS-exposed offspring had smaller livers (prenatal effect p<0.05) while postnatally HFHS-
exposed had larger livers (postnatal effect p<0.05, Figure 4B). 
 
Figure 4. Organ weight in male offspring after the dietary challenge. A Weight of total adipose tissue pads (Visceral, 
epididymal and perirenal)as percentage of body weight. B Weight of liver. *p<0.05, ** p<0.01.  
 
Lipid composition and lipid metabolism after dietary challenge in adulthood 
The dietary challenge increased TAG accumulation in the liver (challenge p<0.05), in particular in 
CCH and CHH, which had significant higher hepatic TAG concentration compared to the CCC group 
(p<0.05 for both, Figure 5A). Hepatic FFA content was elevated in HFHS-born offspring (prenatal 
p<0.001) and most so in the rats that both were born and lactated by HFHS-dams.  Thus, the HHH 
group had in average 3.5 fold higher FFA concentration in the liver than the CCC group and almost 
5-fold higher than the CHH group (p<0.01 (vs CCC, CCH and CHH and p<0.05 (vs HCH) in pair wise 
comparison, Figure 5A).  Offspring lactated by HFHS dams also had decreased levels of hepatic 
phospholipids (postnatal p<0.05), which could indicated structural alterations in the hepatocytes 
(Figure 5A). Finally, hepatic ceramide concentrations were reduced after the dietary challenge 
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(challenge p<0.05, Figure 5A). To determine whether the increased hepatic FFA in HFHS-born rats 
was explained by transcriptional regulation of genes involved in fatty acid metabolism, we 
examined hepatic mRNA levels of genes involved with fatty acid uptake (CD36), fatty acid 
synthesis (srebf1, acaca, fasn) and fatty acid oxidation (ppara, acox, cpt1a), Figure 5B. The mRNA 
level of CD36 was elevated by the dietary challenge, but no effects were seen on srebf1 and ppara 
expression, which are the major transcription factors controlling of fatty acid synthesis and 
oxidation, respectively. Expression of the gene for acetyl-CoA carboxylase (acaca), the rate-limiting 
step in fatty acid synthesis  was neither affected, but mRNA levels of the fatty acid synthase (fasn) 
was elevated in HFHS lactated offspring compared to control lactated (postnatal p<0.05), while the 
HFHS-born offspring had decreased level compared to control born (prenatal p<0.05). Expression 
of the genes coding for the -oxidation enzymes acyl-CoA oxidase (acox) and carnthine-palmitoyl 
transferase 1 (cpt1) were not affected by any of the perinatal interventions or the dietary 
challenge. It was noticeable that the mRNA level of cd36 displayed a pattern similar to hepatic TAG 
among the groups and a correlation analysis (Figure 5C) showed a significant association between 
the two parameters (p<0.01), indicating that hepatic fatty acid uptake through CD 36 was limiting 
the hepatic TAG accumulation.   
 
Discussion 
We have earlier shown that male rats, which have been exposed to a high fat/high sucrose diet 
during gestation and/or lactation in the absence of obesity and altered maternal metabolic 
function (Chapter 4), showed increased adiposity and plasma leptin levels, impaired glucose 
homeostasis, increased hepatic lipid accumulation and an altered hepatic lipid composition at four 
weeks of age. Knowing this, it is important to determine whether the metabolic impairments that 
are induced in early life can be reversed by a transfer to normal low fat diet  and whether the early 
life exposure to the high-energy diet compromise the ability to adapt to metabolic challenges, 
such as high fat load, later in life, as have been observed in small for gestational age humans 260. 
Male offspring from rat mothers fed a HFHS-diet during gestation and/or lactation was therefore 
transferred to a conventional diet for 16 weeks after weaning at four weeks of age, and at 20 
weeks of age challenged with a high fat (45 E%) diet for six weeks.  
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Figure 5. Hepatic lipid composition and lipid metabolism after the dietary challenge. A Hepatic lipid concentrations 
of triacylglycerides (TAG), free fatty acids (FFA), phospholipids (PL) and ceramide in male offspring after the dietary 
challenge. B mRNA levels of genes involved with fatty acid uptake (cd36), fatty acid synthesis (srebf1, acaca, acox) and 
fatty acid oxidation (ppara, acox, cpt1a) in the liver. C Correlation analysis on hepatic TAG concentration and hepatic 
mRNA levels of cd36. * p<0.05, ** p<0.01  
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The six weeks intervention with a HFHS diet in the dams before conception did not affect body 
weight, insulin sensitivity, plasma leptin or TAG levels in the dams (table 2), which shows that 
these general physiological parameters did not cause the altered metabolic response in the 
offspring. Both female and male offspring from HFHS-fed dams had a reduced weight compared to 
the control born pup the day after birth. In our study, the female offspring from HFHS dams also 
displayed smaller BAT depots and decreased hearts compared to offspring from control dams, 
while no effect was seen on liver size. Additionally, they had a modest increase in blood glucose 
but a 2 fold decrease in plasma triglycerides the day after birth, while no effects were seen on 
plasma insulin and leptin. Decreased birth-weight have previously been reported from other 
studies of offspring born by high fat fed rodents 39,261,262. However, the literature also reports 
unaffected 37,256,263 or increased birth weights 140 after prenatal exposure to maternal obesity or 
high fat diets. Akyol and colleagues hypothesised that the pre-pregnancy diet might play a key role 
in the programming of birth weight 264, since they reported a decreased body weight at birth only 
in offspring were the dams had been fed a cafeteria diet prior to gestation. However, a study by 
Zhang and colleagues 39 shows conflicting data, since their dietary intervention started on 
gestation day 2 and resulted in decreased birth weight in the pups.  Thus, it seems as the effect of 
high energy diet interventions during pregnancy on birth weight is determined of a yet 
undetermined parameter.  A reduced protein intake during pregnancy in the high fat groups could 
be one reason. In both the studies of Zhang et al and Akyol and co-workers, the animals given the 
cafeteria diet had a reduced protein intake, this was however not the case in the present study, 
were the percental higher protein content in the high fat diet, compensated for a reduced intake.  
Thus, in present study, this is neither the explanation.  
Male offspring were cross-fostered the day after birth, hereby generating four different groups. 
Male pups lactated by a HFHS dams gained more weight during the lactation period independent 
of the prenatal diet, which resulted in an increased body weight at weaning. We have previously 
published a similar result, were we found that the increased body weight reflected increased 
adiposity, which gave rise to elevated plasma leptin level (Chapter 4). Since we also in this study 
found increased plasma leptin levels in these pups, we find it likely that the increased body weight 
is due to increased adiposity.  Plasma triglycerides were also elevated in the HFHS suckled pups, 
but this effect was mainly driven by a significant difference between the HC and HH group.  265,266. 
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All groups had normal insulin sensitivity (estimated by QUICKI value) at weaning despite the 
increase body weight and increased plasma TAG levels in the CH and HH groups.  
All male pups were transferred to a conventional diet (10E% fat) after weaning and until 20 weeks 
of age. During this time all groups had similar weight gains, why the elevated body weights in the 
CH and HH offspring were sustained throughout the re-establishment period. The increased body 
weight did not give rise to altered insulin sensitivity in the groups, and the chow-diet normalised 
the leptin levels in the HH group over time, to a larger extent than in the CH-group. At 11 weeks of 
age, leptin-levels were still increased in both groups of HFHS-suckled pups, but at 20 weeks of age, 
only the CH group showed a tendency to increased leptin level compared to the CC group 
(p=0.07). Increased leptin levels can be a sign of increased adiposity and/or decreased leptin 
sensitivity in the CH group, which might have root in the mismatch between prenatal and 
postnatal diet. It has previously been shown in humans, that children born with a low birth weight 
have an impaired leptin response when challenge with a high fat over-feeding in adulthood, due to 
an elevated basal leptin level prior to the overfeeding experiment 260 Our data suggest that this 
might also be the case, when there is a mismatch from prenatal to postnatal life. The more rapid 
re-establishment of a normal leptin level in the HH-group indicate that this group might have a 
metabolic advantage when transferred to a healthy diet, due to a greater flexibility to adapt to 
dietary changes, while this was not the case in the CH group.  
Plasma TAG levels were increased in the HFHS lactated offspring at weaning mainly due to a 
significant difference between the HC and HH group, due to a decreased level in the HC-group, this 
effect were also maintained in the pups at 20 weeks of age, although it was not evident in the data 
at 11-weeks of age.  
To test the offspring’s capability of adapting to metabolic changes, we challenged their metabolic 
flexibility with a high fat diet (45 E% fat) for 6 weeks. The dietary challenge increased the body 
weight to a similar degree in all groups, so the elevated body weight in the HFHS suckled pups 
persisted through the challenge. The increased bodyweight were a sign of increased adiposity in 
the animals, since the ratio of adipose tissue mass to body weight was highest in the HFHS 
lactated offspring.  The dietary challenge decreased the insulin sensitivity to the same amount in 
all four groups, but leptin levels did not follow this pattern. Leptin was, as expected, increased 
with the dietary challenge and the increased adiposity, however, HFHS exposure during fetal life 
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decreased the leptin level after the dietary challenge compared to control lactated offspring 
(p<0.05), while HFHS exposure during postnatal life increased it (p<0.05). Thus, among the high fat 
challenged animals, the CHH group had the highest and the HCH group had the lowest leptin level. 
The latter group was the only one that did not respond to the adult exposure to the high fat diet 
with significantly increased leptin levels. Hence,  a mismatch were the animals was been born by 
HFHS-fed dams but lactated by control mothers seems to give some protection against 
hyperleptinemia at a later high fat challenge, while the reversed mismatch increases susceptibility. 
This is in accordance with earlier finding, that have showed fetal development in mothers given a 
cafeteria diet, combined with lactation from chow-fed dams, decreased plasma leptin level in in 
the offspring compared to animals born by control mothers but lactated by cafeteria-diet fed 
mothers 39.  We therefore suggest that the leptin-gene promoter is the target for different 
epigenetic changes due to maternal high fat/high sucrose intake during gestation and lactation, in 
utero exposure will in this scenario, induce a predictive adaptive response that attenuates 
hyperleptinemia when exposed to high energy-diets later in life. This response seems however to 
be limited to a developmental window in utero, while exposure after birth no longer can cause this 
adaption. It is known that that leptin gene expression is under control by promoter DNA and 
histone methylation 56,267, and both impaired glucose metabolism and maternal high fat intake 
during pregnancy and lactation alters the epigenetic pattern of the promoter in rodents 56,267. 
However, to our knowledge no data are available on epigenetic DNA and histone modifications in 
cross-fostered offspring from high fat fed mothers.   
There was no effect of the dietary challenge on plasma TAG levels. The higher plasma TAG level 
the CHH-group, reflected the difference also observed prior to the challenge, at 20 weeks of age. 
Thus, we can conclude that post-, but not prenatal, exposure to the high energy diet programs an 
increased plasma TAG concentration in the offspring, and this was most pronounced in the CHH-
group. .    
 
Looking at figure 4B and 5A, it is evident that liver weight and hepatic TAG concentration followed 
a similar pattern, were the challenge increased both outcomes.  There was however only minor 
effects of the pre- and postnatal treatments on the concentration on these parameters. The 
prenatal exposure to the HFHS-diet did however cause very pronounced effects on the level of 
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free fatty acids in the liver (Figure 5A). Thus, while all animals born by control-fed dams had an 
average concentrations of FFA, between 0.3 and 0.4 mg*g-1 liver weight, which is normal in rodent 
liver, the average concentration for the HCH group was doubled (0.7 mg*g-1 ) and the 
concentration in the HHH-group (1.4 mg*g-1)  was almost five-fold higher  than in the CHH group 
and significantly higher than in all other groups as well (p<0.05 vs HCH, otherwise p<0.01). Thus, 
this suggests that the animals born by dams fed a HFHS-diet during pregnancy had reduced 
metabolic flexibility, with impaired ability to metabolize the increased hepatic influx of fatty acids 
during a high fat challenge as adults. This ability was further impaired, when the pups also were 
exposed to the HFHS-treatment during lactation. An increased hepatic concentration of free fatty 
acids are strongly associated to insulin resistance 268, as well as to hepatocyte injury and apoptosis 
through its lipotoxic activity 269,270. In hepatocytes, free fatty acids induce mitochondrial and 
endoplasmatic reticulum stress, lysosomal disintegration and sensitizes the cells TNF-related 
apoptosis inducing ligand (TRAIL)-mediated cytotoxicity 269-271.  Thus, the increased concentration 
of free fatty acids in rats born by HFHS-dams represent an increased risk for development of 
hepatic insulin resistance as well as serious pathologies associated to the fatty liver, i.e. non-
alcoholic steatohepatitis (NASH).  Furthermore, we have recently shown that rapid weight-loss is 
associated to accumulation of free fatty acids in the liver and the heart in mice 259, this could 
indicate that offspring from mothers that have had high intake of fat and sucrose during the 
pregnancy are more susceptible to lipotoxic effects if they go through a rapid weight-loss.  Under 
normal conditions, free fatty acids are rapidly condensed to CoA, forming acyl-CoA, by the acyl-
CoA synthase and these are metabolized either via the oxidative or lipid synthesis pathway, the 
latter causing formation of TAG and PL 268. When the influx of free fatty acids are larger than the 
flux through these pathways, formation of other lipotoxic intermediates occur, concomitant with 
accumulation of free fatty acids 268. In this study, we do however not see accumulation of 
ceramide as an effect of the high fat challenge, on the contrary, in all groups that were fed the 
high fat diet in adulthood, this caused a decrease in hepatic ceramide concentration. However, in 
a recent study, it was suggested that the hepatocytes rapidly secrets excess ceramide when 
ceramide synthesis is induced by fatty acid oversupply, as a protective mechanism against its 
lipotoxic effects 244. Thus, an up regulation of hepatic ceramide secretion, could potentially explain 
the observed decrease in hepatic ceramide in the animals exposed to the high fat challenge. The 
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challenge also caused an increase in hepatic phospholipids, in animals lactated by control- but not 
HFHS-fed dams. This indicates that cell-size is decreased, intracellular membrane area increased or 
that the storage of TAG in the hepatocytes of these animals occurs in smaller lipid-droplets, 
leading to a larger area of the phospholipid monolayer to volume of the droplets.  Future 
ultrastructural studies are required to determine which of these interpretations that is correct.  
 
To determine whether the altered concentration of free fatty acids can be explained through 
changes in the transcriptional regulation of fatty acid uptake, -oxidation or fatty acid synthesis, 
we assayed mRNA levels of the relevant genes (Figure 5B). The results showed that expression of 
the fatty acid synthase gene (fasn) are slightly up-regulated in animals lactated by high energy diet 
fed dams. Although, we cannot say whether this also means that free fatty acid synthesis are 
increased in these animals, it could potentially mean that they face a larger risk for hepatic lipid 
accumulation and that this could be involved in the large increase in free fatty acids in the HH-
group. This is however speculative and require more detailed studies of fatty acid metabolism in 
the offspring.  
 
It should be noticed, that the prenatal HFHS-exposed rats had a lower birth-weight, than the pups 
born from conventional fed animals, and human low-birth weight subjects are known to have a 
higher risk of developing metabolic syndrome and type-2 diabetes, as well as having an altered 
metabolic adaptability to a high fat challenge  260,272. Thus, in the present study we cannot 
distinguish the effect from the low birth weight, from direct effects of the maternal intake of the 
high energy diet. The pronounced effect of the in utero exposure to HFHS-diet on hepatic free 
fatty acid accumulation might therefore also be a consequence of in utero growth retardation. 
 
In summary, we have in this study showed that maternal intake of a high fat/high sucrose diet 
during pregnancy and lactation do alter the response to a metabolic challenge with a high fat diet 
in the adult offspring. In particular leptin secretion and accumulation of hepatic free fatty acids 
was affected. The increase in circulating leptin levels, induced by the high fat challenge, was 
attenuated in offspring from dams fed the high energy diet during pregnancy, while this treatment 
increased accumulation of free fatty acids. Exposure to the HFHS-diet during lactation increased 
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both plasma leptin levels and free fatty acid accumulation in the liver. Thus, while the gestational 
effect on leptin secretion supported the predictive adaptability hypothesis, the effect on hepatic 
free fatty acids levels contradict it, since animals that have been exposed to a high fat diet in 
utero, are less able to cope with the same environmental challenge in adult life.  
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Supplementary material 
Supplementary table 1. Primers for qPCR, 5’ FAM is the reporter signal from all the probes and 3’ Iowa Black FQ/ZEN 
is quencher  
Gene Forward primer Reverse primer Probe 
srebf1  GAAGCGGATGTAGTCGATGG  GCTACCGTTCCTCTATCAATGAC  TTATTCAGCTTTGCCTCAGTGCCCA  
cpt1a  AAAGTCAAAGAGCTCCACCTG  TGTCCAAGTATCTTGCAGTCG  CCTCCATGGCTCAGACAATACCTCC  
fasn  GCTGATACAGAGAACGGATGAG  GCGAGTCTATGCCACTATTCTG  AATGTCACGCCTTGCTCCTTGC  
cd36  CAATGAGTAGGTCTCCAACCG  TGCTCTTCCTTGATTCTGCTG  TGAGAATGCCTCCAAACACAGCCA  
acaca  CATCTCTAACTTCCTTCACTCCTT  TGCCGAGTCACCTTAAGTACA  AGTCCTTCCTGCTCACACACTTCTG  
acox  GAACTTGATTCTGAACGACCCA  CACTCTTCTTAACAGCCACCT  TTCCTCACTCGAAGCCAGCGTT  
ppara  CGAGCCAAGACTGAAGTTCAAG  CTCTCTGTGTCCACCATGTTG  AGCACCAATCTGTGATGACAACGTCT  
b2m  CCAGATGATTCAGAGCTCCATAG  ACCGAGACCGATGTATATGCT  CCTGGGACCGAGACATGTAATCAAGC  
gapdh  GTAACCAGGCGTCCGATAC  GTTCTAGAGACAGCCGCATC  ATCCGTTCACACCGACCTTCACC  
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6. Maternal high fat/high sucrose feeding during lactation alters systemic 
and adipose tissue inflammation in young and adult rat offspring 
 
Camilla Ingvorsen, Jeppe Madura Larsen, Anna Hammerich Thysen, Lars I. Hellgren, Susanne Brix  
Abstract 
Objective Maternal high fat feeding during gestation and lactation is associated with increased risk of 
obesity and metabolic dysfunction in the offspring, while its impact on chronic low grade inflammation is 
less well documented. Here, we examined immune profiles in young rat offspring after maternal high 
fat/high sucrose (HFHS) diet during gestation and/or lactation, and again after a high fat challenge during 
adulthood.   
Methods Female obese prone rats were fed conventional (C) or HFHS diet before mating and offspring 
were cross-fostered on complementary diets during lactation. At weaning, offspring was administered with 
C diet until week 20, where they were challenged with a 45% high fat diet for 6 weeks. Offspring was 
profiled for immune markers in blood at day 1, week 4, 20 and 26, and within epididymal adipose tissue at 
week 4 and 26. Immune profiles were correlated to metabolic markers at each time point.     
Results Offspring born by C dams and lactated by HFHS dams display a distinct immunological phenotype at 
weaning, characterized by decreased pro-inflammatory gene expression in blood and increased expression 
of the resident M2 macrophage marker, CD163, in adipose tissue. This immune phenotype was associated 
with increased adiposity and lipolysis in adipose tissue. Offspring lactated by HFHS dams also displayed 
altered immunity after high fat challenge in adulthood; characterised by decreased pro-inflammatory gene 
expression in blood, and increased tumor necrosis factor-α secretion after in vitro LPS challenge. In all 
groups, high fat challenge decreased Toll-Like Receptor 4 display on blood monocytes, and increased 
adipose tissue expression of the generic macrophage marker CD68 along with decreased cd163 (M2 
macrophage marker) expression.   
Conclusion Exposure to maternal HFHS diet during lactation alters systemic and adipose tissue immune 
expression profiles at weaning and systemic immunity in adulthood both before and after challenge with a 
high fat diet. However, associations between immune profiles and metabolic markers were only present in 
early life.  
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Introduction 
Maternal obesity is an escalating problem worldwide, since the abundance of obese women in the 
childbearing age is increasing 24. Evidence from epidemiological and animal studies show that 
maternal high fat intake and obesity during pregnancy are associated with increased risk of 
obesity, type 2 diabetes, cardiovascular disease and non-alcoholic fatty liver disease4. 
Development of obesity and metabolic disease is associated with chronic low grade inflammation1, 
but despite innumerable studies which report alterations in the metabolic phenotype of the 
offspring, only a sparse number of studies have investigated the immunological profile in offspring 
after pre- and postnatal exposure to maternal high fat intake. Adipose tissue expandability and 
ectopic lipid distribution might be important for the onset of the low-grade inflammatory 
phenotype147, however the responsiveness of the immune system and the capability to maintain 
adipose tissue homeostasis might also be important for the development of obesity-induced 
inflammation.  A Th2 skewed immune system, like seen in Balb/c mice, protects to a large extend 
development of metabolic disease 64,273.  
Lipid accumulation in the liver and development of non-alcoholic steatohepatitis (inflammation) is 
the hepatic manifestation of metabolic syndrome60. Studies have shown increased activation of 
the inflammatory signalling pathways JNK and NF-κB in liver after exposure to maternal high fat 
feeding during pregnancy and lactation in mice and non-human primates41,274.  Similar result was 
published by Mouralidarane and colleagues, which showed increased TNF-α mRNA expression in 
the liver of offspring derived from a mouse model for maternal obesity. However, the maternal 
diet had no effect on hepatic IL-6 mRNA expression or the number of Kupffer cells (hepatic 
resident macrophages) and their immunological function (ROS production and phagocytosis) 27. 
Vascular inflammation plays a pivotal role in the development of atherosclerosis, and a study in 
non-human primates reported increased mRNA levels of TNF-α in abdominal aorta tissue after 
perinatal exposure to maternal obesity 275. Inflammation in hypothalamus interferes with leptin 
and insulin sensing in the brain, which is important to maintain appetite regulation and glucose 
homeostasis 1. Rother and colleagues studied hypothalamic inflammation in mice offspring at 
weaning after exposure to maternal perinatal high fat feeding and found increased mRNA levels of 
IL-6 and TLR4 in hypothalamus along with increased expression of pJNK and pIKK. Contrary to the 
previously mentioned studies, they found no increase in mRNA levels of either TNF-α or IL-6 in 
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liver or pancreas 276. Microglias (resident macrophages in the brain) showed increased expression 
of CD11b and TLR4 in hippocampus already at birth as a consequence of fetal exposure to 
maternal obesity 38. Additionally, the IL-1β production was elevated in hippocampus and liver after 
an in vivo LPS challenge in offspring born by obese dams compared to control born, which makes 
us speculate that the immune system might be hyper-responsive after exposure to maternal 
obesity during perinatal life, although a similar result was not seen in relation to IL-1β expression 
in adipose tissue and serum 38. Contrarily, other studies report increased serum levels of IL-1β, but 
also TNF-α and CRP in offspring from obese mothers 143,274. 
Adipose tissue inflammation is a hallmark of obesity-induced inflammation, but to our knowledge 
nobody has studied the effect of maternal high fat feeding on adipose tissue inflammation in the 
offspring. We have therefore determined if maternal high fat feeding during pregnancy and/or 
lactation affect the level of macrophage and pro-inflammatory markers in the adipose tissue and 
activation of monocytes both in young rats at weaning and in adulthood after a dietary challenge. 
The purpose of the challenge was to elucidate differences in the robustness of the immune 
response to a metabolic load in offspring exposed to maternal high fat feeding during gestation 
and/or lactation.  
 
Materials and methods 
Animal experiment 
The experimental setups of the rat studies included in this chapter are described in Chapter 4 and 
5, along with the metabolic phenotype of dams and offspring. Thus, the experimental setup will 
only briefly be described here. 
Study 1: 8 weeks old female obese prone rats (strain: OP-CD, Charles River, Kingston, United 
States) were fed HFHS (60E% fat, D12492, Research Diets, Brogaarden, Denmark, supplemented 
with 15% sucrose water) or control (C) diet (10E% fat, D12450B, Research Diets, Brogaarden, 
Denmark) for 17 weeks prior to mating. The dams were maintained on their respective diets 
throughout mating, gestation and   At the end of gestation, female pups were euthanized the day 
after birth and male pups born by control dams were cross-fostered among C (CC, n=11) or HFHS 
dams (CH, n=9), while male pups born by HFHS dams were cross-fostered among C (HC, n=8) or 
HFHS dams (HH, n=6). All male pups were euthanized at weaning and blood and epididymal 
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adipose tissue was collected and analysed as described below.  
Study 2: 8 weeks old female obese prone rats were fed HFHS or C diet for 6 weeks prior to mating, 
and then maintained on their respective diet throughout mating, gestation and lactation (rat strain 
and diets were the same as in study 1) (C: n= 7, H: n=3). At delivery, male pups born by C dams 
were cross-fostered among C (CC, n=15) or HFHS dams (CH, n=7), while male pups born by HFHS 
dams were cross-fostered among C (HC, n=9) or HFHS dams (HH, n=9). After 4 weeks of lactation 
the male offspring were weaned onto a chow diet (Altromin, Broggarden, Denmark) until 20 
weeks of age after which they were challenged with a medium HF diet (45E% fat, D12451, 
Research diets, Brogaarden, Denmark) for 6 weeks before they were sacrificed. Half of the CC 
group was maintained on the chow diet during the challenge period, which resulted in 5 offspring 
groups after the challenge; CCC (n=8), representing a pure control, and 4 groups challenged with 
the medium fat diet (CCH: n=7, CHH: n=7, HCH: n=9, HHH: n=9). Blood and epididymal adipose 
tissue was collected and analysed as described below.  
 
RNA extractions from blood and epididymal adipose tissue from the offspring 
Epididymal adipose tissue from the offspring were collected and stored in RNAlater (Invitrogen) at 
-80°C until usage. Adipose tissue was first homogenised in TriZol (Invitrogen) and then centrifuged 
at 12.000xg for 10 min at 4°C. The layer between the floating lipids in the top and the cell debris 
pellet was transferred to a new tube and mixed with chloroform before being centrifuged at 
12.000xg for 15 minutes at 4°C. The upper aqueous phase is mixed with 70% ethanol and added to 
a RNA purification column from an RNeasy kit (Qiagen). The following procedures were according 
to manufacturer’s instructions. Blood was collected in an EDTA-coated tube and RNA was 
extracted with a PerfectPure RNA blood kit (5PRIME). Red blood cells were lysed with a lysing 
buffer and centrifuged at 2.000xg for 2 minutes. The supernatant was discarded and the pellet, 
containing the leukocytes, was resuspended in RNA cell protect (Qiagen) and stored at -80°C until 
usage. For RNA extractions the leucocytes were centrifuged and the RNA cell protect was 
discarded. The following procedures were according to manufacturer’s instructions. RNA quality 
was assessed on an Agilent 2100 Bioanalyzer (Agilent) with a Agilent RNA 6000 Nano chip 
(Agilent). 
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RT-qPCR 
RNA was reverse transcribed into cDNA by a High Capacity cDNA Reverse Transcription kit 
(Invitrogen). Quantitative PCR was performed with a TaqMan Fast Universal PCR master mix 
(Applied Biosystems) and primers and probes purchased from IDT-DNA (Leuven, Belgium) (please 
refer to table 1). The probes were conjugated with a FAM reporter dye and an Iowa Black FQ/ZEN 
double quenching dye. PCR was run on a 7500HT Fast Real-Time PCR System (Applied Biosystems). 
mRNA levels for Rela/NF-κB, TNFa, TLR4, Ccr2, IL-1b were analysed in blood and CCL2, cd163, 
cd68, TLR4, arg1, Nos2, TNFa and IL-1b were analysed in adipose tissue. Data are plotted as 2^-ΔCt 
values and reference Ct value was calculated as an average Ct value for the two reference genes 
(B2M and GAPDH). 
 
Table 1: Primers for qPCR, 5’ FAM is the reporter signal from all the probes and 3’ Iowa Black FQ/ZEN is quencher 
Gene Forward primer Reverse primer Probe 
Rela GTCTCGCTTCTTCACACACT GCCTCATCCACATGAACTTGT ATGCATCCACAGCTTCCAGAACCT 
TNF-α GTCTTTGAGATCCATGCCATTG AGACCCTCACACTCAGATCA CACGTCGTAGCAAACCACCAAGC 
TLR4 CCATGCCTTGTCTTCAATTGTC 
 
 AACCTAGTTCTGAGCTTCAACC CAGCCACTGAAGTTGTGAGAAATTGGTG 
CCR2 CCACAAAACCAAAGATGAATACCA CCACCACACCGTATGACTATG ATCCTGCCCCCACTCTACTCCC 
IL-1β TCGTTGCTTGTCTCTCCTTG TGACCCATGTGAGCTGAAAG ACCACTTGTTGGCTTATGTTCTGTCCA 
CCL2 ATCTCTCTTCCTCCACCACTA GAATGAGTAGCAGCAGGTGAG TGTCTCAGCCAGATGCAGTTAATGCC 
CD163 TCTCATTGCCTTCCTCTTGTG TCATCCGTCTTCGAATCCATC 
 
ACCCAACGGCTTACAGTTTCCTCAA 
CD68 CAT TCCCTTACGGACAGCTTAC TGAGAATGTCCACTGTGCTG CTCTGATGTCGGTCCTGTTTGAATCCA 
Arg1 TCCACCCAAATGACGCATAG GTAGCAGAGACCCAGAAGAATG TGGAGACCACAGTATGGCAATTGGAA 
Nos2 CGAAGGTGAGTTGAACAAGGA AGCATCCACGCCAAGAAC CAGAGTGAGAAGTCCAGCCGCA 
Gapdh GTAACCAGGCGTCCGATAC GTTCTAGAGACAGCCGCATC ATCCGTTCACACCGACCTTCACC 
B2m CCAGATGATTCAGAGCTCCATAG ACCGAGACCGATGTATATGCT CCTGGGACCGAGACATGTAATCAAGC 
 
 
Flow cytometry and stimulation of blood 
Blood from the adult offspring in study 2 was collected from the tail vein after the dietary 
challenge. It was stained with v450 conjugated anti-rat CD45 antibody (BD Biosciences) and a PE-
konjugated anti-rat TLR4 antibody (Abcam) for 30 minutes at 4°C followed by lysis of red blood 
cells with FACS lysing solution (BD Biosciences). The stained blood samples were analysed on a BD 
FACSCanto II flow cytometer (BD Biosciences). Monocytes were identified as CD45+ cells and 
subsequently divided into lymphocytes, monocytes and granulocytes based on size and granularity 
on a forward vs. side scatter plot (Supplementary figure 1). TLR4 expression levels on monocytes 
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were identified. The remaining blood was diluted 10x in complete media (RPMI-1640 with 1% 
penicillin and streptomycin and 1% L-glutamine) and stimulated with media or lipopolysaccharide 
(LPS) at 100ng/mL. Supernatants were collected after 24 hours and analysed for TNFa production 
by a Meso Scale Discovery TNFα kit on a Meso Scale Selector Imager 6000 according to 
manufacturer’s instructions (Meso Scale Discovery, Rockville, Maryland, US) 
 
Statistics 
26 weeks data: we used a blocked design (10 animals pr day for four days, 2 animals per group per 
day) to enable analysis by flow cytometry and blood stimulations. The data were adjusted for day 
to day variation. Not all data followed a Gaussian distribution or had equal variance among 
groups, so the pre-natal, post-natal and challenge effects were analysed by a permutated 2way 
(before the dietary challenge) or 3way ANOVA (after the dietary challenge) in the “lmperm” 
package in R (http://www.r-project.org/), as described by Anderson (2001)207. Post-hoc tests were 
performed as a pair-wise comparison between groups by a two sample permutation test in the 
“coin” package in R 207 and the p-values from the two sample tests were adjusted for multiple 
testing by the Holm-Bonferroni method. Effects were considered significant when p<0.05. 
 
Results 
Inflammatory mRNA expression profiles in blood and adipose tissue in young offspring 
We characterised the inflammatory status at day 1 and at 4 weeks of age in rat offspring from 
mothers exposed to maternal HFHS or control diet during gestation and/or lactation to examine 
early immunological effects of a maternal high-fat/high sucrose (HFHS) diet on offspring (Figure 
1A). Female dams were fed the HFHS or control diet for 17 weeks prior to mating, however, the 
dietary intervention did not significantly alter body weight, gestational weight gain, litter size or 
the circulating levels of glucose, insulin, leptin and triacylglyceride in the dams (Chapter 4).  
Inflammatory gene expression was determined in blood the day after birth to study the effect of 
HFHS exposure during gestation on the immune status in newborns. We analysed: tlr4, the LPS 
receptor; ccr2, mainly expressed on inflammatory monocytes that migrate to CCL2-expressing 
tissues; TNF-α and IL-1b, pro-inflammatory cytokines; and Rela/NF-κB, a transcription factor that 
regulates the expression of pro-inflammatory genes. TLR4 expression was found increased 
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(p<0.05) in the HFHS born pups (H) compared to the control born (C) offspring, whereas no 
changes in CCR2, TNF-α, IL-1b or Rela/NF-κB expression were observed at birth (Figure 1B).  
We then examined the effect of cross-fostering the C- and HFHS- born pups on complementary 
diets, so that C-pups were lactated by C dams (CC) or HFHS dams (CH) and HFHS-pups were 
lactated by C dams (HC) or HFHS dams (HH), to study pre-natal and post-natal effects of maternal 
HFHS intake on immunity in the offspring at weaning (Figure 1A). Pre-natal refers to the maternal 
HFHS diet during pregnancy and therefore compares the response in the CC and CH groups with 
the response in the HC and HH groups. Post-natal denotes the effect of maternal HFHS diet during 
lactation and therefore compares the response in the CC and HC groups with the response in the 
CH and HH groups. At 4 weeks of age, TLR4 and TNF-α mRNA levels in blood cells were decreased 
in the offspring lactated by HFHS dams compared to the control offspring (postnatal p<0.05, Figure 
1B, d28). Moreover, we observed an increase in TNF-α and IL-1b in HFHS born pups compared to C 
born (prenatal p<0.05, Figure 1B: d28). No effects were seen in CCR2 or Rela/NF-κB expression 
levels in blood from 4 weeks old offspring (Figure 1B, d28).  
In epididymal adipose tissue, we analysed mRNA levels of tlr4, tnfa, il-1b as in blood, and also 
included CCL2 (the chemokine for CCR2), cd68 (overall macrophage marker), nos2, (M1 
macrophage marker), CD163 and Arg1 (M2 macrophage markers) in week 4 offspring (Figure 1C). 
The level of tlr4 was decreased in the HFHS born pups compared to C born offspring (prenatal 
p<0.05, Figure 1C), but we found no changes in the expression of the chemokine CCL2 nor the pro-
inflammatory cytokines tnfa and il-1b in adipose tissue. The markers related to general 
macrophages (cd68) and M1 macrophages (nos2) were not affected. However, the M2 
macrophage marker CD163 was elevated in the HFHS lactated offspring (post-natal p<0.05) and an 
interaction between the pre-natal and post-natal HFHS exposure was found in arg1 (pre:post-natal 
p<0.05, Figure 1C). The result for CD163 and Arg1 appears to be driven by an increase in mRNA 
levels of CD163 and Arg1 in the CH group compared to the CC group, although this did not reach a 
statistically significant level for Arg1 (cd163 p<0.05 for CC vs CH, arg1 p=0.15 for CC vs CH). 
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Figure 1. Gene expression of inflammatory markers in blood and adipose tissue of young offspring at weaning. A) 
Experimental setup. Dams were fed a conventional (C) or high fat/high sucrose (H) diet for 17 weeks prior to mating. 
Female offspring were euthanized the day after birth. Male offspring were cross-fostered on complementary diets 
during lactation and euthanized at weaning. The number of offspring in each group is given as n. B) Blood was 
collected at day 1 and week 4, followed by measurement of mRNA expression levels of TLR4 and CCR2, the 
transcription factor NF-κB and the pro-inflammatory cytokines TNF-α and IL-1β by qRT-PCR. C) Epididymal adipose 
tissue was collected at weaning, and subjected to analysis of mRNA expression of TLR4, the chemokine CCL2 (ligand 
for CCR2 on the blood cells), the cytokines TNF-α and IL-1β, the generic macrophage markers CD68, the M1 
(inflammatory) macrophage marker Nos2 and the two M2 (resident) macrophage markers CD163 and Arg1 by qRT-
PCR. Data are presented as mean±stdev, with n as shown in A). Pre- and post-natal effects are evaluated by a 
permutated 2-way ANOVA.* p<0.05   
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The combined inflammatory phenotype in 4-weeks old offspring is affected by both prenatal and 
postnatal diet and link to adiposity and lipolysis in adipose tissue.  
To evaluate the overall inflammatory phenotype in the offspring at weaning, we performed a 
multivariate principal component analysis (PCA) on the mRNA profiles at week 4 from blood and 
adipose tissue. Score and loading plots are shown in figure 2A and B, respectively, where principal 
component 1 (PC1) makes up 31% of the variation between animals, while PC2 explains 18%. The 
score plot separates individual animals based on overall differences within the groups CC, CH, HC 
and HH (Figure 2A). We found an overall separation of CH offspring from other groups in PC1, 
while no apparent clusters were seen in PC2 (Figure 2A) and PC3 (data not shown). PC1 was found 
to be explained by all 5 inflammatory markers in blood (TLR4, TNF-α, IL-1β, CCR2 and Rela/NF-κB) 
and 5 out of 8 markers from adipose tissue (CCL2, CD68, CD163, TLR4 and arg1, Figure 2B). When 
extracting the coordinates of PC1 and PC2 for all animals (Figure 2C), we observed a post-natal 
effect on early immunity (p<0.001, PC1). Particular cross-fostering from the control diet during 
prenatal life onto the HFHS diet during postnatal life (CH) resulted in an altered immune response 
in offspring at 4 weeks of age (p<0.05 compared to the other groups), characterized by a decrease 
in expression of inflammatory genes in blood and an increase in M2 macrophage markers (Arg1 
and CD163) in adipose tissue. Moreover, we identified a slight effect of the pre-natal diet on early 
immunity in offspring (Figure 2C, PC1). There were no differences among the groups in PC2 
coordinates (Figure 2C) or PC3 (data not shown).   
In order to identify if the changes in inflammatory profiles were linked to metabolic variations, PC1 
immune coordinates were correlated by linear regression analysis to common metabolic markers 
determined simultaneously in the offspring (Chapter 4). PC1 immune coordinates associated with 
weight of epididymal adipose tissue (p<0.05), mRNA levels of adipose triglyceride lipase (atgl), and 
hormone sensitive lipase (hsl) in adipose tissue, both involved in triglyceride lipolysis, and they 
were, moreover, borderline associated to whole body weight (p=0.06) (Figure 2D). Thus, an 
increase in adiposity and lipolysis were linked to decreased gene expression of inflammatory 
genes in the blood and increased expression of M2 macrophage markers in adipose tissue (Figure 
2D). Notably, it is evident that the CH group, which also displayed a distinct elevated adiposity 
compared to all other groups (Chapter 4), showed a divergent immunological profile (Figure 2C). 
 
126 
 
 
Figure 2. Principal component analysis of the immune profile in offspring at weaning. The mRNA levels of immune 
genes in blood and adipose tissue were loaded into a principal component analysis (PCA), where A) shows the score 
plot, and B) the loading plot. Each dot displays one animal, color-coded according to groups. C) The coordinates for 
principal component (PC) 1 and 2 were extracted for each animal. Data are presented in boxplot with whiskers 
representing 5-95 percentiles. Pre- and post-natal effects are evaluated by a permutated 2-way ANOVA. * p<0.05. D) 
Correlations of PC1 with metabolic parameters determined simultaneously in the offspring. N in each group is 
displayed in Figure 1A.  
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Figure 3. Gene expression of inflammatory markers in blood in adult offspring at 20 weeks of age. A. Experimental 
setup. Dams were fed a conventional or high fat/high sucrose diet for 6 weeks prior to mating. Male offspring were 
cross-fostered on complementary diets during lactation and weaned onto a conventional diet at 4 weeks of age. Until 
20 weeks of age, all offspring were administered a control diet. At 20 weeks of age, offspring was challenged with high 
fat diet for 6 weeks and subsequently euthanized at 26 weeks of age. B) Blood was analysed for mRNA levels of TLR4 
and CCR2, the transcription factor NF-κB and the pro-inflammatory cytokines TNF-α and IL-1β by qRT-PCR. Data are 
presented as mean±stdev with n for each group as displayed in A). The combined mRNA immune profile in blood was 
evaluated by PCA, where C) displays the score plot, and D) the loading plot. Each dot represents one animal, color-
coded according to groups. E) The coordinates for principal component (PC) 1 and 2 were extracted for each animal. 
Data are presented in boxplot with whiskers representing 5-95 percentiles. F) Correlations of PC1 with body weight at 
20 weeks of age. Pre- and post-natal effects are evaluated by a permutated 2-way ANOVA  
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We then went on to study if these early immunological changes in the offspring due to maternal 
HFHS intake would be affected by feeding the offspring control diet for 16 weeks post-weaning. 
Subsequently, we applied a dietary challenge to elucidate if the maternal diet during perinatal life 
influenced the offspring’s immunological response during adulthood.  
 
Immunological profiling in cross-fostered rats after intake of a control diet for 16 weeks post-
weaning followed by 6 weeks HF challenge 
In this follow-up study, the offspring was treated as previously (Figure 1A), and then weaned onto 
a control diet for 16 weeks, followed by a challenge with a HF diet for 6 weeks during adulthood 
(week 20 to 26, Figure 3A). The control group (CCC) remained on the control diet for the whole 
period. One important difference from the previous study was that female dams were fed the 
HFHS or control diet for 6 weeks prior to mating, in contrast to 17 weeks. Again, the prenatal diet 
did not alter body weight, gestational weight gain, litter size or the circulating levels of glucose, 
insulin, leptin and triacylglyceride in mothers (Chapter 5).   
After ingestion of control diet for 16 weeks post-weaning, blood was analysed for mRNA 
expression of inflammatory markers (Figure 3B, week 20). A significant interaction was found on 
tlr4 indicating that prenatal HFHS exposure affects the response to a HFHS diet during lactation 
(p<0.05). Additionally, Rela was increase in HFHS born pups compared to control born (p<0.05), 
while no effects were seen on CCR2, TNF-α and IL-1β. The overall variation in inflammatory 
markers between groups was tested in a PCA, where PC1 coordinates made up 79% of the 
variation and PC2 11% (Figure 3C, D). The CH group showed a unique immunological profile at 4 
weeks of age in the first study, however in this study at 20 weeks of age, the immunity in the HH 
group described by PC1 differed from the other groups (pre:postnatal p<0.05, Figure 3E), although 
this effect did not reach statistically significant levels in the pairwise comparison among the 
groups. The combined inflammatory profile in PC1, characterized by expression of inflammatory 
genes in blood, did not correlate to overall body weight at week 20 (Figure 3F), or any metabolic 
markers collected at this time point (Chapter 5). 
After 6 weeks of HF challenge during adulthood (week 20 to 26), we observed decreased levels of 
TLR4, IL-1β and Rela in blood (postnatal p<0.05, p<0.05 and p<0.01, respectively) from HFHS 
lactated offspring compared to C lactated offspring, while no effects were seen on TNF-α and 
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CCR2 (Figure 4A). The mRNA level of TLR4 seemed to be particular affected by maternal diet, since 
it was affected by pre-natal or post-natal HFHS exposure at d1 and d28, respectively, in the first 
study. Additionally, in the second study, we found a interaction effect on TLR4 before the dietary 
challenge and a post-natal effect after the challenge. Therefore, we examined surface TLR4 
expression on fresh blood monocytes drawn at the day of termination at week 26. Monocytes 
express high levels of TLR4 and they are known to play an important role in macrophage 
infiltration of adipose tissue, liver and pancreas in obesity-induced inflammation 277. We found no 
changes in the abundance of monocytes within the circulating blood leukocytes (CD45+ cells, 
Figure 4B), but surface TLR4 expression on monocytes were overall decreased in HF-challenged 
animals (challenge p<0.05, Figure 4C). However, a functional effect of the decreased surface TLR4 
expression was not apparent in the HFHS lactated offspring, which was demonstrated by slightly 
increased secretion of TNFa in the supernatants from CHH- and HHH-derived whole blood upon 
stimulation with the TLR4-ligand lipopolysaccharide (LPS) at 100 ng/mL for 24 hours (post-natal 
p<0.05, Figure 4D). 
Epididymal adipose tissue was collected from adult offspring after the dietary challenge (week 26) 
and subjected to analysis of expression of immune-related markers by qPCR (Figure 4E). 
Decreased expression of the M2 macrophage marker CD163 and increased overall cd68 expression 
indicate that M1 might accumulate in adipose tissue during the HF challenge (Figure 4E). There 
were no apparent effects of the pre- and post-natal diet on other immunological markers assessed 
in adipose tissue after the dietary challenge.  
 
The inflammatory phenotype in the adult rat is affected by the post-natal diet upon later HFHS 
challenge  
The overall inflammatory phenotype in the offspring after the HF challenge was evaluated in a PCA 
(Figure 5A, B). PC1 explained 24% and PC2 16% of the variation between individual animals at 
week 26. PC1 was found to separate the immunological profile according to post-natal exposure 
(Figure 5C, postnatal p<0.01). The PC1 coordinates for the HFHS lactated offspring were 
characterised by increased TNFa secretion in response to LPS-stimulation in blood immune cells, 
despite decreased mRNA levels of inflammatory markers in fresh blood, concurrent with 
decreased CD163 expression in adipose tissue. The combined inflammatory profile in PC1 did not 
130 
 
correlate to overall body weight at week 26 (Figure 5E), or any other marker of metabolic function 
(Chapter 5). 
 
Figure 4. Gene expression of inflammatory markers in blood and epididymal adipose tissue in adult offspring at 26 
weeks of age after 6 weeks of high fat feeding. A) Blood was analysed for mRNA expression of TLR4 and CCR2, the 
transcription factor NF-κB and the pro-inflammatory cytokines TNF-α and IL-1β by qRT-PCR. B) Monocyte abundance 
in blood as identified by flow cytometry. C) TLR4 expression on the surface of blood monocytes, determined by flow 
cytometry. D) TNF-α secretion from whole blood upon stimulation with 100 ng/mL LPS for 24 hours. E) Epididymal 
adipose tissue was analysed for mRNA expression of TLR4, the chemokine CCL2 (ligand for CCR2 on the blood cells), 
the cytokines TNF-α and IL-1β, the generic macrophage markers CD68, the M1 (inflammatory) macrophage marker 
Nos2 and the two M2 (resident) macrophage markers CD163 and Arg1 by qRT-PCR. Data are presented as 
mean±stdev; with n for each group as shown in Figure 3A. Pre-natal, post-natal and challenge effects are evaluated by 
a permutated 3-way ANOVA. * p<0.05 
CCR2
2^-Ct
0.00 0.01 0.02 0.03 0.04
HHH
HCH
CHH
CCH
CCC
TLR4
2^-Ct
0.000 0.001 0.002 0.003
HHH
HCH
CHH
CCH
CCC
post-natal p<0.05
*
Rela/NF-B
2^-Ct
0.000 0.005 0.010 0.015 0.020
HHH
HCH
CHH
CCH
CCC
post-natal p<0.01
TNF-
2^-Ct
0.000 0.001 0.002
HHH
HCH
CHH
CCH
CCC
IL-1
2^-Ct
0.00 0.05 0.10 0.15 0.20 0.25
HHH
HCH
CHH
CCH
CCC
post-natal p<0.05
m
o
n
o
c
y
te
 o
f
to
ta
l 
C
D
4
5
+
 (
%
)
CCC CCH CHH HCH HHH
0
5
10
15
ns
T
L
R
4
 M
F
I
o
n
 m
o
n
o
c
y
te
s
CCC CCH CHH HCH HHH
0
2000
4000
6000 prenatal:postnatal p<0.05
challenge p<0.05
*
*
*
T
N
F
-
 i
n
 s
u
p
e
rn
a
ta
n
ts
(L
P
S
-m
e
d
ia
)
CCC CCH CHH HCH HHH
0
50
100
150
200
250 postnatal p<0.05
CCL2/MCP-1
2^-Ct
0.00 0.01 0.02 0.03 0.04 0.05
HHH
HCH
CHH
CCH
CCC
CD163
2^-Ct
0.00 0.05 0.10 0.15
HHH
HCH
CHH
CCH
CCC
challenge p<0.05
CD68
2^-Ct
0.00 0.05 0.10 0.15 0.20
HHH
HCH
CHH
CCH
CCC
challenge p<0.05
TLR4
2^-Ct
0.000 0.005 0.010 0.015
HHH
HCH
CHH
CCH
CCC
Arg1
2^-Ct
0.0000 0.0005 0.0010
HHH
HCH
CHH
CCH
CCC
Nos2
2^-Ct
0.0000 0.0002 0.0004
HHH
HCH
CHH
CCH
CCC
TNF-
2^-Ct
0.0000 0.0005 0.0010 0.0015
HHH
HCH
CHH
CCH
CCC
IL-1
2^-Ct
0.000 0.002 0.004
HHH
HCH
CHH
CCH
CCC
A
B C D
E
E
131 
 
 
 
Figure 5. Principal component analysis of the immunologic profile of the adult offspring at 26 weeks of age after 6 
weeks of high fat feeding. Immunological parameters from blood and adipose tissue were evaluated by PCA where 
one dot displays the combined profile from one animal, distributed on groups by colors.  A) Score plot, B) Loading plot. 
C) The coordinates for principal component (PC) 1 and 2 were extracted for each animal. Data are presented in 
boxplot with whiskers representing 5-95 percentiles. Pre-natal, post-natal and challenge effects are evaluated by a 
permutated 3-way ANOVA. D) Correlations of PC1 with body weight at 26 weeks of age after 6 weeks of high fat 
feeding.  
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Discussion 
Maternal high fat feeding during pregnancy and lactation increases markers of obesity-induced 
inflammation in circulation143,274, liver27,41,274, vasculature275 and hypothalamus38,276. However, the 
general characterization of obesity-induced inflammation have initially focused on inflammation 
and macrophage infiltration of adipose tissue1, so in this study markers of adipose tissue 
inflammation have been mapped in young and adult rat offspring exposed to maternal high 
fat/high sucrose feeding during gestation and/or lactation.   
Our data demonstrate that both pre-natal and post-natal HFHS feeding impact the immune profile 
in offspring, but with varying effects at different ages and following HF challenge during 
adulthood. The statistically significant findings on the immune profiles collected at different ages 
and interventions are displayed in an overview (Figure 6). From the study in the young offspring 
(Figure 6A), it was apparent that prenatal HFHS resulted in increased expression of TLR4 in blood 
at birth, and also in enhanced blood expression of TNF-α and IL-1b at 4 weeks of age, whereas tlr4 
was reduced in adipose tissue. Contrarily, maternal postnatal HFHS during lactation resulted in 
reduced blood TLR4 and TNF-α, and increased M2 macrophage marker expression at 4 weeks of 
age. We were able to identify correlations between the combined immune profile and specific 
metabolic parameters. At this stage, it was striking that elevated adiposity were linked to reduced 
mRNA expression of pro-inflammatory genes in blood and increased markers of macrophage influx 
into adipose tissue (CD163, and borderline CD68, arg1, CCL2 and TLR4). This immunological profile 
were particular significant in the offspring born by control dams and lactated by HFHS dams (CH). 
Kosteli and colleagues have previously shown that increased lipolysis in adipose tissue during 
weight loss result in macrophage infiltration of the M2 type presumably to enhance lipid clearance 
in adipose tissue123. We found a correlation between the immunological profile and mRNA levels 
of the lipolysis genes atgl and hsl in adipose tissue. This could imply that the elevated levels of 
cd163 in adipose tissue from HFHS lactated offspring might relate to increased lipolysis resulting in 
the need for improved lipid clearance by macrophages. Additionally, it has also been shown that 
the first macrophages that enter the adipose tissue after just a few days of high fat feeding have a 
M2 phenotype278, so the elevated CD163 marker in adipose tissue might also be a very early sign 
of obesity-induced adipose tissue inflammation in the offspring.  
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Figure 6. Summary of the significant pre- and post-natal effects found in the young offspring at weaning (A) and 
after a high fat dietary challenge in adulthood (B). 
 
In the adult offspring that was fed a conventional diet for 16 weeks post-weaning (20 weeks of 
age), we found that HFHS exposure during fetal life increased the TLR4 response to a HFHS 
environment after birth and Rela/NF-κB was elevated in HFHS in blood from offspring born by 
HFHS dams. The overall immunological profile at 20 weeks of age showed general elevated levels 
of inflammatory genes in the HH group only. After 6 weeks of HF challenge in adulthood (from 20-
26 weeks of age), we observed reduced TLR4, IL-1b and Rela in blood of offspring lactated by HFHS 
dams, resembling that of CCC, along with enhanced TNF-α secretion upon blood stimulation with 
LPS. In the present study, we were not able to perform functional analysis of immune 
responsiveness at every time point, besides in 26 weeks old animals. However, the analysis at 26 
weeks of age showed that TNFa secretion was enhanced in the postnatal HFHS groups upon 
stimulation with the TLR4 agonist LPS, although TLR4 surface expression on monocytes were 
reduced to the same level in all HF challenge offspring in whole blood. The tlr4 mRNA expression 
in the blood was also reduced by the HF challenge. This disparity in expression and functionality of 
TLR4 might reflect that HFHS during lactation programs offspring to respond more strongly 
towards TLR4 triggering with LPS when rechallenged with HF later in life or that the functional 
Prenatal-HFHS Postnatal-HFHS
D0: Blood-tlr4
D28: Blood-tnfa/il1b
AT-tlr4
D28: Blood-tlr4/tnfa
AT-cd163
Prenatal-HFHS Postnatal-HFHS
W20: Blood-rela
W26: none 
W20: none
W26: Blood-tlr4/il1b/rela
Blood-TNF-stim.
AT: none
Challenge - HF
W26: Blood-monocytes TLR4
AT-cd163   , AT-cd68 
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response is somewhat independent on surface TLR4 display. This is in conflict with the 
endotoxemia hypothesis, which states that insulin resistance is associated with activation of 
monocytes by elevated circulating levels of lipopolysaccharide via TLR4 dependent mechanism 133 
Despite the alterations in immunity in the blood from HFHS lactated offspring, we identified no 
post-natal effects on markers of inflammation in adipose tissue. The HF challenge, however, 
reduced the mRNA levels of the M2 macrophage marker CD163 and increased the generic 
macrophage marker CD68 independent of perinatal HFHS exposure. A skew in macrophage 
markers away from CD163 and towards CD68, might indicate an elevated infiltration of M1 
macrophage in the adipose tissue, although no effects were seen on the pro-inflammatory 
cytokine mRNA expression levels. It was somewhat surprising that 6 weeks of HF challenge had so 
little effect on the immunity in the blood and only affected few markers in the adipose tissue.  
Collectively, the study revealed that exposure to maternal HFHS diet during lactation alters 
systemic and adipose tissue immune expression profiles at weaning which could be linked to 
metabolic alterations in the offspring. Additionally, post-natal HFHS exposure also altered the 
systemic immunological profile in adult offspring both before and after challenge with a HF diet. 
These results demonstrate that especially maternal HFHS intake during lactation leaves an 
immunological imprinting in blood cells in both young and adult offspring. 
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Supplementary material 
 
Supplementary figure 1. Gating strategy to identify monocytes in fresh blood by flow cytometry. Monocytes were 
identified first as CD45
+
, then according to the forward scatter and side scatter 
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“Nature is beautiful but not correct” 
                                                   - Wilhelm Johannsen, 1911 
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7. Summarizing discussion 
 
Maternal obesity or high fat feeding during gestation and lactation is associated with increased 
risk of obesity and metabolic dysfunction in the offspring4. However, diet induced obesity in the 
mother is associated with a range of alterations in the composition of nutrients, hormones and 
inflammatory markers which all potentially can affect the metabolic imprinting in the 
offspring4,279.  Prepregnancy BMI alone has been associated with elevated birth weight in 
neonates280 and maternal obesity might be a stronger predictor for childhood obesity than 
maternal hyperglycemia281, although conflicting studies have shown that maternal sucrose intake 
and glucose concentrations increases obesity risk in the children independent of prepregnancy 
BMI282,283. The Pedersen hypothesis suggests that maternal hyperglycemia also leads to 
hyperinsulinemia in the offspring284. Studies in rats have additionally shown that maternal fructose 
intake induced hyperglycemia in the pups at birth, 285, and exposure to a sucrose –rich diet during 
gestation and lactation impair glucose and lipid metabolism in the adult offspring226. But again, 
results on this matter are conflicting since other studies have shown that gestation diabetes alone 
is not a predictor for metabolic dysfunction in the children, if they are born with an average birth 
weight6. Maternal intake of saturated fatty acids and maternal triglycerides levels have also been 
associated with elevated birth weight of neonates and childhood obesity280,282, while maternal 
PUFA intake during pregnancy decreases adiposity in the children286. The main problem, about 
trying to elucidate mono causative effects from each of the factors, is that the factors intertwine in 
obesity; Hyperleptinemia occurs naturally in obesity due to elevated adiposity, hyperglycemia is 
counteracted by hyperinsulinemia, and these symptoms are often associated with dyslipidemia. 
Additionally obesity is associated with a chronic low grade inflammatory phenotype, characterizes 
by local inflammation in adipose tissue, liver, pancreas, hypothalamus and muscles along side with 
increased levels of circulating cytokines1. A few studies have brought attention to obesity induced 
inflammation as a potential maternal stimulus during pregnancy that might affect the offspring. 
Challier and colleagues showed that macrophages infiltrate the human placenta, like we know it 
from adipose tissue and liver, in obese mothers during pregnancy190, and subsequently the results 
have also been confirmed in non-human primates41. These studies made us speculate which role 
maternal obesity-induced inflammation might play in programming of metabolic function in the 
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offspring (Chapter 2). To our knowledge, nobody have yet address obesity-induced inflammation 
in fetal programming of metabolic syndrome, so we can only speculate which role it might play 
based on animal models with acute inflammation from LPS injections180-182 and other chronic low 
grade inflammatory diseases, like psoriasis187,188, multiple sclerosis186 and rheumatoid arthritis189. 
In the review (Chapter 2) we hypothesized that pregnancy, a Treg/Th2 skewed immunological 
phenotype, can reduce obesity induced inflammation, which is characterized by a Th1 driven 
phenotype. Subsequently, we tested this hypothesis in a commonly used maternal obesity mice 
model, where metabolic imprinting in the offspring is known25,26. We studied if the low grade 
inflammation were reduced during pregnancy and therefore less likely to play a role in fetal 
programming of obesity and metabolic dysfunction (Chapter 3). The study demonstrated that 
obesity-induced inflammation, characterized by macrophage infiltration in adipose tissue and liver 
along side with decreased abundance of blood monocytes and a tendency to elevated levels of 
circulating MCP-1, was present prior to mating. However, all parameters were similar to the 
control group on gestation day 18 and we found no macrophage infiltration in the placenta of the 
obese dams. This indicated that the obesity-induced inflammation, present before mating, was 
reversed during gestation. This result conflicts with previous findings, which have shown not only 
placental macrophage infiltration in obese women but also elevated circulating levels of C reactive 
protein (CRP) and IL-6 along side with macrophage infiltration in the adipose tissue190,192,193,279. 
However it is important to emphasize, like we did in the review (Chapter 2), that we do not 
suggest a complete reversal of obesity-induced inflammation during pregnancy, but the results 
from the maternal obesity mouse model demonstrate that the inflammation is reduced during 
pregnancy, similar to other low grade inflammatory diseases. Instead, we suggest that the early 
elevated lipid exposure caused by maternal obesity might be more important for long term 
metabolic effect in the offspring, since previous studies have shown increased lipid transport to 
the fetus in obese ewes216 and elevated hepatic lipid accumulation in offspring of obese mothers 
at birth in non-human primates41. The mouse fetuses from obese dams is our study, also showed 
increased accumulation of TAG, but more interestingly hepatic ceramide also tended to 
accumulate. Ceramide can inhibit insulin signaling and induced inflammation which important in 
the etiology of non-alcoholic steatohepatitis (NASH)229. Thus, if the elevation of hepatic ceramide 
is maintained into adulthood, the offspring born by obese dams would have increased risk of 
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developing type 2 diabetes and NASH later in life. Based on these data, we believe that the 
maternal high fat or obesogenic diet and the increased lipid exposure during fetal life are 
important for programming of metabolic dysfunction in the offspring. 
 
White and colleagues published a study in 2009 showing that maternal obesity was necessary for 
programming effects in rat offspring256, however conflicting studies have proven otherwise both in 
rats37 and non-human primates41. In the two rat studies included in this thesis, we neither 
observed a difference in body weight or circulating metabolic markers at the time of mating 
among dams fed a pre-gestational conventional or a high fat /high sucrose (HFHS) diet for 6 or 17 
weeks. However, the offspring perinatally exposed to the HFHS diet still showed distinct metabolic 
and immunological phenotypes both at weaning and in adulthood. The metabolic phenotype of 
the dams was surprising, since the obese dams on average had a 1.25 fold higher caloric intake 
(Chapter 4), but many metabolic markers are not being evaluated in our setup. The length of the 
intervention period prior to mating might be important for the outcome in the offspring262,264. 
Therefore, we cannot assume that the maternal phenotypes in the two rat studies are 
comparable. The metabolic profile of the first (6 weeks of pre-gestational intervention, w6) and 
second litter (17 weeks of pre-gestational intervention, w17) were therefore described by body 
weight and circulating metabolic markers at weaning and compared by principal component 
analysis, to elucidate if the two litters displayed similar metabolic patterns (Figure 1). The score 
plot (Figure 1A) showed that length of the pre-gestational intervention of the dams separates the 
metabolic phenotype in the male offspring at weaning both along PC1 and PC2 (p<0.001 and 
p<0.01, respectively, Figure 1B). PC1 separates the litters according to body weight and plasma 
insulin and leptin levels, which demonstrates that an extended pre-gestational intervention 
increases the metabolic dysfunction in the offspring at weaning. Thus comparison of the two 
studies therefore has to be done with caution.  
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Figure 1. Principal component analysis of metabolic markers in male offspring at weaning according to length pre-
gestational intervention. Body weight and circulating metabolic markers were used du describe the metabolic 
phenotype. w6 (red), offspring born by dams with a 6 weeks intervention period prior to mating, w17 (black) offspring 
born by dams with a 17 weeks intervention prior to mating. A. Scoring and loading plots for the PCA. The square 
symbol is the average phenotype of the group. B Extracted scores for principal component (PC) 1 and 2. Data are 
presented as mean±stdev. Effects between w6 and w17 offspring were analysed by a permutated t-test. ** p<0.01, 
*** p<0.001. TAG triacylglyceride..   
 
Offspring exposed to a maternal HFHS diet during gestation (HC), lactation (CH) or both (HH) have 
been metabolically and immunologically phenotyped at weaning. These results are separately 
reported in Chapter 4 and 6. However, as mention previously, the obesogenic phenotype is 
complex and many of the factors intertwine, so a multivariate principal component analysis (PCA) 
was performed on both metabolic and immunologic parameters to elucidate overall phenotypical 
changes between the groups (Figure 2). Score and loading plots are shown in Figure 2A. the 
offspring clustered according to the four different groups (CC = black circle, CH = red circle, HC = 
green circle, HH = blue circle, Figure 2A, scoring plot). however, no apparent clustering was visible 
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when plotting PC2 vs PC3 (data not shown). To analyze if the clustering was significant, the scores 
of principal components 1 (Dim 1, PC1) and 2 (Dim 2, PC2) were extracted and the statistical 
analysis showed that all groups were significantly different from the other along the PC1 axis 
(Figure 2B). PC1 explained 28% of the variation between the animals and was characterized by an 
increase in: adiposity, lipolysis in adipose tissue (indicated by mRNA levels of atgl and hsl) and 
hepatic accumulation of triacylglycerides and phospholipids, in combination with a decrease in: 
expression of inflammatory genes in blood (indicated by mRNA levels of tnfa, ccr2 and tlr4) and 
hepatic ceramide accumulation. It is surprising that lipolysis in adipose tissue and hepatic 
triacylglyceride accumulation were clustered opposite from ceramide concentration along PC1. 
Hepatic steatosis is normally linked to accumulation of lipotoxic intermediate like ceramide and 
FFA228, however, ceramide might be rapid secreted to avoid the lipotoxic effects 244. Ceramide can 
interfere with insulin signaling 229 and it was therefore not surprising that hepatic ceramide 
content clustered with mRNA levels on inflammatory genes in the blood along PC1, since obesity-
induced inflammation operates locally in various tissue but also systemic. Additionally it was 
surprising that inflammatory parameters clustered opposite from the obesity parameters 
indicating that the obese CH group (Chapter 4), might have a less tendency to develop obesity-
induced inflammation and subsequently metabolic disease, while the HC offspring might have a 
higher risk despite their lean phenotype (HC). However, as mentioned in Chapter 6, the decreased 
pro-inflammatory phenotype is the CH group could potentially also indicate the very early stage of 
obesity-induced inflammation, since M2 macrophages are recruited to the adipose tissue after 
short term high fat feeding278 probably due to an increased lipid turn over in the tissue123. Further 
research is needed to elucidate if dietary mismatch between prenatal and postnatal life can affect 
the offspring’s immunity. The HFHS lactated offspring (CH and HH) grouped on one side of the CC 
group along the PC1 axis while the HC clustered on the other, thus the mismatch groups (CH and 
HC) were phenotypically furthest from each other leaving the match phenotypes (CC and HH) in 
the intermediate area. The CC were closer related to the HC and HH group than the CH group, 
demonstrating that a dietary mismatch between the control diet in utero and the maternal HFHS 
intake during lactation, cause more severe phenotypic alteration in the offspring at weaning than 
when the pups that have been exposed to the HFHS diet both in utero and during lactation. This is 
in good accordance with the predictive adaptability hypothesis19, which suggest that epigenetic 
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adaptions occur in utero to predisposes the fetuses, in this case, to a high energy diet after birth. 
PC2 explained 10.5% of the variation between the animals and was characterized by an increase in 
overall hepatic lipid synthesis (indicated my mRNA levels of fads1, fads2, scd1 and acaca) and a 
decrease in circulating metabolic markers (leptin, insulin and glucose). Both prenatal and postnatal 
HFHS exposure affected the PC2 score (p<0.001 and p<0.01 respectively, Figure 2B), however the 
separation between the groups along PC2 was much smaller compared to PC1. 
 
 
 
Figure 2. Principal component analysis of immunity and metabolism in male offspring at weaning. A. Scoring and 
loading plots for the PCA. The squares are the average phenotype of the group. B Extracted scores for principal 
component (PC) 1 and 2. Data were analysed by a permutated 2-way ANOVA for prenatal and postnatal effects and 
presented as mean±stdev. * p<0.05, ** p<0.01, *** p<0.001 
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adulthood, to elucidate if the maternal HFHS diet influenced the offspring’s capability to deal with 
a high fat load as adults. Similar to the previous study in young offspring at weaning, we were 
interested in changes in the overall phenotype describes by both metabolic (Chapter 5) and 
immunologic (Chapter 6) parameters between the groups, so an PCA were performed (Figure 3). 
Score and loading plots are shown in figure 3A. As expected, the control group that were exposed 
to conventional diet throughout the experiment clustered along PC1 (challenge p<0.001, Figure 
3B), which explained 20% of the variation between the animals. PC1 was characterized by an 
increase in: adiposity and plasma leptin, hepatic de novo lipogenesis (indicated by mRNA levels of 
fasn and acaca), triacylglyceride accumulation in the liver and plasma insulin levels and a decrease 
in: TLR4 expression on the surface of blood monocytes, expression of the M2 macrophage marker 
cd163 in adipose tissue and hepatic ceramide accumulation. Again, the disparity between hepatic 
triacylglyceride content and hepatic ceramide content was observed along PC1, similar to the 
young offspring at weaning. However, as discussed in Chapter 5, this was very surprising, not only 
due to the elevation in hepatic triacylglyceride, but in particular due to a dramatic increase in 
hepatic free fatty acids in the HFHS born offspring (HCH and HHH) .When free fatty acids 
accumulate in the liver, due to limited capacity in the synthesis of complex lipids and the oxidation 
pathways, they are shuttled into alternative pathways, which creates lipotoxic intermediates like 
ceramide268. Based on the data reported in chapter 5, we are not capable of concluding if 
ceramide is actually produced to a larger extend in the HFHS born offspring, due to the elevated 
level of hepatic free fatty acids, but just rapidly secreted resulting in a ceramide accumulating 
similar to the C born offspring 244.  
Postnatal effects were also affecting the separation of PC1, so the phenotype in the HFHS lactated 
offspring diverged more from the CCC group than the control lactated offspring (postnatal p<0.05, 
Figure 3B). Similar to the overall phenotype observed in the young offspring at weaning, the HC 
and CH groups were furthest apart along the PC1 axis with the matched phenotypes (CCH and 
HHH) in between (Figure 3B). Plasma leptin levels might be one of the factors explaining this 
separation. The CHH groups had the highest leptin concentration after the dietary challenge and 
HCH had the lowest, so in Chapter 5 we suggested that offspring born by HFHS dams but lactated 
by control mothers seems to protect against hyperleptinemia during high fat feeding in adulthood, 
while the reversed mismatch increase the susceptibility, which is in accordance with earlier 
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finding39. We proposed that the leptin-gene promotor was the target for epigenetic changes due 
to maternal high fat/high sucrose intake during gestation and lactation, since maternal high fat 
feeding during pregnancy and lactation alters the epigenetic pattern on the leptin promoter56. 
Thus, in utero exposure would induce a predictive adaptive response that attenuates 
hyperleptinemia in our scenario, when exposed to high energy-diets later in adulthood. However, 
this response seemed to be limited to a developmental window in utero, while exposure after 
birth did not cause this adaptation.  
PC2 explained 13% of the variation between animals and was characterized by an increase in 
expression of inflammatory markers in blood (indicated by mRNA levels of tnfa, il1b, tlr4 and Rela) 
concurrent with a decrease in TLR4 expression on the surface of blood monocytes. This opposite 
clustering of TLR4 on monocytes and expression of inflammatory genes indicates that the 
monocytes are activated by a TLR4 independent mechanism. This is in conflict with the 
endotoxemia hypothesis, which states that insulin resistance is associated with activation of 
monocytes by elevated circulating levels of lipopolysaccharide via TLR4 dependent mechanism 133. 
In this study, TLR4 expression cluster with insulin sensitivity along PC1 and opposite from the 
expression of inflammatory genes, indicating that insulin resistance might develop via a TLR4 
independent mechanism. Offspring exposed to a HFHS diet during lactation had a profile similar to 
the CCC group along PC2, but the profile of the control lactated offspring were skewed towards 
higher expression of inflammatory markers in the blood after the dietary challenge (postnatal 
p<0.01, figure 3B). This indicates that the HFHS lactated offspring might display as smaller 
tendency to develop obesity-induced inflammation despite increased adiposity, and therefore 
more capable of dealing with a high fat diet in adulthood without developing metabolic disease. 
Further research is needed to elucidate this matter. 
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Figure 3. Principal component analysis of metabolic and inflammatory markers in male offspring at 26 weeks of age 
after a metabolic load. Dams were fed a conventional of a HFHS diet for 6 weeks prior to mating. Male offspring were 
cross-fostered on complementary dams during lactation and weaned onto a conventional diet from 4-20 weeks of 
age. A. Scoring and loading plots for the PCA. The squares are the average phenotype of the group. B Extracted scores 
for principal component (PC) 1-2. Data were analysed by a permutated 2-way ANOVA for prenatal and postnatal 
effects and presented as mean±stdev. ** p<0.01 
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8. Conclusion and future perspectives 
 
In this thesis we have demonstrated that obesity induced inflammation is reversed during 
pregnancy in mice, and is therefore less likely to affect the fetal programming of metabolic 
dysfunction. However, macrophage infiltration has been found in the human placenta from obese 
mothers along with elevated levels of circulating. Further research is therefore needed, to first 
elucidate how obesity-induced inflammation is affected by pregnancy in humans, and secondly, 
investigate if pro-inflammatory cytokines can cross the placenta and direct affect the fetus, or 
alternatively alter the placental function and transfer of nutrients and hereby indirectly affect 
have a effect. If obesity-induced inflammation plays a role in metabolic imprinting in the offspring, 
then anti-inflammatory treatment during pregnancy might improve the metabolic outcome in the 
offspring. However, we suggest that the early elevated lipid exposure caused by maternal high fat 
feeding might be more important for long term metabolic effect in the offspring. Thus, we have 
demonstrated that a dietary mismatch between pre- and post-natal life alters the phenotype at 
weaning, so that exposure to a control diet in utero and a high fat/high sucrose diet during 
lactation cause more severe phenotypic alteration in the offspring at weaning than pups exposed 
to the high fat/high sucrose diet both in utero and during lactation. The same pattern was seen in 
the adult offspring after being challenged with a high fat diet for 6 weeks. However, HFHS 
exposure during fetal life protected against hyperleptinemia in the adult offspring during the 
challenge. Since the epigenetic regulation of the leptin-gene promoter is known to be altered by 
maternal high fat feeding, it could be interesting to investigate if this attenuation of the leptin 
response is linked to changes in the epigenome. HFHS lactated offspring displayed a decrease level 
of inflammatory genes in the blood after the dietary challenge, which could indicated that 
perinatal HFHS exposure protect against the detrimental effects of high fat feeding leading to 
metabolic disease, which is in accordance with the predictive adaptive response hypothesis. LPS 
injections in mothers induce tolerance in the offspring in a mouse model, so it could also be 
interested to investigate if maternal high fat feeding also can induce tolerance towards high fat 
intake in the offspring. However, a more thorough phenotyping of the immunity in blood and 
tissues from the offspring is needed to resolve this question.  
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